mitomycin has been researched along with Cancer of Stomach in 877 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "We performed combination chemotherapy adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in 11 patients with gastric cancer and 7 with colorectal cancer." | 9.09 | [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer]. ( Iesato, H; Kamoshita, N; Kato, Y; Morishita, Y; Nagaoka, H; Ohwada, S; Ohya, T; Okabe, T; Takeyoshi, I; Yokomori, T, 2000) |
| "Thirty-seven consecutive patients with advanced and/or metastatic gastric adenocarcinoma received a combination of 5-fluorouracil 600 mg/m2 on days 1, 8, 29, 36; epidoxorubicin 75 mg/m2 i." | 9.07 | Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. ( Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R, 1994) |
| "Activated carbon particles adsorbing mitomycin C (MMC-CH) was administered to four patients with peritoneal carcinomatosis of gastric cancer into their abdominal cavities." | 7.72 | [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. ( Chou, H; Fujita, Y; Hagiwara, A; Kawakami, S; Ohgaki, M; Shiomi, A; Takashina, K; Takenaka, A; Yamagishi, H, 2004) |
| "We investigated the mechanism of mitomycin C (MMC)-induced apoptosis in SNU-16 human gastric adenocarcinoma cells." | 7.70 | Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. ( Choe, TB; Hong, SI; Hwang, CS; Jang, JJ; Lee, SH; Park, IC; Park, MJ; Rhee, CH; Whang, DY, 2000) |
| "We examined red cell fragmentation syndrome (RCFS) induced by mitomycin C (MMC) (13 patients), by thrombotic thrombocytopenic purpura (TTP) (17 patients), and by disseminated intravascular coagulation (DIC) (15 patients)." | 7.69 | Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. ( Deguchi, K; Minami, N; Miyanishi, E; Nagaya, S; Oka, K; Tamaki, S; Tanigawa, M; Tsuzi, K; Wada, H; Wakita, Y, 1995) |
| "The purpose of this study was to assess the efficacy of verapamil (20 microM) and hyperthermia (42 degrees C) as modifiers of mitomycin C (MMC), used at different concentrations, in inhibiting the growth of human gastric adenocarcinoma (AGS) cells." | 7.69 | Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. ( Buras, RR; Evans, SR; Nauta, RJ; Shabahang, M; Shchepotin, IB, 1994) |
| "The intensity of lymphoid cell infiltration and distribution of lymphocyte subsets in tumors were investigated immunohistochemically on tumor tissues obtained from 11 patients with gastric carcinoma, who had been treated with mitomycin C (MMC), 12 mg/m2, i." | 7.68 | Immunohistochemical analysis of lymphocyte subsets infiltrating gastric carcinoma after mitomycin C administration. ( Adachi, M; Akiyoshi, T; Arinaga, S; Inoue, H; Karimine, N; Korenaga, D; Ueo, H, 1992) |
| "We retrospectively examined the long-term results of adjuvant chemotherapy with mitomycin-C (MMC) in 50 patients with gastric carcinoma invading the adjacent organs." | 7.68 | Adjuvant mitomycin-C prolongs survival time of patients undergoing extensive en bloc resection of carcinoma of the stomach invading the adjacent organs. ( Baba, H; Haraguchi, M; Kakeji, Y; Korenaga, D; Maehara, Y; Orita, H; Sugimachi, K; Watanabe, A, 1990) |
| " We determined the increase in antineoplastic activities of mitomycin C (MMC) and carboquone (CQ) against human tumor cells under conditions of in vitro hypoxia, with the following results." | 7.67 | Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro. ( Kusumoto, T; Maehara, Y; Sakaguchi, Y; Saku, M; Sugimachi, K, 1989) |
| "Thirty-four patients with gastric cancer, 16 after failure of first-line chemotherapy and 18 after failure of at least two prior chemotherapies, were included." | 6.73 | Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study. ( Al-Batran, SE; Bokemeyer, C; Hartmann, JT; Horger, M; Jäger, E; Kanz, L; Königsrainer, A; Meisinger, I; Nehls, O; Pintoffl, JP; Quietzsch, D, 2007) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 6.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "Although hepatic metastases were detected, total gastrectomy was initially performed for hemorrhage control." | 5.40 | [A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy]. ( Abe, H; Ishibashi, H; Ishigaki, K; Itobayashi, E; Iwai, Y; Katagiri, T; Komata, S; Kubota, M; Matsushima, T; Miyakawa, A; Nakamura, A; Sakaguchi, Y; Shimura, H; Shimura, K; Suzuki, Y; Takashina, A; Tamura, T, 2014) |
| "A 71-year-old man with Borrmann type 3 gastric cancer and peritonitis carcinomatosa was treated with 5'-DFUR 600 mg/body p." | 5.30 | [Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa]. ( Ando, S; Katanuma, A; Maekubo, H; Mori, M; Tsuji, K, 1997) |
| "For these studies, MKN-74 gastric cancer cells and MDA-MB-468 breast cancer cells were exposed to either no drug, 1 microgram/ml MMC alone, 300 nM flavopiridol alone, or a combination of chemotherapy with flavopiridol for 24 h." | 5.30 | Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. ( Farsi, K; Kelsen, DP; Maslak, P; Schwartz, GK; Spriggs, D, 1997) |
| " Twenty-one patients with PC (12 gastric cancer, 5 colorectal cancer, 2 ovarian cancer, 1 pseudomyxoma peritonei, 1 malignant mesothelioma) were treated with CRS + HIPEC with hydroxycamptothecin 20 mg and mitomycin C 30 mg in 12,000 mL of normal saline at 43 +/- ." | 5.14 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. ( al-shammaa Hassan, AH; Li, Y; Liu, SY; Lu, YL; Yang, GL; Yang, XJ; Yonemura, Y; Zhang, JW, 2009) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "The aim of this study was to evaluate the activity and toxicity of a combination regimen of CPT-11 and mitomycin-c as second-line chemotherapy for pretreated patients with advanced, metastatic, or both, gastric adenocarcinoma." | 5.11 | Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). ( Battaglia, C; Colucci, G; Di Bisceglie, M; Gebbia, N; Gebbia, V; Giuliani, F; Maiello, E; Molica, S; Vinciarelli, G, 2005) |
| "The aim of this phase II study was to investigate the tolerance and efficacy of a second-line irinotecan/mitomycin C combination in patients with advanced gastric or colorectal cancer, pretreated with 5-fluorouracil." | 5.10 | Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer. ( Bamias, A; Papamichael, D; Pavlidis, N; Syrigos, K, 2003) |
| "We performed combination chemotherapy adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in 11 patients with gastric cancer and 7 with colorectal cancer." | 5.09 | [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer]. ( Iesato, H; Kamoshita, N; Kato, Y; Morishita, Y; Nagaoka, H; Ohwada, S; Ohya, T; Okabe, T; Takeyoshi, I; Yokomori, T, 2000) |
| "Adjuvant intraperitoneal therapy of gastric cancer by mitomycin bound to activated carbon particles is associated with an increased rate of postoperative complications." | 5.08 | Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. ( Czeijka, M; Holzberger, P; Jatzko, G; Lisborg, P; Neudorfer, H; Potrc, S; Rabl, H; Repse, S; Rosen, HR; Sandbichler, P; Zacherl, J, 1998) |
| "Thirty-seven consecutive patients with advanced and/or metastatic gastric adenocarcinoma received a combination of 5-fluorouracil 600 mg/m2 on days 1, 8, 29, 36; epidoxorubicin 75 mg/m2 i." | 5.07 | Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. ( Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R, 1994) |
| "The combination of cisplatin, epirubicin, and leucovorin preceding fluorouracil (PELF) includes three novel agents compared with the standard combination of fluorouracil, doxorubicin, and mitomycin (FAM) in the treatment of advanced gastric carcinoma." | 5.07 | Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research. ( Algeri, R; Bella, M; Cocconi, G; De Lisi, V; Di Costanzo, F; Luppi, G; Mazzocchi, B; Rodinò, C; Soldani, M; Zironi, S, 1994) |
| "Two hundred forty-one patients with unresectable gastric adenocarcinoma were entered, between December 1978 and March 1981, into a prospectively randomized comparison of three chemotherapy regimens to identify therapeutic activity and determine patient tolerability: (1) 5-fluorouracil plus Adriamycin (FA); (2) FA plus methyl-CCNU (FAMe); and (3) FA plus mitomycin C (FAMi)." | 5.05 | Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group. ( , 1984) |
| "The FAM combination with the simultaneous administration of 5-fluorouracil, doxorubicin, and mitomycin C is considered standard chemotherapy for gastric adenocarcinoma." | 5.05 | Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study. ( Athens, J; Chen, TT; Costanzi, JJ; Haas, C; Heilbrun, LK; McDonald, B; Oishi, N; Panettiere, FJ; Talley, RW, 1984) |
| "In a prospectively randomized trial, patients with advanced locally recurrent or metastatic gastric adenocarcinoma were randomized to receive 5-fluorouracil (5-FU) and methyl-CCNU; 5-FU, Adriamycin (Adria Laboratories, Columbus, Ohio), and methyl-CCNU; 5-FU, Adriamycin, and mitomycin C; or Adriamycin and mitomycin C alone." | 5.05 | An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). ( Douglass, HO; Goudsmit, A; Klaassen, DJ; Lavin, PT; Paul, AR, 1984) |
| " More than 50% of centers administer oxaliplatin (74%), or mitomycin-C (65%) in colorectal cancer; cisplatin in gastric cancer (73%) and mesothelioma (74%)." | 3.88 | Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey. ( Barrios, P; Cascales-Campos, P; Esteve-Pérez, N; Morales-Soriano, R; Segura-Sampedro, JJ, 2018) |
| "Mitomycin has also demonstrated efficacy when given in combination with doxorubicin and in the three-drug regimen FAM (5-fluorouracil/doxorubicin/mitomycin)." | 3.77 | Mitomycin therapy in gastric cancer. ( Macdonald, JS; Schnall, S, 1993) |
| "Prior to 1974 gastric cancer was considered refractory to chemotherapy." | 3.75 | The role of anthracyclines in the treatment of gastric cancer. ( Green, M; Muggia, F; Wadler, S, 1985) |
| "For patients with locally advanced gastric cancer, combined-modality therapy has resulted in long-term survival for approximately 15% of cases." | 3.75 | The role of chemotherapy in the management of gastric and pancreatic carcinomas. ( Schein, PS, 1985) |
| "Activated carbon particles adsorbing mitomycin C (MMC-CH) was administered to four patients with peritoneal carcinomatosis of gastric cancer into their abdominal cavities." | 3.72 | [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. ( Chou, H; Fujita, Y; Hagiwara, A; Kawakami, S; Ohgaki, M; Shiomi, A; Takashina, K; Takenaka, A; Yamagishi, H, 2004) |
| "We investigated the mechanism of mitomycin C (MMC)-induced apoptosis in SNU-16 human gastric adenocarcinoma cells." | 3.70 | Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. ( Choe, TB; Hong, SI; Hwang, CS; Jang, JJ; Lee, SH; Park, IC; Park, MJ; Rhee, CH; Whang, DY, 2000) |
| "We examined red cell fragmentation syndrome (RCFS) induced by mitomycin C (MMC) (13 patients), by thrombotic thrombocytopenic purpura (TTP) (17 patients), and by disseminated intravascular coagulation (DIC) (15 patients)." | 3.69 | Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. ( Deguchi, K; Minami, N; Miyanishi, E; Nagaya, S; Oka, K; Tamaki, S; Tanigawa, M; Tsuzi, K; Wada, H; Wakita, Y, 1995) |
| "The purpose of this study was to assess the efficacy of verapamil (20 microM) and hyperthermia (42 degrees C) as modifiers of mitomycin C (MMC), used at different concentrations, in inhibiting the growth of human gastric adenocarcinoma (AGS) cells." | 3.69 | Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. ( Buras, RR; Evans, SR; Nauta, RJ; Shabahang, M; Shchepotin, IB, 1994) |
| "In 62 human gastric carcinomas, the expression of GST pi was immunohistochemically evaluated, and sensitivity to the anticancer drugs, cisplatin (CDDP), doxorubicin (DXR) aclacinomycin A (aclarubicin), (ACR), 5-fluorouracil (5-FU), mitomycin C (MMC) and carboquone (carbazilquinon) (CQ) was examined using the in vitro succinate dehydrogenase inhibition test." | 3.69 | Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. ( Adachi, Y; Baba, H; Endo, K; Kuwano, M; Maehara, Y; Okuyama, T; Sugimachi, K, 1994) |
| " In order to evaluate the HDRA with the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide end point for clinical use, chemosensitivity to mitomycin C, doxorubicin, 5-fluorouracil, and cisplatin of 107 advanced gastric and 109 advanced colorectal cancers was determined in vitro in a correlative clinical trial." | 3.69 | Clinical applications of the histoculture drug response assay. ( Furukawa, T; Hoffman, RM; Kubota, T, 1995) |
| "The intensity of lymphoid cell infiltration and distribution of lymphocyte subsets in tumors were investigated immunohistochemically on tumor tissues obtained from 11 patients with gastric carcinoma, who had been treated with mitomycin C (MMC), 12 mg/m2, i." | 3.68 | Immunohistochemical analysis of lymphocyte subsets infiltrating gastric carcinoma after mitomycin C administration. ( Adachi, M; Akiyoshi, T; Arinaga, S; Inoue, H; Karimine, N; Korenaga, D; Ueo, H, 1992) |
| "A 63-year-old male had undergone combination chemotherapy including adriamycin, cisplatin, mitomycin C, 5-fluorouracil and vindesine for six months for double cancer of esophagus and stomach." | 3.68 | [Chemotherapy-associated hemolytic uremic syndrome--a case report]. ( Kanamaru, R; Kikuchi, H, 1992) |
| "We retrospectively examined the long-term results of adjuvant chemotherapy with mitomycin-C (MMC) in 50 patients with gastric carcinoma invading the adjacent organs." | 3.68 | Adjuvant mitomycin-C prolongs survival time of patients undergoing extensive en bloc resection of carcinoma of the stomach invading the adjacent organs. ( Baba, H; Haraguchi, M; Kakeji, Y; Korenaga, D; Maehara, Y; Orita, H; Sugimachi, K; Watanabe, A, 1990) |
| "Eighty-nine patients with advanced gastric carcinoma were treated with a combination chemo-immunotherapy regimen that consisted of active immunotherapy with Vibrio cholerae neuraminidase (VCN) treated autologous tumor cells admixed with BCG and drugs including cyclophosphamide, mitomycin C (MMC) and 5-fluorouracil, followed by long term tegafur (FT) and immunomodulators." | 3.67 | Combination chemoimmunotherapy for advanced gastric carcinoma. ( Akiyoshi, T; Arinaga, S; Kawaguchi, M; Koba, F; Miyazaki, S; Tsuji, H; Wada, T, 1984) |
| "Twenty-two previously untreated patients with advanced gastric adenocarcinoma were treated with a modification of the original 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (FAM) combination chemotherapy." | 3.67 | Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM). ( Cohen, Y; Epelbaum, R; Haim, N; Robinson, E, 1984) |
| "A 68-year-old man was treated with FAM (5-fluorouracil, doxorubicin [Adriamycin], mitomycin-C) for metastic gastric adenocarcinoma." | 3.67 | Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. ( Kerwin, DM; Smith, FP; Tsou, E; Waldhorn, RE, 1984) |
| " We determined the increase in antineoplastic activities of mitomycin C (MMC) and carboquone (CQ) against human tumor cells under conditions of in vitro hypoxia, with the following results." | 3.67 | Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro. ( Kusumoto, T; Maehara, Y; Sakaguchi, Y; Saku, M; Sugimachi, K, 1989) |
| " Following our former report in which the combination effects of mitomycin C (MMC) and 5'-deoxy-5-fluorouridine (5'-DFUR) were clarified, combined applications of 4 drugs, vindesine (VDS), methotrexate (MTX), cisplatin (CDDP) and 5'-DFUR against 3 lines of human breast cancer (H-62, H-31, H-71), and one line each of gastric cancer (H-55) and colon cancer (H-110) xenografted into nude mice were evaluated in comparison with CAF (cyclophosphamide, adriamycin and 5-FU) therapy which is commonly used for breast cancer." | 3.67 | [Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)]. ( Fujita, F; Fujita, M; Inaba, H; Sakamoto, Y; Shimozuma, K; Taguchi, T, 1987) |
| "A 55-year-old female, in which an unresectable Borrmann II-type gastric cancer (moderately differentiated adenocarcinoma) extending from vicinity of the cardia to the lower portion of the corpus, with direct invasion into the pancreas and extensive lymph node metastases, confirmed by laparotomy, was treated postoperatively by 3 courses of chemotherapy with cisplatinum in combination with mitomycin C and 5-fluorouracil." | 3.67 | Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5-fluorouracil. ( Azuma, S; Furuta, T; Kawata, R; Ohashi, H; Saji, S; Sakata, K; Shimokawa, K; Suzuki, M; Tanemura, H, 1988) |
| "Following gastrectomy for locally advanced adenocarcinomas, three patients developed microangiopathic hemolytic anemia and renal failure shortly after completing courses of adjuvant chemotherapy with mitomycin and 5-FU." | 3.66 | Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. ( Band, PR; Bettez, P; Giroux, L; Gruber, J; Jolivet, J; Laurin, S, 1983) |
| "A total of 268 patients with stage II gastric cancer underwent D2 resection in our Cancer Center between January 1990 and December 2006 were recruited." | 2.76 | No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer. ( Chen, S; Chen, YB; Feng, XY; Guan, YX; Li, W; Li, YF; Sun, XW; Xu, DZ; Zhan, YQ; Zhou, ZW, 2011) |
| "Postoperative complications were anastomotic leakage (2." | 2.75 | Effect of preoperative intraperitoneal injection of Sapylin in advanced gastric cancer. ( Du, P; Huang, YN; Liu, Y; Xu, YY; Yang, SJ; Yang, Y, 2010) |
| "Although fatigue was the most frequently encountered toxicity safety profiles were generally predictable and manageable." | 2.73 | Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. ( Cho, EK; Chung, M; Hong, J; Kim, YS; Lee, JH; Lee, WK; Nam, E; Park, J; Park, SH; Shin, DB, 2008) |
| "To evaluate the enhancing effects of ginsenoside Rg3 combined with mitomycin C and tegafur (MF) on postoperative chemotherapy in advanced gastric cancer." | 2.73 | [Effect of adjuvant chemotherapy of ginsenoside Rg3 combined with mitomycin C and tegafur in advanced gastric cancer]. ( Chen, ZJ; Cheng, J; Han, SL; Huang, YP; Liu, NX; Yao, JG; Zhu, GB, 2007) |
| "Thirty-four patients with gastric cancer, 16 after failure of first-line chemotherapy and 18 after failure of at least two prior chemotherapies, were included." | 2.73 | Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study. ( Al-Batran, SE; Bokemeyer, C; Hartmann, JT; Horger, M; Jäger, E; Kanz, L; Königsrainer, A; Meisinger, I; Nehls, O; Pintoffl, JP; Quietzsch, D, 2007) |
| "D2 gastrectomy has improved survival in gastric cancer." | 2.72 | Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer. ( Dimitriou, T; Fiska, A; Karanikiotis, C; Manolopoulos, VG; Markakidis, SK; Tentes, AA; Tentes, IK, 2006) |
| "169 patients with radically resected gastric cancer were randomized to receive CPT-11 (180 mg/m2 day 1), leucovorin (100 mg/m2 days 1-2), FU (400-600 mg/m2 days 1-2, q 14; for four cycles; FOLFIRI regimen), followed by docetaxel (85 mg/m2 day 1), cisplatin (75 mg/m2 day 1, q 21; for three cycles; arm A), or MMC (8 mg/m2 days 1-2 as 2-hour infusion, q 42; for four cycles; arm B)." | 2.72 | Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial. ( Agostana, B; Aitini, E; Ardizzoia, A; Ardizzoni, A; Bajetta, E; Bochicchio, AM; Bordonaro, R; Botta, M; Buzzoni, R; Cicero, G; Comella, G; Di Bartolomeo, M; Duro, M; Fagnani, D; Ferrario, E; Gevorgyan, A; Katia, D; Kildani, B; Mantovani, G; Mariani, L; Marini, G; Massidda, B; Mozzana, R; Oliani, C; Palazzo, S; Pinotti, G; Reguzzoni, G; Schieppati, G; Villa, E; Zilembo, N, 2006) |
| "A total of 280 patients with advanced gastric cancer were randomly allocated and analyzed for survival, response, and toxicity." | 2.71 | Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). ( Boku, N; Fukuda, H; Hyodo, I; Ikeda, N; Miyata, Y; Ohtsu, A; Saito, H; Shimada, Y; Shirao, K; Yamamichi, N; Yamamoto, S; Yoshida, S, 2003) |
| "Only 1-year metastasis in the WCA group was 15." | 2.71 | [Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an]. ( Shen, KP; Yang, JK; Zhen, J, 2003) |
| "Mitomycin C (MMC) in combination with infusional 5-fluorouracil (FU) plus folinic acid (FA) is an effective treatment for metastatic gastrointestinal cancer." | 2.71 | Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer. ( Gnad, U; Hartmann, JT; Hehlmann, R; Hochhaus, A; Hofheinz, RD; Kreil, S; Saussele, S; Weisser, A; Willer, A, 2004) |
| "Despite curative resection, 50%-90% of gastric cancer patients die of disease relapse." | 2.71 | Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. ( Czupryna, A; Kulig, J; Popiela, T; Szczepanik, AM; Zembala, M, 2004) |
| "Mitomycin C (MMC) in combination with infusional 5-fluorouracil (5-FU) is a well-tolerated active combination therapy for advanced gastric cancer." | 2.71 | Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial. ( Gnad-Vogt, SU; Hehlmann, R; Hochhaus, A; Hofheinz, RD; Kreil, S; Pilz, L; Saussele, S; Willeke, F; Willer, A, 2005) |
| "Forty-two gastric cancer patients at T(3)II-T(4)III( B) stages and 96 patients with colorectal cancer at B to D stages admitted from January 1996 to October 1998 were randomly divided into control group (group I, 65 cases) receiving intraperitoneal thermochemotherapy, and group II (73 cases) receiving both intraperitoneal thermochemotherapy and intraperitoneal IL-2 immunotherapy." | 2.70 | Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. ( Fu, QG; Guo, RX; Meng, FD; Shen, XD, 2002) |
| "A total 124 patients with advanced gastric cancer were enrolled in this study." | 2.70 | [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer]. ( Akiyama, H; Kunisaki, C; Matsuda, G; Nomura, M; Ono, H; Otsuka, Y; Shimada, H, 2002) |
| "To observe the effects of chemotherapy combined with Chinese herbal medicine (Spleen-Kidney tonifying) in treating advanced tumor patients and on immune parameters." | 2.70 | [Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters]. ( Gong, LY; Jiang, CM; Pang, MR, 2001) |
| " In the present study, local injection of mitomycin C bound to activated carbon (M-CH) combined with i." | 2.70 | Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. ( Fan, Y; Hagiwara, A; Huang, Y; Ma, D; Qi, X; Su, G; Wang, W, 2002) |
| "Two hundred forty-eight gastric cancer patients thought to have resectable cancer were randomized intraoperatively to receive EPIC with mitomycin C on postoperative day 1 and 5-fluorouracil on postoperative days 2 to 5 versus surgery only." | 2.69 | Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. ( Averbach, A; Chang, D; Sugarbaker, PH; Whang, I; Yu, W, 1998) |
| "Thirty-two patients with advanced gastric cancer underwent continuous hyperthermic peritoneal perfusion (CHPP) combined with surgery: to prevent peritoneal recurrence in 15 patients without peritoneal metastasis (prophylactic CHPP) and to treat 17 patients with peritoneal metastases (therapeutic CHPP)." | 2.69 | Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. ( Hirose, K; Iida, A; Katayama, K; Kusaka, Y; Nakagawara, G; Umeda, S; Yamaguchi, A, 1999) |
| "Combination chemotherapy with multiple drugs (FLMP therapy), in which the drugs were determined based on biochemical modulation and the dosing schedule was established in accordance with the circadian rhythms of the human body, was performed in cases of advanced recurrent gastric cancer." | 2.69 | [Effect of combination chemotherapy with multiple drugs (FLMP therapy) based on the circadian rhythms of the human body in advanced recurrent gastric cancer]. ( Iesato, H; Kamoshita, N; Kato, Y; Nagaoka, H; Okabe, T; Yokomori, T, 1999) |
| "This study was performed to investigate the activity and safety of high dose 5-fluorouracil (5-FU) given as a weekly 24-hour infusion in combination with folinic acid plus mitomycin C in patients with advanced gastric cancer." | 2.69 | Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer. ( Benter, T; Dörken, B; Hohenberger, P; Köhne, CH; Kretzschmar, A; Reichardt, P; Thuss-Patience, PC, 2000) |
| "To assess the clinical effect and safety of Shenqi Fuzheng Injection (SQFZI) combined with chemotherapy in treating malignant tumor of digestive tract." | 2.69 | [Clinical study on Shenqi Fuzheng injection combined with chemotherapy in treating malignant tumor of digestive tract]. ( Wang, J; Xin, M; Zhou, C, 1998) |
| "To assess the effect and mechanism of composite Xiansu Capsule (CXSC) combined with chemotherapy in treating gastric carcinoma of mid-late stage." | 2.69 | [Clinical study on treatment of mid-late stage gastric carcinoma by composite xiansu capsule combined with chemotherapy]. ( Hua, B; Wang, A, 1999) |
| "To assess the clinical effect of Shenqi Fuzheng Injection (SQFZI) combined with chemotherapy in treating gastric cancer." | 2.69 | [Clinical study on effect of shenqi fuzheng injection combined with chemotherapy in treating gastric cancer]. ( Liu, B; Wang, J; Zhou, K, 1999) |
| "To evaluate the efficacy of intra-arterial chemotherapy combined with hyperthermia for metastatic liver cancer, our cooperative study group carried out a randomized clinical trial comparing intra-arterial chemotherapy alone and intra-arterial chemotherapy combined with hyperthermia." | 2.68 | [A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer]. ( Hiraoka, M; Itani, K; Kondo, M; Miura, K; Noguchi, M; Tanaka, Y; Watanabe, N; Yoshikawa, T, 1995) |
| "40813) on adjuvant chemotherapy in gastric cancer, results obtained after administration of the FAM2 regimen (fluorouracil [5-FU], doxorubicin, and mitomycin) were compared with results obtained after surgery alone to assess the effect of this regimen on overall survival, time to progression, and disease-free interval." | 2.68 | Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. ( Buyse, M; Dos Santos, JG; Duez, N; Fiorentino, M; Labianca, R; Lise, M; Marchet, A; Nitti, D; Rougier, P; Sahmoud, T, 1995) |
| "Fourteen advanced gastric cancer patients allocated to RT and Control group randomly and received each amino acid as protein source for 7 days TPN with 5-FU administration." | 2.68 | [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C]. ( Endo, M; Goseki, N; Kando, F; Maruyama, M; Nagai, K; Shimoju, K; Wada, Y, 1995) |
| " These results show that AO-90 in combination with MF therapy is efficacious in the treatment of patients with gastric cancer." | 2.68 | [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)]. ( Akazawa, S; Kitamura, S; Kosaki, G; Kurihara, M; Nakano, S; Ohtani, T; Sasaki, T; Takahashi, H; Tokunaga, K, 1995) |
| "The prognosis in gastric cancer has been almost unchanged for the last 20 years." | 2.68 | Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens. ( Angelsen, V; Norum, J, 1995) |
| "To evaluate the efficacy of adjuvant immunochemotherapy, especially the long-term administration of HCFU to patients with noncuratively resected and unresected gastric cancer, a randomized controlled study was conducted by 16 institutions in Hokkaido." | 2.68 | [Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer]. ( Fujisawa, J; Kondo, Y; Miyakawa, K; Nakanishi, Y; Nishimura, A; Oku, T; Osawa, S; Shiroto, H; Uchino, J, 1996) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 2.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "We studied how gastric cancer tissues and cells changed as a result of preoperative chemotherapy." | 2.68 | [Influence of preoperative on gastric cancer tissues and cells]. ( Chen, Z; Li, G; Liu, F, 1997) |
| "61 cases of the gastric cancers have been treated with Replenishing Qi and Invigorating Spleen (RQIS) combined with chemotherapy." | 2.67 | [Clinical and experimental study in treating gastric cancer with replenishing qi and invigorating spleen oral liquid combined with chemotherapy]. ( Chen, CH; Sun, GZ; Wang, GM, 1994) |
| "19 advanced gastric cancer (AGC) patients were divided into the following groups: group A (n = 7): in addition to their oral intake, received a PNS for 5 days, which yielded 117 Kj." | 2.67 | [Effects of preoperative parenteral nutritional support with chemotherapy on tumor cell kinetics in gastric cancer patients]. ( Cao, WX; Xiao, HB; Yin, HR, 1994) |
| "Mitomycin C was injected via the indwelling catheter placed in the proper hepatic artery, when the mean systolic blood pressure rose to 50 percent above the level in the untreated state by intravenous administration of noradrenaline." | 2.67 | [Effects and problems of intraarterial noradrenaline-induced hypertensive chemotherapy for liver metastasis of gastric cancer]. ( Arai, K; Iwasaki, Y; Kitamura, M, 1994) |
| "Ninety-five patients with gastric cancer underwent gastrectomy with D1 or D2 lymph node dissection." | 2.67 | [Survival of patients with gastric cancer treated with intra-lymph nodal injection of activated carbon particles absorbed mitomycin C]. ( Fujioka, T; Hagiwara, A; Minato, H; Ohara, M; Sakakibara, T; Sawai, K; Takahashi, T; Yada, Y; Yamaguchi, M; Yamaguchi, T, 1994) |
| "A new drug dosage form comprising activated carbon particles absorbing mitomycin C (MMC-CH) has the advantage of being retained in the peritoneal cavity and distributes a larger amount of mitomycin C for a long time." | 2.67 | [The prevention of peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles absorbing mitomycin C]. ( Chohei, S; Hagiwara, A; Imanishi, T; Ohgaki, M; Ohyama, T; Ozaki, K; Shimotsuma, M; Takahashi, T; Tsujimoto, H, 1994) |
| "Twenty-one stomach cancer patients and 34 colorectal cancer patients were registered in the study." | 2.67 | [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)]. ( Hachisuka, K; Honda, H; Honda, K; Maeda, A; Nakazato, H; Tsuruga, N; Yamaguchi, A; Yoshizaki, S; Yura, J, 1994) |
| "Results of 6589 gastric cancer operations at the Department of Surgery, Seoul National University Hospital, from 1970 to 1990 were reported." | 2.67 | Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. ( Kim, JP; Kwon, OJ; Oh, ST; Yang, HK, 1992) |
| "For 15 patients with refractory gastric cancer and peritoneal metastasis, intraperitoneal hyperthermic perfusion (IPHP) using mitomycin C combined with extensive surgery was prescribed." | 2.67 | Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. ( Fujimoto, S; Kobayashi, K; Kure, M; Mutoh, T; Nagano, K; Ohkubo, H; Takahashi, M, 1992) |
| " No severe side effects appeared in either of the groups, and a long-term administration was safe." | 2.67 | [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy]. ( Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Taira, A; Yamamoto, H; Yamanouchi, A, 1991) |
| "Treatment of gastric cancer still presents a challenge in cancer chemotherapy." | 2.67 | Evaluation of two consecutive regimens in advanced gastric cancer. ( Crivellari, D; Figoli, F; Frustaci, S; Galligioni, E; Lo Re, G; Monfardini, S; Saracchini, S; Sorio, R; Talamini, R; Tumolo, S, 1991) |
| "A total of 848 patients with gastric cancer underwent curative resection were eligible." | 2.67 | [Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supp ( Ichihashi, H; Imaizumi, M; Kamei, H; Kondo, T, 1990) |
| "140 patients with advanced gastric cancer confirmed by pathology were treated by UFT (Uracil, FT-207) and mitomycin C (MMC) from Sept." | 2.66 | [Combined UFTM for 140 patients with advanced gastric cancer]. ( Jin, ML, 1989) |
| "Until now advanced gastric cancer has been generally treated with the FAM chemotherapy protocol." | 2.66 | An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer. ( Bleiberg, H; Buyse, M; Duez, N; Klein, HO; Wils, J, 1989) |
| "After curative surgery for gastric cancers judged macroscopically to be at stage 2 or 3, patients were divided into 4 groups by randomization." | 2.66 | [Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy]. ( Awane, Y; Ishibiki, H; Kamei, H; Nakajima, T; Nomoto, K; Sekiguchi, M; Tamada, R; Toge, T; Tsuru, S, 1986) |
| "The cumulative survival rate of 166 gastric cancer patients after noncurative resection and nonresection treated by combination therapy using carmofur (HCFU), mitomycin C (MMC) and immunopotentiators was investigated." | 2.66 | [A randomized controlled trial of immunochemotherapy using carmofur (HCFU), mitomycin C and immunopotentiators in advanced gastric cancer following noncurative resection and nonresection]. ( Nakanishi, Y, 1986) |
| " The first and the second study revealed that postoperative bolus injection of MMC and long-term administration of Tegafur improved the survival rate of patients with stage III and lymphatic with serosal metastasis." | 2.66 | [Surgery and adjuvant therapy of gastric cancer]. ( Tamada, R, 1986) |
| "Fifty of 80 cases had advanced gastric cancer, 30 had pancreatic cancer or other cancers, such as colon cancer, and biliary tract cancer." | 2.66 | [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy]. ( Baba, T; Furukohori, N; Itoh, T; Kawata, K; Kimura, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y, 1988) |
| "An analysis of 3,630 gastric cancer cases from 412 institutions who were treated with 6 randomly-assigned protocols was carried out to study the effect of daily PSK and Futraful administration and the adjuvant effect of PSK and/or Picibanil (OK 5 KE) combined with MMC and FT." | 2.66 | [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer]. ( Abe, O; Hattori, T; Inokuchi, K; Inoue, K; Kikuchi, K; Kondo, T; Nakajima, T; Ogawa, N; Taguchi, T; Tanabe, T, 1985) |
| "Transperitoneal and lymph node metastases were the major causes of treatment failure." | 2.66 | Gastric cancer: overview of current therapies. ( Douglass, HO, 1985) |
| "positive cases in gastric cancer (4/40)." | 2.65 | [Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach]. ( Kitaoka, H, 1983) |
| "Kondo) in Japan." | 2.65 | [Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer]. ( Ichihashi, H; Imaizumi, M; Kamei, H; Kondo, T, 1984) |
| "This finding was clinically applied to cancer chemotherapy for enhancing drug delivery to tumor tissue selectively." | 2.65 | [Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels]. ( Sato, H; Wakui, A, 1984) |
| " Then, it was followed by long-term administration of tegafur (FT) and immunomodulators." | 2.65 | A trial of adjuvant combination chemoimmunotherapy for stage III carcinoma of stomach. ( Akiyoshi, T; Arinaga, S; Kawaguchi, M; Koba, F; Miyazaki, S; Tsuji, H; Wada, T, 1984) |
| " In patients who underwent of curative resection, the long-term administration of Ftorafur alone tended to prevent recurrence postoperatively, especially within the first two postoperative years." | 2.65 | [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)]. ( Abe, O; Akiyama, H; Hattori, T; Inokuchi, K; Inoue, K; Kikuchi, K; Kondo, T; Muto, T; Nakajima, T; Taguchi, T, 1984) |
| "Levamisole group was treated with Mitomycin C (day 0, 20 mg, day 1, 10 mg, one shot i." | 2.65 | [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1]. ( Abe, O; Fujimoto, S; Furue, H; Furusawa, M; Hashimoto, I; Hattori, T; Inokuchi, K; Itoh, I; Koga, S; Kondo, T; Niimoto, M; Ogawa, N; Ohya, M; Orita, K; Sugiyama, Y; Tamada, R; Toda, T, 1982) |
| "The levamisole group was treated with Mitomycin C, 5-FU and levamisole." | 2.65 | [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1]. ( Furue, H; Furusawa, M; Hattori, T; Hioki, K; Hirano, M; Inokuchi, K; Itoh, I; Iwanaga, T; Izuo, M; Kondo, T; Kosaki, G; Miura, K; Niimoto, M; Ogawa, N; Orita, K; Taguchi, T; Takemiya, S; Tamada, R; Tomita, M; Tsuji, H; Yura, J, 1982) |
| " Furthermore, the survival was elevated in proportion to the increase of total dosage of futraful." | 2.65 | [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)]. ( Abe, O; Akiyama, H; Hattori, T; Hayasaka, A; Inokuchi, K; Inoue, K; Ito, I; Kasai, Y; Kikuchi, K; Kondo, T; Muto, T; Nakajima, T; Sugie, S; Taguchi, T, 1982) |
| "The effect of fibrinolytic agents, Tissue Culture Urokinase (TCUK) and Urinary Urokinase (UUK), was investigated in a total of 146 patients with gastric cancer, pulmonary cancer or breast cancer who received various anti-cancer agents, mainly MMC, in combination with the fibrinolytic agents." | 2.65 | [Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)]. ( Yamamoto, M, 1982) |
| "In a prospective randomized study, 53 patients with advanced gastric cancer previously untreated by chemotherapy were randomly assigned to treatment with 5-FU alone or combined with mitomycin and cytarabine (MFC)." | 2.65 | Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. ( Cocconi, G; DeLisi, V; Di Blasio, B, 1982) |
| "Adjuvant chemotherapy for gastric cancer after potentially curative surgery has been under clinical investigation for more than four decades." | 2.43 | Postoperative chemotherapy for gastric cancer. ( Hejna, M; Raderer, M; Schmidinger, M; Wöhrer, S, 2006) |
| "Because patients with advanced gastric cancers have less than 50% chance of cure after R0 resection, the need for an adjuvant treatment to eradicate residual microscopic disease is clear." | 2.43 | A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. ( Yu, W, 2006) |
| "Adjuvant chemotherapy for gastric cancer has been extensively explored in Japan since the 1950s, and a combination of oral fluorinated pyrimidines (o-FP) and mitomycin C (MMC) has been mainly utilized for adjuvant chemotherapy." | 2.43 | Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan. ( Kobayashi, M; Kodera, Y; Morita, S; Oba, K; Sakamoto, J; Tsuburaya, A, 2006) |
| " For advanced gastric cancer, although gastric cancer cells are generally not very sensitive to most of the currently available chemotherapeutic agents, it has been reported that biochemical modulation with treatments including low-dose cisplatin + 5-FU (fluorouracil) have high response rates and exert an immunomodulatory effect especially when used in combination with BRMs." | 2.41 | Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience. ( Andou, K; Fujisaki, S; Fukuzawa, M; Nezu, T; Shibata, M; Tomita, R, 2002) |
| "Because of the low chemosensitivity of gastric cancer to conventionally available agents, several approaches were investigated to design "order made" treatments using chemosensitivity tests, including the histoculture drug response assay (HDRA) which was useful in evaluating the appropriate cancer chemotherapy for the patients with Stage III/IV gastric cancer." | 2.41 | [Recent advance in gastric cancer chemotherapy]. ( Kubota, T, 2000) |
| "A 42-year-old female with stage III gastric cancer underwent radical gastrectomy and was given mitomycin-C at 10 mg/m2 intravenously every four weeks as adjuvant therapy." | 2.40 | Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. ( Chen, LT; Chen, YM; Liu, JM; Liu, SM; Whang-Peng, J; Wu, DC; Yang, S, 1997) |
| "The recurrence rate of resected gastric cancer with curative intent was around 20%." | 2.40 | [Treatment of recurrent gastric cancer]. ( Sakata, Y; Tsushima, K, 1998) |
| "Chemotherapy for gastric cancer should be evaluated with survival advantages or rate of long-term survivors in future studies." | 2.39 | [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages]. ( Miyata, Y; Ohtsu, A; Shimada, Y; Yoshida, S, 1995) |
| "For Dukes' C colon cancer, postoperative adjuvant chemotherapy with a combination of fluorouracil and levamisole is now recommended as standard therapy." | 2.39 | Adjuvant postoperative therapy of gastrointestinal malignancies. ( Ilson, DH; Kelsen, DP, 1994) |
| "In giant fold type scirrhous gastric cancer, the extended operation is favorable." | 2.39 | [An extended operation for scirrhous gastric cancer--its significance and procedure]. ( Furukawa, H; Hiratsuka, M; Iwanaga, T; Kameyama, M; Nakamori, S; Nakano, H; Ohigashi, H; Sasaki, Y; Tamura, S; Yasuda, T, 1994) |
| " It is expected that the dose intensity may clear dose-response relationships which are sometimes obscure in cancer chemotherapy because dose reduction or treatment delay caused by adverse effects." | 2.38 | [Dose intensity in cancer chemotherapy in gastric cancer]. ( Ishibiki, K; Kumai, K, 1990) |
| "Thirty one patients with diagnosis of Gastric Cancer were admitted in this study." | 2.38 | [Combined chemotherapy with the FEM protocol in advanced gastric cancer]. ( Casanova, L; Celis, J; Montalbetti, J; Nuñez, J; Otero, J; Payet, C; Salazar, F; Sánchez, J; Solidoro, A; Vallejos, C, 1989) |
| "The sensitivity of various human tumors xenografted to nude mice has been tested to antitumor agents to establish the system which could select the clinically active drugs." | 2.37 | [Recent advanced studies on mitomycins, antitumor activity and mode of action]. ( Morimoto, M; Taguchi, T, 1987) |
| "For example, the role of cisplatin in gastric cancer has not been completely defined." | 2.37 | Chemotherapy of advanced gastric cancer: present status, future prospects. ( Gohmann, JJ; Macdonald, JS, 1988) |
| "Mitomycin-C (MMC) was used in 20% and oxaliplatin in 10%." | 1.56 | Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. ( Ashwin, KR; Kumar C, R; Rauthan, A; Somashekhar, SP; Yethadka, R; Zaveri, S, 2020) |
| " We evaluated an optimized anti-tumor protocol comprising 5-fluorouracil (5-FU) combined with cisplatin (CDDP) and mitomycin C (MMC) in vitro for clinical use of HIPEC." | 1.48 | 5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer. ( Kaida, S; Miyake, T; Murata, S; Naitoh, H; Shimizu, T; Takebayashi, K; Tani, M; Tani, T; Yamaguchi, T; Yamamoto, H, 2018) |
| " Four patients experienced grade 1 or 2 adverse events." | 1.46 | Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer. ( Kaida, S; Murata, S; Naitoh, H; Naka, S; Shimizu, T; Shiomi, H; Tani, M; Tani, T; Yamaguchi, T; Yamamoto, H, 2017) |
| " Herein, we fabricated a safe delivery system of iPS cells treated with MMC loading with gold nanorods (AuNRs) for the targeted photothermal treatment of gastric cancer." | 1.46 | Mitomycin C-treated human-induced pluripotent stem cells as a safe delivery system of gold nanorods for targeted photothermal therapy of gastric cancer. ( Cui, D; Hou, W; Jiang, X; Liu, Y; Ni, J; Pan, F; Yang, M; Yang, Y; Zhang, C; Zhi, X, 2017) |
| "For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment." | 1.43 | Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin. ( Ohi, H; Ozaki, T; Seki, H; Yabusaki, H, 2016) |
| "Signet ring cell gastric cancer (SRCGC) has very poor prognosis worldwide, and studying its molecular characteristics is urgent for improving the outcome." | 1.42 | Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. ( Cao, J; Feng, JG; Gu, LH; He, KF; Jin, KT; Li, GL; Qian, LJ; Su, XY; Teng, LS; Wang, HH; Xu, X; Xu, ZZ; Zhang, J; Zhou, Q, 2015) |
| "Although hepatic metastases were detected, total gastrectomy was initially performed for hemorrhage control." | 1.40 | [A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy]. ( Abe, H; Ishibashi, H; Ishigaki, K; Itobayashi, E; Iwai, Y; Katagiri, T; Komata, S; Kubota, M; Matsushima, T; Miyakawa, A; Nakamura, A; Sakaguchi, Y; Shimura, H; Shimura, K; Suzuki, Y; Takashina, A; Tamura, T, 2014) |
| "Mitomycin C (88." | 1.40 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. ( Hiotis, S; Jibara, G; Labow, DM; Romanoff, A; Sarpel, U; Shrager, B; Tabrizian, P; Yang, MJ, 2014) |
| "Chemosensitivity of the gastric cancer cells varied; the rates of inhibition of cells exposed to HCPT, CDDP and 5-FU were significantly higher than that of cells exposed to ADM and MMC (p < 0." | 1.39 | The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. ( Cao, R; Chen, X; Geng, M; Li, P; Wang, L, 2013) |
| "The vincristine-resistant human gastric cancer cell line SGC7901/VCR and its parental cell line SGC7901 were treated with ROS, MMC (negative control), cyclosporine A+MMC (positive control) or ROS+MMC." | 1.38 | Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells. ( Hu, JF; Li, GQ; Su, Q; Xiao, X; Zhang, L, 2012) |
| "In pN0 gastric cancers, prognostic factors differed significantly between early stage and advanced stage." | 1.38 | Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer. ( Kang, WM; Ma, ZQ; Wang, J; Yu, JC, 2012) |
| "To study the effect of the sphingosine kinase 1 (SphK1) inhibitor N,N-dimethylsphingosine (DMS) in combination with chemotherapeutic drugs (DDP, 5-Fu, MMC) on the proliferation of gastric cancer cells (SGC7901) in vitro, and to evaluate whether SphK1 inhibitors could be used as synergetic agents in chemotherapy." | 1.38 | [Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro]. ( Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ, 2012) |
| " We examined the administration sequence of combining 5FU with MMC to maximize toxicity against a human gastric cancer cell line, and then investigated the possible molecular mechanisms underlying the observed toxic effects." | 1.36 | Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress. ( Alpers, DH; Hara, A; Hirayama, R; Kaai, K; Kohno, S; Komoda, T; Matsunaga, T; Tsuji, Y, 2010) |
| "One of the key obstacles against the success in cancer chemotherapy is the toxic and side effects of the chemotherapeutic agents." | 1.36 | Using activated carbon nanoparticles to decrease the genotoxicity and teratogenicity of anticancer therapeutic agents. ( Shuzheng, M; Yingge, Z; Zhong, Y, 2010) |
| "Patients with liver cancer were examined with diffusion-weighted MRI at two b values (0 and 500 s/mm(2)) before and after chemoemblization." | 1.35 | [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer]. ( Dong, S; Sun, ZC; Xiao, XS; Xu, LC; Ye, XD; Yuan, Z, 2009) |
| "The lower differentiated gastric cancer cells were more sensitive than the higher ones." | 1.35 | [Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Yin, YC, 2008) |
| "Chemosensitivity of the mouse gastric cancer cells to 6 chemotherapeutic drugs was investigated using MTT assay before the 6 drugs were applied in mice with implanted tumors." | 1.34 | [Drug sensitivity test and drug-resistance gene assessment for chemotherapy planning for tumors derived from high-passage mouse gastric cancer cells: therapeutic effect observation in mice]. ( Jia, HS; Sun, T; Zhang, JR, 2007) |
| "Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours." | 1.34 | [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007) |
| "After Smac gene was transferred into gastric cancer cell line MKN-45, subclone cells were obtained by persistent G418 selection." | 1.33 | Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells. ( Liu, J; Qian, W; Tong, QS; Wang, L; Zheng, LD, 2005) |
| "To investigate the effects of mitomycin (MMC) combined with sulindac on cell viability, apoptotic induction and expression of apoptosis-related gene Bcl-2 and cyclooxygenase-2 (COX-2) in gastric cancer SGC-7901 cells." | 1.33 | Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac. ( Ma, L; Xie, YL; Yu, Y; Zhang, QN, 2005) |
| "Expressions of GST-pi and P-gp in gastric cancer tissues were detected by immunohistochemistry." | 1.33 | [Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi]. ( Ji, J; Ji, YB; Lin, YZ; Liu, BY; Yuan, F; Zhang, J; Zhu, ZG, 2005) |
| "Overexpression of Smac in gastric cancer cell line significantly improves expression and activity levels of caspase-3 after induction by MMC." | 1.33 | [Regulatory effects on apoptotic activities of gastric cancer cell line by over-expression of Smac gene]. ( Tong, QS; Wang, L; Wu, CH; Wu, RL; Zheng, LD, 2005) |
| " Pharmacokinetic assays were carried out at different time points (0." | 1.33 | [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles]. ( Hao, XS; Li, W; Liang, H; Sun, H; Tang, HW, 2005) |
| "A total of 104 patients with primary gastric cancer with peritoneal dissemination were enrolled in this study." | 1.33 | [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer]. ( Fujimura, T; Fujita, H; Fushida, S; Kinami, S; Ninomiya, I; Nishimura, G; Ohta, T, 2005) |
| "These results suggest that gastric cancer,in which liver metastasis is considered to be a prognostic factor,can be effectively treated by combination therapy with hepatic arterial infusion therapy, followed by thermochemotherapy for the primary lesion." | 1.33 | [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy]. ( Aoki, T; Hamaya, M; Kouno, T; Nishida, J; Ogata, T; Sato, S; Seo, K; Tsuchida, A; Yoshida, K, 2005) |
| "Paclitaxel was ineffective, and so we opted for weekly administration of low-dose CDDP combined with TS-1, which led to the third recovery." | 1.33 | [A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs]. ( Aiko, S; Ishizuka, T; Kumano, I; Maehara, T; Sakano, T; Sugiura, Y; Yoshizumi, Y, 2006) |
| "To prepare a new dosage formulation of activated carbon nanoparticles adsorbing mitomycin C (MMC-ACNP) and evaluate the beneficial effects of intraperitoneally applied MMC-ACNP as a drug delivery system for lymphatic targeting in preventing metastasis and recurrence of gastric cancer." | 1.33 | [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma]. ( Qu, QL; Sun, L; Yang, LZ; Zhang, YG, 2006) |
| "To evaluate the effect of pirarubicin (THP) in combination with hyperthermia on gastric cancer tissues in vitro and explore the underlying mechanisms." | 1.33 | [Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro]. ( Fu, J; Li, GX; Luo, RC; Wang, XG; Zheng, H, 2006) |
| "No Mitomycin C was added in control group." | 1.32 | The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs. ( Chen, C; Li, JS; Liu, FK; Qi, XP, 2003) |
| "Thirty-five gastric cancer specimens surgically resected at our institute between 1998 and 1999 were studied for quantification of expression of 6300 genes by means of oligonucleotide microarray methods, and the results were evaluated in comparison with the chemoresistance of the specimens, which was determined by MTT (tetrazolium-based 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay." | 1.32 | Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray. ( Abe, S; Furukawa, T; Hasegawa, H; Kitajima, M; Kubota, T; Kumai, K; Nakayama, H; Okabe, H; Otani, Y; Saikawa, Y; Suganuma, K; Watanabe, M, 2003) |
| "He then underwent excision of the brain metastases and consecutive radiation by X-knife." | 1.32 | [A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy]. ( Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T, 2003) |
| "In advanced gastric cancer, peritoneal recurrence is the main cause of death after curative surgical resection." | 1.32 | Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma. ( Azama, T; Fujiwara, Y; Ishii, T; Monden, M; Mori, T; Sugita, Y; Takiguchi, S; Taniguchi, K; Yamazaki, K; Yano, M; Yasuda, T, 2004) |
| "We demonstrated here that AFP-producing gastric cancer (AFP-gastric cancer) could be treated by a combination therapy with a low dose of Mitomycin-C (MMC) and lymphokineactivated killer T (LAK-T) cells." | 1.32 | Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. ( Asai, K; Joh, T; Kataoka, H; Miura, Y; Nakanishi, M; Okada, H; Okada, N; Tada, T, 2004) |
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
| "Marimastat seems to be a candidate for the prevention of peritoneal spread of gastric carcinoma." | 1.31 | Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice. ( Fujii, M; Igarashi, N; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T; Yoshimizu, N, 2002) |
| "The prognosis for gastric cancer patients who undergo noncurative resection is extremely poor." | 1.31 | Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. ( Doki, Y; Fujiwara, Y; Inoue, M; Monden, M; Shiozaki, H; Tamura, S; Tsujinaka, T; Yano, M; Yasuda, T, 2002) |
| "We report a case of inoperable gastric cancer with multiple liver metastases, which responded significantly to the short-term administration of TS-1 following intravenous FMP therapy." | 1.31 | [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization]. ( Chinzei, T; Okada, Y; Tasaka, K; Tomofuji, Y, 2002) |
| "In patients with pancreatic cancer, the overall response rate was 42% with a median survival of 8 months." | 1.31 | Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen. ( Gallagher, CJ; Shamash, J; Slater, S; Slevin, ML; Wilson, P, 2002) |
| "Six patients with gastric cancer, stage IIIA to IV, received intraabdominal cisplatin (CDDP) at laporotomy." | 1.31 | [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion]. ( Kagawa, R; Nakayama, N; Sakata, S; Tada, M; Yamaguchi, T, 2002) |
| "Twenty-four patients with gastric cancers who underwent the intraoperative systemic chemotherapy were taken as controls." | 1.31 | [Clinical comparison between intraoperative local arterial infusion chemotherapy and systemic venous chemotherapy of gastric cancer]. ( Chen, D; Lai, Y; Peng, B; Xiao, Q; Zhang, S, 2001) |
| "112 cases of fresh human gastric cancer samples were obtained for drug sensitivity testing using MTT." | 1.31 | [Study on the chemosensitivity test of human gastric cancer using the MTT assay]. ( Chen, J; Chen, Z; Hu, J; Mao, Y; Yan, L; Zou, L, 2001) |
| "For both of the two patients with pancreatic cancer, although they were responsive to the therapy, there was no prolongation of survival." | 1.31 | [Hepatic arterial infusion chemotherapy for unresectable liver metastasis of gastrointestinal cancers]. ( Hirakawa, K; Nishino, H; Ohira, M; Shimizu, S; Tamamori, Y; Tanaka, H; Yamada, N, 2000) |
| "We treated a case of unresectable gastric cancer in which peritoneal lavage cytology and the primary tumor responded to combined chemotherapy by intravenous, intraarterial and intraperitoneal injection." | 1.31 | [A case of stage IV gastric cancer responding to combined chemotherapy by intravenous, intraarterial and intraperitoneal injection]. ( Hattori, T; Hirano, K; Kase, H; Kobayashi, K; Ogawa, M; Teramoto, T; Tokura, N; Washizawa, N, 2000) |
| "5-Fluorouracil and cisplatin were administered intraperitoneally on postoperative days 1-4, and this was repeated at 4-week intervals." | 1.31 | Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. ( Chung, HC; Min, JS; Noh, SH; Roh, JK; Shin, DW; Yoo, CH, 2001) |
| "A total of 18 patients (13: colon cancer, 5: gastric cancer) with multiple liver metastases (H3) underwent hepatic arterial infusion chemotherapy (HAI) using an implanted arterial port with portable syringe pumps in our outpatient clinic." | 1.31 | [Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases]. ( Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H, 2000) |
| "We have experienced a case of advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-fluorouracil (5-FU), mitomycin C (MMC) and peroral administration of 5-FU." | 1.31 | Advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-FU, MMC and peroral administration of 5-FU: a case report. ( Aoyagi, K; Koufuji, K; Murakami, N; Shirouzu, K; Takeda, J; Terasaki, Y; Yamasaki, Y; Yano, S, 2000) |
| "Advanced gastric cancer is classified into four Borrmann types, types 1 to 4." | 1.31 | Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses. ( Iwamoto, K; Kagami, M; Kikuchi, S; Kunii, Y; Narushima, Y; Saito, T; Takahashi, M; Teshima, S; Yamada, Y; Yamauchi, H; Yokota, T, 2000) |
| " Thirty-one patients with superficial oesophageal or gastric cardiac carcinomas, who refused or were unsuitable for surgery, received endoscopic Nd:YAG laser therapy combined with local injection of chemotherapeutic drugs 5-fluorouracil and mitomycin." | 1.31 | Endoscopic Nd:YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia. ( Huang, T; Jia, J; Wang, Y; Zhou, C, 2001) |
| "The aim of this study was to evaluate the clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and the possibility of predicting the effectiveness of the chemotherapy by pretreatment diagnostic imaging." | 1.31 | [Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging]. ( Majima, T; Nakajima, T; Nozu, S; Okayasu, K; Saitou, AY; Yagi, A, 2001) |
| "We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
| "IHCP combined with aggressive surgery was performed in 48 gastric carcinoma patients with peritoneal carcinomatosis; 18 gastric carcinoma patients with peritoneal carcinomatosis serving as controls were treated with surgery alone." | 1.30 | Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. ( Fujimoto, S; Isawa, E; Kobayashi, K; Mutou, T; Ohkubo, H; Sumida, M; Takahashi, M; Toyosawa, T, 1997) |
| "A 71-year-old man with Borrmann type 3 gastric cancer and peritonitis carcinomatosa was treated with 5'-DFUR 600 mg/body p." | 1.30 | [Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa]. ( Ando, S; Katanuma, A; Maekubo, H; Mori, M; Tsuji, K, 1997) |
| "About one-third of patients with gastric cancer are unresectable at the time of diagnosis." | 1.30 | Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer. ( Cho, JY; Chung, HC; Kim, BS; Kim, CB; Kim, JH; Min, JS; Noh, SH; Park, JO; Rha, SY; Roh, JK; You, NC, 1997) |
| "Eighty gastric cancer patients with peritoneal dissemination were analyzed to evaluate the effect of intraperitoneal chemo- and/or immunotherapy on abdominal ascites." | 1.30 | [Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination]. ( Kajiura, Y; Kondoh, Y; Makuuchi, H; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T, 1997) |
| "Of 125 cases of advanced gastric cancer, 41 cases received intraarterial chemotherapy (A group) and the rest were given systemic infusion (S group)." | 1.30 | [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer]. ( Akiyama, T; Kita, I; Kosaka, T; Nakano, Y; Saito, H; Sugaya, J; Takashima, S; Tomita, F; Ueshige, N, 1998) |
| "Many cases with metastatic hepatic cancer have a poor prognosis because of the appearance of extrahepatic lesions in spite of the fact that a partial response can be obtained by hepatic arterial infusion chemotherapy." | 1.30 | [Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy]. ( Hasegawa, K; Ichikawa, T; Kawai, S; Kirihara, M; Kume, S; Maruo, H; Tominaga, S, 1998) |
| "We report 42 cases of gastric cancer with peritoneal carcinosis treated with intraperitoneal chemohyperthermia." | 1.30 | [Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis]. ( Bienvenu, J; François, Y; Garbit, F; Gilly, FN; Glehen, O; Grandclément, E; Peyrat, PP; Sadeghi-Looyeh, B; Sayag-Beaujard, AC; Vignal, J, 1997) |
| "For these studies, MKN-74 gastric cancer cells and MDA-MB-468 breast cancer cells were exposed to either no drug, 1 microgram/ml MMC alone, 300 nM flavopiridol alone, or a combination of chemotherapy with flavopiridol for 24 h." | 1.30 | Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. ( Farsi, K; Kelsen, DP; Maslak, P; Schwartz, GK; Spriggs, D, 1997) |
| " To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound." | 1.30 | FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice. ( Fujiwara, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S; Yamazaki, S, 1998) |
| "Mitomycin C (20 mg) was injected through out the induced hypertension (1." | 1.30 | [A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II]. ( Arai, K; Iwasaki, Y; Kitamura, M; Nakajima, Y, 1999) |
| "Mitomycin C was injected for 10 minutes via implanted port, whose tip was located in the hepatic artery, when the mean systolic blood pressure rose to 50 percent above the level in the untreated state by intravenous administration of angiotensin II." | 1.30 | [Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer]. ( Arai, K; Iwasaki, Y; Ohashi, M; Takahashi, T, 1999) |
| "A patient with advanced gastric cancer with multiple liver metastases was treated by reduction surgery at the primary site as well as by the intraarterial administration of mitomycin C (MMC) and cisplatin (CDDP) through a reservoir catheter inserted into the proper hepatic artery." | 1.29 | Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases. ( Furukawa, T; Ishibiki, K; Kitajima, M; Kubota, T; Kumai, K; Saikawa, Y; Yoshino, K, 1994) |
| "Six patients with gastric cancer and two patients with colon cancer underwent these procedures." | 1.29 | [Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer]. ( Fujimura, T; Fujita, H; Fushida, S; Hirono, Y; Itoh, H; Kaji, M; Kinami, S; Nakagawara, H; Nakai, M; Yonemura, Y, 1995) |
| "A case of far advanced gastric cancer with multiple liver metastasis (H3) was treated with transarterial intermittent chemotherapy (5-FU: 250 mg/week, Farmorubicin: 10 mg/4 weeks, MMC: 4 mg/2 weeks) and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans." | 1.29 | [A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans]. ( Fukuma, E; Goto, S; Imai, I; Ishiyama, J; Kano, N; Kasugai, H; Kera, J; Miyajima, N; Takeuchi, S; Yamakawa, T, 1995) |
| "In this bsMAb, one arm could react with gastric cancer-associated antigen, and the other with a hapten TNP." | 1.29 | [A bispecific monoclonal antibody with versatile adaptor mediating different cytotoxicities]. ( Lu, LJ; Wan, WH; Wang, LM, 1994) |
| "An anti-gastric cancer monoclonal antibody MGb2-mitomycin C conjugate via dextran T-70 as intermediate (MGb2-PAD-MMC) was produced, and 28-30 g molecules of MMC were introduced into 1 g molecule of MGb2." | 1.29 | [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm]. ( Chen, LJ; Chen, M; Chen, XT; Li, S; Zhang, JL; Zhang, SY; Zhang, XY; Zhang, Z, 1993) |
| "A 67-year-old man with advanced gastric cancer with multiple liver metastases was treated by a new combination chemotherapy using 5-FU, THP and MMC (FTM)." | 1.29 | [A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)]. ( Kusano, F; Maekawa, N; Sakai, Y; Sasaki, N; Tajiri, K; Tazawa, J; Yamamoto, C, 1994) |
| "Hyporeninemic hypoaldosteronism was transiently seen in case 2." | 1.29 | Long-term follow-up of mitomycin C nephropathy. ( Ikeda, K; Motoo, Y; Ohta, H; Okai, T; Sawabu, N; Takemori, Y; Yokoyama, H, 1994) |
| "22 patients with gastric cancer underwent preoperative endoscopical MMC-CH injection before radical resection." | 1.29 | [Intraoperative lymph nodes dissection guided by preoperative endoscopical injection of mitomycin C absorbed activated carbon (MMC-CH40) at pericancerous gastric mural in patients with gastric cancer]. ( Qi, XD, 1993) |
| "All the gastric cancer lesions without liver metastases were resected 14 days after implantation of VX2 cancer cells into the stomach, and all the animals were autopsied 14 days after resection." | 1.29 | [Prophylactic effects of mitomycin C (MMC) on the liver recurrence in a rabbit gastric VX2 cancer model with high frequency of the recurrence]. ( Nakamura, T; Saitoh, Y; Tabuchi, Y; Tada, Y, 1993) |
| " The appropriate dosage of six well-known antitumor drugs [mitomycin C (MMC), cyclophosphamide (CPA), nimustine hydrochloride 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), cis-platinum (II) diaminodichloride (CDDP), adriamycin (ADM) and 5-fluorouracil (5-FU)] in human tumor-bearing nude mice was determined based on the maximum tolerance dose of the drug." | 1.29 | A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors. ( Abe, O; Hattori, T; Imaizumi, M; Kitano, M; Kondo, T; Taguchi, T; Wakui, A, 1993) |
| "Nine gastric cancer patients with simultaneous liver metastases were given intermittent transarterial administration of chemotherapeutics (adriamycin, mitomycin C or 5-fluorouracil) and biological response modifiers (BRM; OK-432 and interleukin (IL) -2) after gastrectomy." | 1.29 | [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]. ( Azuma, S; Furuta, T; Kato, M; Kida, H; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T, 1993) |
| " The dosage was 14 mg/m2 (7 mg/m2 at second and following administrations) of MMC and 35 mg/m2 of CDDP and they were repeatedly administered in the abdominal cavity via the drug delivery system." | 1.29 | [Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis]. ( Arai, K; Kitamura, M; Miyashita, K, 1993) |
| "Forty gastric cancer patients and 29 colorectal cancer patients were treated by subselective intraarterial infusion chemotherapy." | 1.29 | [Evaluation of subselective intraarterial infusion chemotherapy in far advanced gastric and colorectal cancer]. ( Fujimoto, T; Kitada, M; Murotani, M; Okumura, Y; Saito, M; Shibata, T; Takada, T; Takami, M; Tsukahara, Y; Watanabe, Y, 1993) |
| "A new dosage format (MMC-CH) of mitomycin C, which is composed of mitomycin C on activated carbon particles, was efficacious for prevention of peritoneal recurrence of gastric cancer." | 1.29 | [Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles]. ( Hagiwara, A; Oyama, T; Ozaki, K; Sakakibara, T; Sakakura, C; Sasaki, S; Shimotsuma, M; Takahashi, T; Tsujimoto, H, 1993) |
| "Tegafur or UFT was administrated orally to patients with gastric or colorectal cancers after surgery for at least a year." | 1.29 | [Evaluation of long-term administration of oral anti-cancer agent]. ( Sakakibara, N; Watanabe, H, 1993) |
| "This metastatic model of human stomach cancer shows that locally growing and metastatic tumors may have different chemosensitivities, and provides the opportunity to test both with various treatment regimens." | 1.29 | Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice. ( Furukawa, T; Hoffman, RM; Kitajima, M; Kubota, T; Kuo, TH; Watanabe, M, 1993) |
| "Mitomycin C 26 mg was given intravenously on the day of operation and 5-fluorouracil (5-FU) 150 mg/day orally since postoperative 14th day as adjuvant chemotherapy." | 1.29 | [A case of advanced gastric cancer with liver metastasis with no recurrence and long survival]. ( Kajiura, Y; Kondo, Y; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T, 1996) |
| "In an attempt to prevent postoperative intraperitoneal recurrence in patients with advanced gastric cancer and consequently to improve survival time, we treated patients with intraperitoneal hyperthermic perfusion (IPHP) using mitomycin C (MMC) combined with surgery." | 1.29 | Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer. ( Fujimoto, S; Kobayashi, K; Kondoh, K; Mutou, T; Ohkubo, H; Takahashi, M; Toyosawa, T, 1996) |
| "A 51-year-old man with 2 type gastric cancer (H0) underwent subtotal gastrectomy (D2)." | 1.29 | [Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer]. ( Hirose, K; Katayama, K; Kobayashi, T; Nakagawara, G; Niimoto, S; Yamaguchi, A, 1996) |
| " Pharmacokinetic examination after intravenous injection of low-dose MMC (0." | 1.29 | A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics. ( Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S, 1996) |
| "A case of gastric cancer with liver metastasis who responded well to low-dose PMUE (CDDP, MMC, UFT, etoposide) therapy is reported." | 1.29 | [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy]. ( Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y, 1996) |
| "The expression of MRP gene in gastric cancer cell lines varied from a low to a high level, but mdrl was not detected in any of these cell lines." | 1.29 | The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. ( Cowan, KH; Fukuda, M; Ikeda, K; Kohno, S; Matsuo, I; Nakano, R; Narasaki, F; Oka, M; Soda, H; Takatani, H; Terashi, K; Tomonaga, M, 1996) |
| "Highly purified fresh human gastric cancer cells could be obtained from 43 solid tumours and eight malignant ascites for the MTT assay." | 1.28 | Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. ( Hotta, T; Iwahashi, M; Iwakura, S; Noguchi, K; Tamai, M; Tani, M; Tanimura, H; Tsunoda, T; Yamaue, H, 1992) |
| " At the dosage level used in the present study (5 micrograms/mouse x 6), 3H11-DEX-ADM showed an inhibition rate of 51." | 1.28 | [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo]. ( Dong, ZW; Li, N; Liu, T; Wang, NQ; Zhang, YT, 1992) |
| "Often operations for gastric cancer accompanied with multiple liver metastasis meet with little success, and almost no case of prolonged survival has been reported." | 1.28 | [A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy]. ( Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K, 1992) |
| "A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989." | 1.28 | Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. ( Hosokawa, T; Kajiwara, T; Ogawa, K; Otani, Y, 1992) |
| "Eighty-one cases of advanced gastric cancer, who had been treated by intra-arterial infusion chemotherapy, were examined for complications related to catheter indwelling." | 1.28 | [Complications related to catheter indwelling in intra-arterial infusion chemotherapy from the standpoint of the route of cannulation]. ( Arai, K; Kitamura, M; Miyashita, K, 1992) |
| " Pharmaceutical dosage was set at approximately 30% of the increased life span (ILS) for Meth-A." | 1.28 | [Experimental study of the treatment of carcinomatous peritonitis in gastric cancer]. ( Arai, K; Kitamura, M; Miyashita, K, 1992) |
| "Repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy was performed in 29 patients with unresectable primary or secondary cancer of the liver." | 1.28 | [Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver]. ( Hayashi, T; Kimoto, T; Kohno, H; Makino, Y; Nagasue, N; Ohiwa, K; Ono, T; Takemoto, Y; Taniura, H; Uchida, M, 1992) |
| " A marked pharmacokinetic advantage was observed when 5-FU and CDDP were administered." | 1.28 | [Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer]. ( Ito, A; Ito, K; Kodera, Y; Kondo, K; Kuzuya, T; Nagai, S; Nakahara, H; Satta, T; Takagi, H; Yamauchi, M, 1992) |
| "A 74-year-old man with advanced gastric cancer of Borrmann type III and liver metastasis was treated by combined administration of UFT (400 mg/day, p." | 1.28 | [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. ( Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J, 1992) |
| "The in vitro drug sensitivity of gastric cancer tissues obtained from 40 patients with advanced cancer was compared in terms of the pathological classifications which were assigned according to the General Rules for the Gastric Cancer Study in Surgery and Pathology in Japan." | 1.28 | Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. ( Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M, 1992) |
| "Etoposide was administered orally at 25-50 mg/day to the gastric cancer patient with liver metastasis." | 1.28 | [A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT]. ( Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K, 1992) |
| "A care system for cancer bearing patients at a highly advanced stage should be informed by a better quality of life based on a life style of the patients and their families." | 1.28 | [Nutritional support for cancer bearing patients]. ( Yamada, S, 1991) |
| "Eighteen patients with advanced gastric cancer were treated with cisplatin 80 mg/m2 d 1, doxorubicin 30 mg/m2 d 3 and mitomycin-C 12 mg/m2 d 3." | 1.28 | [Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer]. ( Cady, J; de Gramont, A; Demuynck, B; Krulik, M; Lagadec, B; Louvet, C; Varette, C, 1991) |
| "The subjects were 41 cases of gastric cancer with peritoneal dissemination but without hepatic metastasis, which we have experienced in the past 7 years." | 1.28 | [Treatment of gastric cancer patients with peritoneal metastasis by continuous hyperthermic peritoneal infusion with mitomycin C and cisplatin]. ( Fujimura, T; Kamata, T; Katayama, K; Kimura, H; Matsuki, N; Ohoyama, S; Sakuma, H; Sawa, T; Takekawa, S; Yonemura, Y, 1991) |
| "Thermochemotherapy was performed on gastric cancer cases of hepato-metastasis." | 1.28 | [Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer]. ( Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y, 1991) |
| "Feasibility of utilizing human gastric cancers as first transplant generation xenografts in nude mice for determining tumor sensitivity to chemotherapeutic agents was demonstrated by applying subrenal capsule (SRC) assay." | 1.28 | Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy. ( Akiyama, S; Ito, A; Ito, K; Kondo, K; Satta, T; Takagi, H; Watanabe, T; Yamauchi, M, 1991) |
| "Etoposide was found to be most effective against gastric carcinoma in this test." | 1.28 | [Chemosensitivity test for gastric cancer by in vitro MTT assay]. ( Endo, Y; Kimura, H; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Tugawa, K; Yonemura, Y, 1991) |
| "A 55-year-old woman with gastric cancer underwent laparotomy and was found to have an unresectable tumor characterized by S3 (invasion of the pancreas), N3, P0 and H0." | 1.28 | [A long-term survival case of advanced gastric cancer undergoing radical gastrectomy by second-look operation after successful chemotherapy (CDDP, MMC, 5-FU)]. ( Azuma, S; Furuta, T; Kawata, R; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Umemoto, T, 1991) |
| " When an intraperitoneal dosage of 20 mg MMC was given to 3 patients, the portal venous blood, at 10 min after the administration, produced a 1." | 1.28 | [Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer]. ( Gasa, F; Hada, R; Hakamada, K; Konn, M; Mikami, Y; Miyagishima, K; Ono, K; Seino, K; Sugiyama, Y; Suzuki, H, 1991) |
| "A total of 22 patients (12 cases of gastric cancer, 6 of colon cancer, 2 of pancreas cancer, 1 of gall bladder cancer and 1 of biliary tract carcinoid) were treated according to the following schedule: both 10 mg of ADM (or MMC) and 0." | 1.28 | [Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer]. ( Azuma, S; Furuta, T; Kawai, M; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Umemoto, T, 1991) |
| "5-fluorouracil (5-FU) was administered by arterial continuous infusion, adriamycin (ADM) and mitomycin C (MMC) by bolus infusion in the hospital, and continuous arterial 5-FU infusion and ADM low dose intermittent bolus infusion chemotherapy (AF therapy) was used for outpatients." | 1.28 | [Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer]. ( Niitsu, Y; Saito, K; Sato, M; Takagane, A; Terashima, M; Yokkaichi, H, 1991) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "Tegafur p." | 1.28 | Alternating chemotherapy in advanced gastric cancer. A phase II study. ( Barón-Saura, JM; Berrocal, A; Feliu, J; Girón, CG; González-Baron, M, 1991) |
| "In the present study, an anti-gastric cancer monoclonal antibody, MGb2, was chosen to prepare antibody-mitomycin C (MMC) conjugate with dextran T-40 as intermediary." | 1.28 | Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody. ( Chen, LJ; Chen, XT; Fan, DM; Li, S; Shu, YH; Zhan, SY; Zhang, JL; Zhang, XY, 1991) |
| "These consisted of four gastric cancers (H-55, H-111, H-81 and H-154), one breast cancer (H-31) and one pancreatic cancer (H-48)." | 1.28 | [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice]. ( Fujita, F; Fujita, M; Inaba, H; Okuyama, Y; Sugimoto, T; Taguchi, T, 1991) |
| "A total of 31 patients with gastric cancer showing peritoneal dissemination received continuous hyperthermic peritoneal perfusion (CHPP) in combination with the administration of cisplatin (CDDP) and mitomycin C (MMC)." | 1.28 | Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. ( Fujimura, T; Fushida, S; Hasegawa, H; Kamata, T; Katayama, K; Miwa, K; Sugiyama, K; Takegawa, S; Urade, M; Yonemura, Y, 1990) |
| "A 59-year-old man with a gastric cancer underwent a laparotomy and was found to have an unresectable tumor that formed a large mass with metastatic lymph nodes around the aorta." | 1.28 | [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. ( Adachi, M; Kobori, O; Nomura, K; Sano, T, 1990) |
| " Then the adequate dosage of each anticancer drug for this assay system was investigated so that the body weights of mice do not decrease more than 20%, and the following doses were determined; Mitomycin C: 5mg/kg; Cisplatinum: 4mg/kg; Cyclophosphamide: 100mg/kg and 5FU: 90 mg/kg." | 1.28 | [Subrenal capsule assay in normal mice immunosuppressed by cyclosporin A]. ( Takagi, H; Yamamoto, K; Yamauchi, M, 1990) |
| "Forty-four patients with advanced gastric cancer were treated with a combination including 5-fluorouracil, 4-epi-doxorubicin and mitomycin C." | 1.28 | Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer. ( Kolarić, K; Luetić, J; Roth, A; Zupanc, D, 1990) |
| "Six patients with peritoneal recurrence after radical operation for gastric cancer were treated by an intraperitoneal hyperthermic perfusion (IPHP) combined with surgery (IPHP group)." | 1.28 | [Clinical results of intraperitoneal hyperthermic perfusion combined with surgery in patients with peritoneal recurrence from gastric cancer]. ( Fujimoto, S; Kiuchi, S; Kobayashi, K; Kokubun, M; Konno, C; Okui, K; Shrestha, RD, 1990) |
| " These results indicated that rIL 2 in combination with MMC might be effective against advanced carcinoma without causing severe toxicity when these drugs are used in an appropriate combination." | 1.28 | The effect of recombinant interleukin 2 in combination with mitomycin C on advanced cancer. ( Abe, R; Akiyoshi, T; Arinaga, S; Inoue, H; Karimine, N; Matsuoka, H; Nagamatsu, M; Nanbara, S; Takamuku, K; Watanabe, D, 1990) |
| "Some 74 of 469 patients of gastric cancer, who underwent surgical treatment over the last 7 years in our department, had peritoneal dissemination and 24 of them were treated with the drugs described above." | 1.28 | [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer]. ( Azuma, S; Furuta, T; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Yoshida, A, 1990) |
| "The cases were comprised of 9 gastric cancers, 6 colorectal cancers, 1 appendiceal carcinoma, and 1 malignant tumor of retroperitoneum, all of which were observed to have peritoneal dissemination during surgical operations." | 1.28 | [Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa]. ( Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T, 1990) |
| "In 93 cases of stomach cancer with liver metastasis, the influence of surgery and chemotherapy on the patients' prognosis was examined." | 1.28 | [Multivariate analysis of gastric cancer patients with liver metastases]. ( Fujimura, T; Hasegawa, H; Kamata, T; Katayama, K; Kimura, H; Matsuki, N; Ohyama, S; Sakuma, H; Sawa, T; Yonemura, Y, 1990) |
| "Mitomycin C (MMC) is an alkylating agent which has been associated with microangiopathic hemolytic anemia and acute renal failure, with an overall incidence between 2 and 10%." | 1.28 | Silent renal microangiography after mitomycin C therapy. ( Botey, A; Darnell, A; González-Clemente, JM; Poch, E; Revert, L; Torras, A, 1990) |
| "An anti-gastric cancer monoclonal antibody, MGb2, was chosen to prepare MGb2-mitomycin C (MMC) conjugate." | 1.28 | Selective cytotoxicity against human tumor cells by an anti-gastric cancer monoclonal antibody-mitomycin C conjugate. ( Chen, LJ; Chen, XT; Li, S; Zhang, JL; Zhang, SY; Zhang, XY, 1990) |
| "A conjugate of an anti-gastric cancer monoclonal antibody and mitomycin C linked by polyaldehyde dextran T-40 (MGb2-PAD-MMC) was prepared." | 1.28 | [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice]. ( Chen, LJ; Chen, XT; Li, S; Shu, YH; Zhang, SY; Zhang, XY, 1990) |
| "Twenty-five patients with advanced gastric cancer were treated with a combination chemotherapy." | 1.28 | [The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer]. ( Imamura, Y; Masuda, T; Matsushita, K; Ohno, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y, 1990) |
| "In the present study, an anti-gastric cancer monoclonal antibody, MGb2, was chosen to prepare antibody-mitomycin C (MMC) conjugate with dextran T-40 as intermediary." | 1.28 | [Specific targeting of mitomycin C to tumors with the use of anti-gastric cancer monoclonal antibody]. ( Li, S, 1990) |
| "This study observed the effect of chemotherapy combined with Chinese herbs and western drugs on white blood cell count in 31 patients with gastric cancer." | 1.28 | [Clinical effect of chemotherapy combined with Chinese herbs and western drugs on leukocytes of gastric cancer patients]. ( Chen, JZ, 1990) |
| "Mitomycin C was ineffective on the subcutaneous tumors, but effective on the tumors in the stomach wall and the inhibition rate was 52 and 63% at doses of 0." | 1.28 | [The drug sensitivity of human gastric cancer implanted into the subcutis and stomach wall of nude mice]. ( Yamashita, T, 1989) |
| "For prevention and therapy of peritoneal dissemination, a new dosage from (MMC-CH) comprising carbon particles adsorbing mitomycin C was given to 44 patients (the MMC-CH group) undergoing gastrectomy for gastric cancer, of which advancing stage was classified into the category of H0, and S2 or S3, and P0, P1, P2 or P3 according to the General Rules for the Gastric Cancer Study." | 1.28 | [Intraoperative chemotherapy against peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles adsorbing mitomycin C]. ( Hagiwara, A; Iwamoto, A; Sawai, K; Takahashi, T; Yamaguchi, T; Yoneyama, C, 1989) |
| "Nineteen far-advanced gastric cancer patients, including peritoneal dissemination, underwent surgical treatment followed by intraperitoneal hyperthermic perfusion (IPHP)." | 1.28 | [Clinical evaluation of intraperitoneal hyperthermic perfusion in far-advanced gastric cancer]. ( Fujimoto, S; Kiuchi, S; Kobayashi, K; Kokubun, M; Konno, C; Okui, K; Shrestha, RD; Takahashi, M, 1989) |
| "A new form of dosage (MMC-CH) was composed of activated carbon particles adsorbing mitomycin C." | 1.28 | [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer]. ( Hagiwara, A; Itoh, M; Iwamoto, A; Kondoh, S; Sasabe, T; Seiki, K; Shimotsuma, M; Takahashi, T; Yamaguchi, T; Yoneyama, C, 1989) |
| "Fifty-five gastric cancer patients with liver metastasis received arterial infusion chemotherapy." | 1.28 | [Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment]. ( Arai, K; Kitamura, M; Kosaki, G; Miyashita, K, 1989) |
| "Sixteen cases of gastric cancer with liver metastases (H2 less than) as group A, fifteen with distant peritoneal metastases (P2 less than) as group B, twenty-five with distant lymph nodes metastases (N3 less than) as group C, twenty-eight with two prognostic factors as group D, and seven with three factors as group E were treated." | 1.28 | [Comparative study of tegafur (p.o.) and mitomycin C (MMC) plus tegafur in cases of unresectable gastric cancer]. ( Ishiguro, E; Iwa, T; Kawaura, Y; Munemoto, Y; Omura, K; Sasaki, M; Sekido, N, 1989) |
| "A 58-year-old woman who was inoperable because of S3 (pancreas and colon) and P1 at the initial operation was treated with UFT, ADM and MMC at a dosage of 242." | 1.28 | [An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy]. ( Hayashi, S; Kamejima, N; Kasugai, T; Kataoka, M; Kureyama, Y; Masaoka, A; Mitsui, T; Taniwaki, S; Tsuji, H; Watarai, N, 1989) |
| " The dosage was 250 mg/day for 5-FU continuously, 10 mg/week for MMC and 5 KE/week for OK-432, respectively." | 1.28 | [Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer]. ( Hamada, H; Mori, N; Nakajima, I; Nakamura, T; Nakamura, Y; Tanaka, A; Wada, T; Yasutomi, M, 1989) |
| "Thirty-four patients with advanced gastric cancers had received continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination (PD)." | 1.28 | [Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer]. ( Fujimura, T; Hasegawa, H; Hashimoto, T; Katayama, K; Matsuda, Y; Miyata, R; Sugiyama, K; Urade, M; Yamaguchi, A; Yonemura, Y, 1989) |
| "We report a case of advanced gastric cancer with Virchow's node metastasis which responded to concomitant plasma exchange and immunochemotherapy." | 1.28 | [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy]. ( Iga, C; Kawashima, Y; Nishimura, J; Okajima, K; Sakuramoto, K; Toyoda, M, 1989) |
| " The median dosage of FAM agents delivered to nonresponders was reduced." | 1.28 | 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. ( Biran, H; Biran, S; Sulkes, A, 1989) |
| "Overall median survival was 352 days in colon cancer and 449 days in gastric cancer." | 1.28 | [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer]. ( Arai, Y; Endo, T; Kido, C; Miyake, Y; Sakamoto, K, 1989) |
| "5-fluorouracil (5-FU) was administered by arterial continuous infusion, and adriamycin (ADM) and mitomycin C (MMC) by bolus infusion." | 1.28 | [Clinical effectiveness of arterial infusion chemotherapy in advanced and recurrent gastric cancer]. ( Odaka, Y; Oikawa, K; Saito, K; Sato, M; Takagane, A; Terashima, M, 1989) |
| "In early gastric cancer and Stage I disease, the mean values of chemotaxis and CL were elevated in comparison to controls." | 1.27 | Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer. ( Hirano, T, 1984) |
| "Thirty patients with advanced gastric cancer were treated with a combination chemotherapy consisting of adriamycin 20-30 mg/m2 iv day 1 q3wks, mitomycin C 2." | 1.27 | [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur]. ( Ezaki, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Miyamoto, H; Nakada, H; Ogawa, M; Okada, Y; Usui, N, 1983) |
| "Among 56 patients with stomach cancer preoperative cell-mediated immunity in relation to clinical staging was studied: eight cases were subjected to a control study in order to evaluate effects of PSK on cell-mediated immune status, preoperatively and postoperatively at 1, 3, 6, 9 and 12 months." | 1.27 | [Effect of PSK on cell-mediated immune status in the patients of stomach cancer]. ( Kondoh, Y; Mitomi, T; Ogoshi, K; Tajima, T, 1983) |
| "In case of recurrent colorectal cancer, 17 cases of 27 patients has multiple liver metastasis." | 1.27 | [Treatment of recurrent gastrointestinal cancer]. ( Taguchi, T, 1983) |
| "A short-term intensive chemotherapy (STIC) consisting of large dose of mitomycin C (MMC), tegafur (FT-207), streptococcus preparation picibanil (OK-432) and Krestin (PSK), combined with IVH was performed in 72 patients with advanced gastric cancer." | 1.27 | [Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer]. ( Hamazoe, R; Kanayama, H; Karino, T; Koga, S; Maeta, M; Oda, M; Osaki, Y; Shimizu, N; Yamane, T, 1983) |
| "In the inoperable Borrmann type 4 Gastric cancer, which is to be used as a synonym of gastric scirrhus clinically, it is regrettable but effect is hardly expected from radiotherapy or immunotherapy, and the treatment relies entirely on chemotherapy." | 1.27 | [Chemotherapy of unresectable Borrmann's type IV stomach cancer]. ( Izumi, T; Kurihara, M; Maruyama, T; Miyasaka, K; Sasaki, Y, 1983) |
| "Levamisole (LMS) was given to stage III gastric cancer patients starting three days before gastrectomy, at a does of 150 mg/day for three consecutive days every other week." | 1.27 | Immunochemotherapy with levamisole for stage III gastric cancer patients. ( Miwa, H; Orita, K, 1983) |
| "We studied 161 gastric cancer patients with P0, H(+) and 51 colorectal cancer patients with P0, H(+) from among cancer patients of the digestive organs and obtained the following conclusions." | 1.27 | [Basic and clinical studies on metastatic cancer--with special reference of multidisciplinary treatment of gastric and colorectal cancer patients with hepatic metastasis]. ( Hanaoka, A; Isono, K; Kimura, M; Koide, Y; Okuyama, K; Onoda, S; Ryu, M; Satoh, H; Tohnosu, N; Yamamoto, Y, 1983) |
| "Splenectomy for gastric cancer at stage IV, particularly in combination with immunotherapy, produced augmentation of cell-mediated immunity and longer survival as well." | 1.27 | [The tumor--immunological significance of splenectomy for cancer therapy]. ( Gohchi, A; Iijima, T; Inoue, T; Kobayashi, T; Kojima, K; Miwa, H; Moriyama, M; Nakamura, K; Oka, T; Tsurumi, T, 1983) |
| "Tow cases of gastric cancer were reported." | 1.27 | [2 cases of solitary metastasis to the large intestine from gastric carcinoma]. ( Hattori, T; Matsuki, K; Nakano, A; Niimi, K; Tomoda, S; Yoshinaka, K, 1984) |
| "The PR cases were 4 of stomach cancer and 2 of lung cancer, the former being all undifferentiated adenocarcinoma." | 1.27 | [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers]. ( Harashima, S; Kanko, T; Nakao, I; Nishi, I; Ohashi, Y; Saito, T; Yokoyama, T, 1984) |
| "Eighty-four patients with advanced gastric cancer treated in four centres in Scotland between June 1980 and December 1982 were reviewed following treatment with 5-fluorouracil, adriamycin and mitomycin-C (FAM)." | 1.27 | Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. ( Allan, SG; Calman, KC; Carter, DC; Cunningham, D; Hutcheon, AW; Kaye, SB; McArdle, CS; Sangster, G; Smyth, JF; Soukop, M, 1984) |
| " Although the dosage of the anticancer chemotherapy was quite small, this treatment may have promoted the regression of the tumor in conjunction with activated antitumor immunity of the host." | 1.27 | [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy]. ( Furuta, K; Hara, K; Kiyomitsu, Y; Nakazaki, S; Shinoda, M; Watanabe, K; Yajima, K; Yasuda, S; Yokoyama, T, 1984) |
| "A 64-year-old male with advanced gastric cancer with multiple liver metastasis was treated with intensive chemotherapy including mitomycin C and tegafur after palliative gastrectomy." | 1.27 | [A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy]. ( Akita, N; Furukawa, H; Iwanaga, T; Koyama, H; Wada, A; Wada, T; Yasutomi, M, 1988) |
| "Investigations were made on 76 cases of scirrhous carcinoma of the stomach in the care of our department, and the treatment methods in these cases were as follows: 1) Lymph node dissection: Lymphadenectomy of over R2 is performed." | 1.27 | [Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period]. ( Hamakubo, S; Higashino, K; Nabeya, K; Nyumura, T, 1988) |
| "For the response of advanced gastric cancer to chemotherapy in the National Cancer Center Hospital, the combined use of UFT and Mitomycin C gave the highest rate, 46%." | 1.27 | Radiation therapy for advanced gastric cancer. ( Akine, Y; Egawa, S; Hijikata, J; Kajiura, Y; Kitagawa, T; Ogino, T; Tsukiyama, I; Yamashita, K, 1988) |
| "A 56-year-old woman with recurrent gastric cancer treated with PMU therapy, combined CDDP 75 mg/m2 i." | 1.27 | [PMU therapy of recurrent gastric cancer. A case report]. ( Matsuki, N; Miyata, R; Miyazaka, I; Noto, H; Ogino, S; Ohyama, S; Sakuma, H; Sawa, T; Yagi, M; Yonemura, Y, 1986) |
| "She died from general metastasis seven months after the radical mastectomy in spite of adjuvant immunochemotherapy." | 1.27 | [A case of bilateral metastatic breast carcinoma from gastric carcinoma]. ( Hanamura, N; Iida, F; Kasuga, Y; Katsuyama, T; Oota, H; Senga, O; Tsuchiya, S, 1986) |
| "Spread of the gastric cancer is multifarious according to its pathological and biophysiological characteristics." | 1.27 | [Treatment of gastric cancer based on the pathological and biophysiological aspects of cancer]. ( Nakajima, T; Nishi, M; Ohta, H, 1986) |
| "The Borrman type 2 of advanced gastric cancer was found on the greater curvature of the antrum at the first radiological examination." | 1.27 | A case of advanced gastric cancer with long-term survival as the results of combined radiation therapy and chemotherapy. ( Akine, Y; Egawa, S; Hirota, T; Ono, R; Tsukiyama, I; Ushio, K; Watai, K; Yamaguchi, H; Yanagawa, S; Yoshida, S, 1986) |
| "A case of advanced gastric cancer associated with metastatic carcinomatosis of the bone marrow, microangiopathic hemolytic anemia (MAHA) and disseminated intravascular coagulation (DIC) was reported." | 1.27 | [Microangiopathic hemolytic anemia associated with gastric cancer]. ( Hattori, T; Kanou, T; Kuramoto, J; Miura, K; Niimoto, M; Nosou, Y; Yanagawa, E; Yoshinaka, K, 1986) |
| "An aged female patient with inoperable gastric cancer was treated with a combined chemotherapy using UFT and Mitomycin C." | 1.27 | [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C]. ( Adachi, M; Sasaki, M, 1986) |
| " Based on the observed objective tumor response rate and median patient survival, further studies of these drugs in combination for the treatment of advanced gastric cancer are indicated." | 1.27 | Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer. ( Hahn, RG; Moertel, CG; O'Connell, MJ; Schutt, AJ, 1987) |
| "A 55-year-old woman with gastric cancer underwent laparotomy and was found to have an unresectable tumor at the MC region, characterized by S3 (invasion into the pancreas), N3, P0, H0, Borrmann-II and moderately differentiated tubular adenocarcinoma." | 1.27 | [Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report]. ( Ando, T; Azuma, S; Furuta, T; Kawata, R; Ohashi, H; Saji, S; Shimokawa, K; Suzuki, M; Tanemura, H; Tsuya, H, 1987) |
| "Twenty patients with advanced gastric cancer were treated with FAP." | 1.27 | [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer]. ( Horikoshi, N; Imajo, K; Inoue, K; Ito, Y; Mukaiyama, T; Nagamine, D; Ogawa, M; Ozeki, H; Shinagawa, K, 1988) |
| "Combined chemotherapy for human gastric cancer Transplanted into nude mice has been performed to determine whether misonidazole (MIS) and metronidazole (MTR), derivatives of nitroimidazole, would enhance the antitumor activity of MMC." | 1.27 | [Chemosensitization with nitroimidazole to human gastric cancer transplanted into nude mice]. ( Arimizu, N; Fujimoto, S; Kobayashi, K; Kokubun, M; Miyoshi, T; Mori, T; Ohta, M; Okui, K; Shrestha, RD, 1988) |
| " This extensive surgery combined with IPHP using MMC and MIS was well tolerated and is a safe antitumor treatment for gastric cancer with peritoneal dissemination." | 1.27 | Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. ( Arimizu, N; Fujimoto, S; Kiuchi, S; Kobayashi, K; Kokubun, M; Miyoshi, T; Ohta, M; Okui, K; Shrestha, RD; Takahashi, M, 1988) |
| "A 75-year-old man with gastric cancer metastatic to the liver was treated by combined administration of Tegafur (800 mg/body/day), 5-fluorouracil (300 mg/body/day) and Mitomycin C (hepatic arterial infusion of 20 mg/body and intravenous infusion of 8 mg/body)." | 1.27 | [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C]. ( Ito, T; Nehashi, Y; Sasaki, J; Sasaki, Y, 1988) |
| "A new dosage form of activated carbon particles adsorbing mitomycin C (MMC-CH) was studied for its therapeutic effects on peritoneal dissemination in both animal experiments and preliminary clinical trials." | 1.27 | Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits. ( Hagiwara, A; Itoh, T; Lee, R; Takahashi, T; Takeda, M; Ueda, T, 1988) |
| "Fourteen patients with far-advanced gastric cancer were treated surgically followed by intraperitoneal hyperthermic perfusion (IPHP) with mitomycin C (MMC) and misonidazole (MIS), a thermosensitizing drug." | 1.27 | [Extended treatment for gastric cancer patients with peritoneal seeding]. ( Fujimoto, S; Kiuchi, S; Kobayashi, K; Kokubun, M; Ohta, M; Okui, K; Shrestha, RD, 1988) |
| "The therapy of advanced stomach cancer is used to exemplify the clinicians' thoughts when confronted with the decision of adapting a standard treatment for a particular disease." | 1.27 | [Medical decision in clinical oncology: the example of drug therapy of gastric cancer in the advanced stage during the last decade]. ( Kenis, Y, 1987) |
| "The dominant location of metastasis was the liver in 21 pts (48." | 1.27 | Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM). ( Amadori, D; Amadori, M; Biserni, R; Bonaguri, C; Faedi, M; Gentilini, P; Ravaioli, A; Ridolfi, R, 1986) |
| "Preoperative cancer chemotherapy for gastric cancer was reviewed with special emphasis on histologic findings and survival." | 1.27 | [Preoperative cancer chemotherapy for gastric cancer]. ( Endoh, F; Fujimoto, S; Kawata, S; Kurihara, M; Miyazaki, M; Ohta, M; Shimura, T; Sugasawa, H; Takahashi, O; Udagawa, I, 1985) |
| "Four out of five xenografts (three gastric cancer, one colon cancer) showed synergistic effects for the combination of MMC with alpha-interferon." | 1.27 | [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique]. ( Hattori, T; Hirabayshi, N; Niimoto, M; Nishiyama, M; Nosoh, Y; Ohkita, T; Toge, T; Yamaguchi, M; Yoshinaka, K, 1985) |
| "Two patients who had advanced gastric cancer and metastatic liver tumors were treated with a combined chemotherapy using UFT and mitomycin C." | 1.27 | [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases]. ( Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M, 1985) |
| "The median survival periods for stomach cancer (Stage 4) after non-radical surgery by means of intraarterial chemotherapy with and without noradrenaline were, respectively, 12 months (n = 8) and 5." | 1.27 | [Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel]. ( Katsumi, S; Kawaguchi, T; Murai, T; Sato, T, 1985) |
| " As systemic cancer chemotherapy was not so effective, targeted cancer chemotherapy for lymph node metastasis and carcinomatous peritonitis was carried out by modification of drug dosage form as fat emulsion and activated carbon incorporating anticancer agent." | 1.27 | [Combined therapy of gastric cancer]. ( Takahashi, T, 1985) |
| "Though two gastric cancer xenografts exhibited synergistic effects in combination of gamma-interferon with Mitomycin C, antagonistic effects, which was not found in combination of alpha-interferon with Mitomycin C, were observed in one gastric cancer and one colon cancer xenografts." | 1.27 | In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon. ( Hattori, T; Hirabayashi, N; Niimoto, M; Nosoh, Y; Ohkita, T; Toge, T; Yoshinaka, K, 1985) |
| "At present hyperthermia shows great promise when combined with other modalities." | 1.27 | [Clinical application of local hyperthermia combined with antineoplastic agents]. ( Ishiwata, J; Iwamoto, S; Koike, M; Maeda, Y; Masuda, T; Sasaki, T; Takeshita, Y; Tanaka, Y, 1985) |
| "A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
| "In all gastric cancer bearers and patients with portal hypertension operated on, however, colony formation was restricted to spleen cells from patients with advanced gastric cancer and from a group of patients with portal hypertension." | 1.27 | Mononuclear phagocyte colony formation of human spleen cells in liquid culture. ( Hasegawa, Y; Ito, Y; Kamei, H; Kato, N; Kojima, T; Kondo, T; Nakashima, I, 1985) |
| "Hypertensive chemotherapy of advanced gastric cancer is reported in this paper." | 1.27 | [Hypertensive chemotherapy of advanced gastric cancer]. ( Bai, XW, 1985) |
| "In 161 cases of gastric cancer with liver metastasis but without peritoneal dissemination, evaluations were executed to find effective treatment." | 1.27 | Evaluation of treatment for gastric cancer with liver metastasis. ( Isono, K; Juan, IK; Koide, Y; Ochiai, T; Okuyama, K; Onoda, S; Satoh, H; Yamamoto, Y, 1985) |
| "One case of each of ovarian cancer and gastric cancer showed minor response." | 1.27 | [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)]. ( Takahashi, H; Takahashi, K; Wakui, A; Yokoyama, M, 1985) |
| "For stage I and II gastric cancer, radical gastrectomy and postoperative immunotherapy for 3 months would be the best treatment." | 1.27 | Immunochemosurgery for gastric cancer. ( Kim, JP, 1985) |
| "In this study, eight beagle dogs with gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG) received weekly administration of 7-N-(p-hydroxyphenyl)-mitomycin C (M-83), a variant of mitomycin C." | 1.27 | Sequential changes of nuclear DNA content caused by chemotherapy in experimental canine gastric cancer. ( Ochi, K; Tanaka, N, 1985) |
| "Out of 42 gastric cancer cases treated with only anticancer drugs, 37 cases exhibited hardly cytologic changes in the smears of biopsied materials." | 1.26 | [Cytological studies of esophageal carcinoma and gastric carcinoma receiving radiation and chemotherapy]. ( Asakawa, H; Nakano, N; Takeda, T, 1982) |
| "The levels of anticancer drugs in tissue were measured by bioassay method in 28 patients with gastrointestinal cancer, who were treated with intravenous administration of 500 mg of 5-FU combined with ANG-II during surgery." | 1.26 | [Clinical studies of cancer chemotherapy combined with angiotensin-II (ANG-II)]. ( Kanno, H; Kikuchi, K; Kunii, Y; Takahashi, N, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 323 (36.83) | 18.7374 |
| 1990's | 343 (39.11) | 18.2507 |
| 2000's | 166 (18.93) | 29.6817 |
| 2010's | 42 (4.79) | 24.3611 |
| 2020's | 3 (0.34) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasa, K | 1 |
| Moriyasu, M | 1 |
| Yamori, T | 1 |
| Turuo, T | 1 |
| Lee, DU | 1 |
| Wiegrebe, W | 1 |
| Somashekhar, SP | 1 |
| Yethadka, R | 1 |
| Kumar C, R | 1 |
| Ashwin, KR | 1 |
| Zaveri, S | 1 |
| Rauthan, A | 1 |
| Blum Murphy, M | 1 |
| Ikoma, N | 1 |
| Wang, X | 3 |
| Estrella, J | 2 |
| Roy-Chowdhuri, S | 1 |
| Das, P | 2 |
| Minsky, BD | 1 |
| Song, S | 1 |
| Mansfield, P | 2 |
| Ajani, J | 2 |
| Badgwell, B | 2 |
| Archid, R | 2 |
| Zieker, D | 2 |
| Weinreich, FJ | 1 |
| Hönes, F | 1 |
| Königsrainer, A | 3 |
| Quintanilla-Martínez, L | 1 |
| Reymond, MA | 1 |
| Solass, W | 1 |
| Blum, M | 1 |
| Fournier, K | 1 |
| Royal, R | 1 |
| Murata, S | 2 |
| Yamamoto, H | 7 |
| Naitoh, H | 2 |
| Yamaguchi, T | 11 |
| Kaida, S | 2 |
| Shimizu, T | 3 |
| Shiomi, H | 1 |
| Naka, S | 1 |
| Tani, T | 4 |
| Tani, M | 4 |
| Gayarre, J | 1 |
| Martín-Gimeno, P | 1 |
| Osorio, A | 1 |
| Paumard, B | 1 |
| Barroso, A | 1 |
| Fernández, V | 1 |
| de la Hoya, M | 1 |
| Rojo, A | 1 |
| Caldés, T | 1 |
| Palacios, J | 1 |
| Urioste, M | 1 |
| Benítez, J | 1 |
| García, MJ | 1 |
| Morales-Soriano, R | 1 |
| Esteve-Pérez, N | 1 |
| Segura-Sampedro, JJ | 1 |
| Cascales-Campos, P | 1 |
| Barrios, P | 1 |
| Takebayashi, K | 1 |
| Miyake, T | 1 |
| Xin, J | 1 |
| Wang, S | 2 |
| Zhang, L | 2 |
| Xin, B | 1 |
| He, Y | 1 |
| Wang, J | 4 |
| Shen, L | 1 |
| Zhang, Z | 3 |
| Yao, C | 1 |
| Kissane, J | 1 |
| Waybill, P | 1 |
| Wang, L | 5 |
| Li, PF | 1 |
| Geng, M | 4 |
| Cao, YC | 3 |
| Yin, YC | 3 |
| Kang, YK | 3 |
| Chang, HM | 4 |
| Yook, JH | 3 |
| Ryu, MH | 3 |
| Park, I | 1 |
| Min, YJ | 1 |
| Zang, DY | 2 |
| Kim, GY | 1 |
| Yang, DH | 2 |
| Jang, SJ | 2 |
| Park, YS | 2 |
| Lee, JL | 3 |
| Kim, TW | 3 |
| Oh, ST | 3 |
| Park, BK | 1 |
| Jung, HY | 2 |
| Kim, BS | 4 |
| Farshid, P | 1 |
| Darvishi, A | 1 |
| Naguib, N | 1 |
| Bazrafshan, B | 1 |
| Paul, J | 1 |
| Mbalisike, E | 1 |
| Vogl, TJ | 1 |
| Ahn, MS | 2 |
| Kang, SY | 2 |
| Lee, HW | 2 |
| Jeong, SH | 2 |
| Park, JS | 2 |
| Lee, KJ | 1 |
| Cho, YK | 3 |
| Han, SU | 2 |
| Lee, SY | 1 |
| Lim, HY | 2 |
| Choi, JH | 3 |
| Werner, D | 1 |
| Atmaca, A | 2 |
| Pauligk, C | 1 |
| Pustowka, A | 1 |
| Jäger, E | 3 |
| Al-Batran, SE | 4 |
| Yoo, C | 1 |
| Lee, YJ | 1 |
| Kim, JH | 2 |
| Ueda, A | 1 |
| Hosokawa, A | 1 |
| Ogawa, K | 2 |
| Yoshita, H | 1 |
| Mihara, H | 1 |
| Ando, T | 2 |
| Kajiura, S | 1 |
| Fujinami, H | 1 |
| Nishikawa, J | 1 |
| Minemura, M | 1 |
| Terada, M | 1 |
| Kobayashi, T | 11 |
| Horikawa, N | 1 |
| Yabushita, K | 3 |
| Note, M | 2 |
| Sugiyama, T | 1 |
| Chen, X | 1 |
| Cao, R | 1 |
| Li, P | 1 |
| Passot, G | 2 |
| Bakrin, N | 2 |
| Roux, AS | 1 |
| Vaudoyer, D | 1 |
| Gilly, FN | 4 |
| Glehen, O | 4 |
| Cotte, E | 3 |
| Miyakawa, A | 1 |
| Ishibashi, H | 3 |
| Takashina, A | 1 |
| Ishigaki, K | 1 |
| Iwai, Y | 1 |
| Abe, H | 2 |
| Katagiri, T | 1 |
| Sakaguchi, Y | 3 |
| Matsushima, T | 1 |
| Tamura, T | 1 |
| Komata, S | 1 |
| Kubota, M | 1 |
| Suzuki, Y | 1 |
| Nakamura, A | 2 |
| Itobayashi, E | 1 |
| Shimura, H | 2 |
| Shimura, K | 1 |
| Miranda, MB | 1 |
| Hartmann, JT | 5 |
| Kripp, M | 1 |
| Gencer, D | 1 |
| Hochhaus, A | 4 |
| Hofheinz, RD | 5 |
| Merx, K | 1 |
| Tabrizian, P | 1 |
| Shrager, B | 1 |
| Jibara, G | 1 |
| Yang, MJ | 1 |
| Romanoff, A | 1 |
| Hiotis, S | 1 |
| Sarpel, U | 1 |
| Labow, DM | 1 |
| Ahlgren, J | 1 |
| Patel, N | 1 |
| Simmens, S | 1 |
| Akin, E | 1 |
| Bishop, C | 1 |
| Kirkel, D | 1 |
| Siegel, P | 1 |
| Schuck, S | 1 |
| Guebre-Xabiher, H | 1 |
| Siegel, R | 1 |
| Song, GW | 1 |
| Choi, YW | 1 |
| Sheen, SS | 1 |
| Han, JH | 1 |
| Xu, X | 1 |
| Qian, LJ | 1 |
| Su, XY | 1 |
| He, KF | 1 |
| Jin, KT | 1 |
| Gu, LH | 1 |
| Feng, JG | 1 |
| Li, GL | 1 |
| Zhou, Q | 1 |
| Xu, ZZ | 1 |
| Wang, HH | 1 |
| Zhang, J | 3 |
| Cao, J | 1 |
| Teng, LS | 1 |
| Schneider, CC | 1 |
| Fischer, N | 1 |
| Bühler, S | 1 |
| Venturelli, S | 1 |
| Berger, A | 1 |
| Burkard, M | 1 |
| Kirschniak, A | 1 |
| Bachmann, R | 1 |
| Glatzle, J | 1 |
| Seki, H | 1 |
| Ohi, H | 1 |
| Ozaki, T | 1 |
| Yabusaki, H | 2 |
| Zhao, J | 2 |
| Bai, Z | 1 |
| Feng, F | 1 |
| Song, E | 1 |
| Du, F | 1 |
| Shen, G | 1 |
| Ji, F | 1 |
| Li, G | 2 |
| Ma, X | 1 |
| Hang, X | 1 |
| Xu, B | 1 |
| Yang, M | 1 |
| Liu, Y | 2 |
| Hou, W | 1 |
| Zhi, X | 1 |
| Zhang, C | 1 |
| Jiang, X | 1 |
| Pan, F | 1 |
| Yang, Y | 2 |
| Ni, J | 1 |
| Cui, D | 1 |
| Park, SH | 1 |
| Kim, YS | 1 |
| Hong, J | 1 |
| Park, J | 1 |
| Nam, E | 1 |
| Cho, EK | 1 |
| Shin, DB | 1 |
| Lee, JH | 1 |
| Lee, WK | 1 |
| Chung, M | 1 |
| Yang, XJ | 2 |
| Li, Y | 3 |
| al-shammaa Hassan, AH | 1 |
| Yang, GL | 2 |
| Liu, SY | 1 |
| Lu, YL | 1 |
| Zhang, JW | 1 |
| Yonemura, Y | 24 |
| Ota, K | 3 |
| Kurita, S | 1 |
| Nishimura, M | 2 |
| Ogawa, M | 8 |
| Kamei, Y | 1 |
| Imai, K | 1 |
| Ariyoshi, Y | 3 |
| Kataoka, K | 1 |
| Murakami, M | 4 |
| Oyama, A | 1 |
| Hoshino, A | 1 |
| Amo, H | 1 |
| Kato, T | 3 |
| Yuan, Z | 1 |
| Ye, XD | 1 |
| Dong, S | 1 |
| Xu, LC | 1 |
| Sun, ZC | 1 |
| Xiao, XS | 1 |
| Miyamoto, H | 3 |
| Yoshida, M | 6 |
| Yamanouchi, T | 1 |
| Kanda, K | 1 |
| Zinnouchi, K | 1 |
| Kiyozumi, T | 1 |
| Koba, I | 1 |
| Akashi, R | 1 |
| Sagara, K | 1 |
| Li, M | 1 |
| Wang, D | 1 |
| Zhong, B | 1 |
| Tucker, S | 1 |
| Lu, C | 1 |
| Cheng, J | 2 |
| Cao, C | 1 |
| Xu, J | 2 |
| Pan, H | 1 |
| Matsunaga, T | 1 |
| Tsuji, Y | 8 |
| Kaai, K | 1 |
| Kohno, S | 2 |
| Hirayama, R | 2 |
| Alpers, DH | 1 |
| Komoda, T | 1 |
| Hara, A | 1 |
| Takada, J | 3 |
| Kenno, S | 1 |
| Aoki, T | 6 |
| Hamada, H | 5 |
| Katsuki, Y | 5 |
| Kanagavel, D | 1 |
| Pokataev, IA | 1 |
| Fedyanin, MY | 1 |
| Tryakin, AA | 1 |
| Bazin, IS | 1 |
| Narimanov, MN | 1 |
| Yakovleva, ES | 1 |
| Garin, AM | 1 |
| Tjulandin, SA | 1 |
| Huang, YN | 1 |
| Xu, YY | 1 |
| Yang, SJ | 1 |
| Du, P | 1 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Cascinu, S | 2 |
| Galizia, E | 1 |
| Labianca, R | 5 |
| Ferraù, F | 1 |
| Pucci, F | 1 |
| Silva, RR | 2 |
| Luppi, G | 2 |
| Beretta, GD | 2 |
| Berardi, R | 1 |
| Scartozzi, M | 1 |
| Chen, S | 1 |
| Chen, YB | 1 |
| Zhou, ZW | 1 |
| Li, W | 2 |
| Sun, XW | 1 |
| Xu, DZ | 1 |
| Li, YF | 1 |
| Guan, YX | 1 |
| Feng, XY | 1 |
| Zhan, YQ | 1 |
| Zhong, Y | 1 |
| Shuzheng, M | 1 |
| Yingge, Z | 1 |
| Tod, M | 1 |
| Steghens, A | 1 |
| Mohamed, F | 1 |
| Huang, CQ | 1 |
| Suo, T | 1 |
| Mei, LJ | 1 |
| Cheng, FL | 1 |
| Zhou, YF | 1 |
| Xiong, B | 1 |
| Hamaguchi, T | 1 |
| Shirao, K | 4 |
| Ohtsu, A | 5 |
| Hyodo, I | 4 |
| Arai, Y | 8 |
| Takiuchi, H | 1 |
| Fujii, H | 1 |
| Saito, H | 5 |
| Denda, T | 1 |
| Koizumi, W | 4 |
| Iwase, H | 4 |
| Boku, N | 4 |
| Hu, JF | 1 |
| Li, GQ | 1 |
| Xiao, X | 1 |
| Su, Q | 1 |
| Gabizon, A | 1 |
| Amitay, Y | 1 |
| Tzemach, D | 1 |
| Gorin, J | 1 |
| Shmeeda, H | 1 |
| Zalipsky, S | 1 |
| Yu, JC | 2 |
| Kang, WM | 2 |
| Ma, ZQ | 1 |
| Yin, GJ | 1 |
| Lan, KH | 1 |
| Hu, CY | 1 |
| Lu, Q | 1 |
| Tang, W | 1 |
| Wang, SF | 1 |
| Cui, S | 1 |
| Ba, M | 1 |
| Tang, Y | 1 |
| Liu, J | 4 |
| Wu, Y | 1 |
| Wang, B | 1 |
| Zhang, X | 1 |
| Tang, H | 1 |
| Zhong, S | 1 |
| Benizri, EI | 1 |
| Bereder, JM | 1 |
| Rahili, A | 1 |
| Bernard, JL | 1 |
| Benchimol, D | 1 |
| Hartung, G | 1 |
| Samel, S | 2 |
| Pichlmeier, U | 1 |
| Post, S | 2 |
| Hehlmann, R | 3 |
| Queisser, W | 4 |
| Kimata, M | 1 |
| Otani, Y | 5 |
| Kubota, T | 17 |
| Igarashi, N | 3 |
| Yokoyama, T | 3 |
| Wada, N | 1 |
| Yoshimizu, N | 1 |
| Fujii, M | 5 |
| Kameyama, K | 1 |
| Okada, Y | 4 |
| Kumai, K | 7 |
| Kitajima, M | 11 |
| Shibata, M | 2 |
| Nezu, T | 1 |
| Fujisaki, S | 1 |
| Andou, K | 1 |
| Tomita, R | 1 |
| Fukuzawa, M | 1 |
| Yano, M | 5 |
| Shiozaki, H | 3 |
| Inoue, M | 3 |
| Tamura, S | 2 |
| Doki, Y | 2 |
| Yasuda, T | 8 |
| Fujiwara, Y | 3 |
| Tsujinaka, T | 4 |
| Monden, M | 5 |
| Yano, S | 4 |
| Koufuji, K | 5 |
| Aoyagi, K | 6 |
| Murakami, N | 5 |
| Terasaki, Y | 3 |
| Miyagi, M | 2 |
| Takeda, J | 5 |
| Shirouzu, K | 5 |
| Sato, A | 1 |
| Ito, T | 7 |
| Tomita, T | 1 |
| Taguchi, S | 3 |
| Tasaka, K | 1 |
| Tomofuji, Y | 1 |
| Chinzei, T | 1 |
| Slater, S | 1 |
| Shamash, J | 1 |
| Wilson, P | 1 |
| Gallagher, CJ | 1 |
| Slevin, ML | 1 |
| Tebbutt, NC | 2 |
| Norman, A | 2 |
| Cunningham, D | 6 |
| Iveson, T | 1 |
| Seymour, M | 1 |
| Hickish, T | 1 |
| Harper, P | 1 |
| Maisey, N | 1 |
| Mochlinski, K | 1 |
| Prior, Y | 1 |
| Hill, M | 2 |
| Fushida, S | 9 |
| Nao, F | 1 |
| Kinami, S | 3 |
| Ninomiya, I | 5 |
| Fujimura, T | 16 |
| Nishimura, G | 5 |
| Ohta, T | 7 |
| Yokogawa, K | 1 |
| Miyamoto, K | 1 |
| Miwa, K | 11 |
| Jung, KH | 1 |
| Kim, TY | 1 |
| Kim, WS | 1 |
| Yang, HK | 2 |
| Lee, KU | 1 |
| Choe, KJ | 1 |
| Heo, DS | 1 |
| Bang, YJ | 1 |
| Kim, NK | 1 |
| Brown, TA | 1 |
| Ridge, JA | 1 |
| Goldberg, M | 1 |
| Fu, QG | 1 |
| Meng, FD | 1 |
| Shen, XD | 1 |
| Guo, RX | 1 |
| Kagawa, R | 1 |
| Nakayama, N | 2 |
| Sakata, S | 1 |
| Tada, M | 1 |
| Shizawa, R | 1 |
| Nagahori, Y | 1 |
| Kumamoto, N | 1 |
| Takeda, K | 1 |
| Hamaguchi, Y | 1 |
| Fukushima, T | 1 |
| Yamamoto, M | 7 |
| Mogaki, M | 1 |
| Fukasawa, S | 1 |
| Eguchi, K | 1 |
| Kawahara, M | 1 |
| Nagahori, K | 1 |
| Hosoi, H | 1 |
| Ohara, T | 3 |
| Akiyama, H | 6 |
| Kunisaki, C | 1 |
| Nomura, M | 2 |
| Matsuda, G | 1 |
| Otsuka, Y | 1 |
| Ono, H | 1 |
| Shimada, H | 2 |
| Akamo, Y | 2 |
| Takeyama, H | 2 |
| Funahashi, H | 1 |
| Yamamori, Y | 1 |
| Teranishi, F | 2 |
| Manabe, T | 2 |
| Shimada, Y | 4 |
| Yamamichi, N | 2 |
| Miyata, Y | 3 |
| Ikeda, N | 1 |
| Yamamoto, S | 3 |
| Fukuda, H | 2 |
| Yoshida, S | 7 |
| Nakajima, T | 21 |
| Ohta, K | 3 |
| Ohyama, S | 9 |
| Xiao, Q | 1 |
| Peng, B | 1 |
| Lai, Y | 1 |
| Zhang, S | 1 |
| Chen, D | 1 |
| Chen, C | 1 |
| Liu, FK | 1 |
| Qi, XP | 1 |
| Li, JS | 1 |
| Jiang, CM | 1 |
| Pang, MR | 1 |
| Gong, LY | 1 |
| Zhao, Q | 1 |
| Wang, LL | 1 |
| Yu, RC | 1 |
| Tang, WJ | 1 |
| Duan, P | 1 |
| Wang, ZM | 1 |
| Aihara, H | 1 |
| Maruoka, H | 1 |
| Kiyozaki, H | 2 |
| Konishi, F | 1 |
| Grau, JJ | 4 |
| Martín, M | 1 |
| Fuster, J | 2 |
| Pera, M | 2 |
| García-Valdecasas, JC | 2 |
| Bombí, JA | 1 |
| Bordas, JM | 1 |
| Alcobendas, F | 3 |
| Grande, L | 1 |
| Estapé, J | 4 |
| Yamaguchi, K | 2 |
| Miyashita, K | 9 |
| Aizawa, K | 2 |
| Todoroki, H | 2 |
| Kiyonaga, H | 1 |
| Chen, Z | 2 |
| Hu, J | 1 |
| Chen, J | 1 |
| Yan, L | 1 |
| Mao, Y | 1 |
| Zou, L | 1 |
| Tao, K | 1 |
| Zhou, X | 1 |
| Kelleher, M | 1 |
| Andreyev, J | 1 |
| Allen, M | 1 |
| Nashimoto, A | 2 |
| Furukawa, H | 9 |
| Kitamura, M | 19 |
| Kinoshita, T | 2 |
| Yamamura, Y | 6 |
| Sasako, M | 2 |
| Kunii, Y | 7 |
| Motohashi, H | 1 |
| Suganuma, K | 1 |
| Saikawa, Y | 6 |
| Abe, S | 2 |
| Furukawa, T | 8 |
| Hasegawa, H | 6 |
| Watanabe, M | 7 |
| Nakayama, H | 1 |
| Okabe, H | 1 |
| Bamias, A | 1 |
| Papamichael, D | 1 |
| Syrigos, K | 1 |
| Pavlidis, N | 1 |
| Wen, MC | 1 |
| Chen, CH | 2 |
| Ho, WL | 1 |
| Liang, H | 2 |
| Wang, P | 1 |
| Wang, XN | 1 |
| Liu, N | 1 |
| Yue, X | 1 |
| Wang, DC | 1 |
| Wang, JC | 1 |
| Hao, XS | 2 |
| Chen, JS | 1 |
| Lin, YC | 1 |
| Liau, CT | 1 |
| Wang, CH | 1 |
| Liaw, CC | 1 |
| LANGDON, EA | 1 |
| OTTOMAN, RE | 1 |
| ROCHLIN, DB | 1 |
| SMART, CR | 1 |
| MARSHALL, SF | 1 |
| FUJIMORI, M | 1 |
| SAKAUCHI, G | 1 |
| IZUO, M | 2 |
| ABE, C | 1 |
| MORITA, S | 3 |
| NASHIMOTO, T | 1 |
| ISHIKAWA, S | 1 |
| SADMITSU, H | 1 |
| KAWAI, T | 1 |
| HATTORI, T | 40 |
| ITO, H | 1 |
| HIRATA, K | 3 |
| FUJITA, H | 5 |
| ENDO, S | 1 |
| KAGEYAMA, T | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| SULLIVAN, RD | 1 |
| ZUREK, WZ | 1 |
| ITO, I | 5 |
| KIKUCHI, K | 12 |
| ANEHA, Y | 1 |
| YAMANAKA, M | 1 |
| TANEICHI, T | 1 |
| NATSUME, R | 1 |
| KANNO, H | 2 |
| NAGANUMA, H | 1 |
| SATO, Y | 7 |
| YOSHIZUMI, M | 1 |
| SATO, T | 4 |
| YAMAGATA, S | 1 |
| WATANABE, R | 1 |
| KATSUMI, M | 1 |
| SHINO, K | 1 |
| OKAMURA, T | 4 |
| KARIYA, Y | 1 |
| IWAHASHI, H | 1 |
| NAKASE, Y | 1 |
| NISHIGAKI, A | 1 |
| SHIOZAKI, A | 1 |
| INOKUCHI, K | 22 |
| NAKAMURA, T | 7 |
| IENAGA, S | 1 |
| AKIYOSHI, T | 10 |
| IKEDA, T | 2 |
| Yang, JK | 1 |
| Zhen, J | 1 |
| Shen, KP | 1 |
| Taniguchi, H | 2 |
| Kimura, Y | 2 |
| Takiguchi, S | 2 |
| Takeno, A | 1 |
| Fujitani, K | 1 |
| Hirao, M | 1 |
| Takeda, Y | 1 |
| Kashiwazaki, M | 1 |
| Mishima, H | 1 |
| Ikenaga, M | 1 |
| Sawamura, T | 1 |
| Hasuike, Y | 1 |
| Katayanagi, S | 2 |
| Arai, K | 22 |
| Iwasaki, Y | 14 |
| Takahashi, K | 4 |
| Matsumoto, H | 3 |
| Douglass, HO | 6 |
| Mori, T | 5 |
| Sugita, Y | 1 |
| Azama, T | 1 |
| Ishii, T | 1 |
| Taniguchi, K | 3 |
| Yamazaki, K | 2 |
| Schreiber, V | 1 |
| Sayag-Beaujard, AC | 2 |
| Osinsky, D | 1 |
| Freyer, G | 1 |
| François, Y | 2 |
| Vignal, J | 2 |
| Miura, Y | 2 |
| Kataoka, H | 1 |
| Joh, T | 1 |
| Tada, T | 1 |
| Asai, K | 1 |
| Nakanishi, M | 2 |
| Okada, N | 2 |
| Okada, H | 2 |
| Hirao, K | 1 |
| Hirasaki, S | 1 |
| Tsuzuki, T | 1 |
| Kajiwara, T | 2 |
| Bennett, JJ | 1 |
| Adusumilli, P | 1 |
| Petrowsky, H | 1 |
| Burt, BM | 1 |
| Roberts, G | 1 |
| Delman, KA | 1 |
| Zager, JS | 1 |
| Chou, TC | 1 |
| Fong, Y | 1 |
| Willer, A | 2 |
| Weisser, A | 1 |
| Gnad, U | 1 |
| Saussele, S | 2 |
| Kreil, S | 2 |
| Domingo-Domenech, J | 1 |
| Morente, V | 1 |
| Bombí, A | 1 |
| Mellado, B | 1 |
| Albanell, J | 2 |
| Gascón, P | 1 |
| Katsumata, D | 1 |
| Sasaki, K | 1 |
| Miyachi, K | 1 |
| Joujima, T | 1 |
| Tsumuraya, M | 1 |
| Onodera, S | 1 |
| Shimoda, W | 1 |
| Yoda, N | 1 |
| Ohkawa, T | 1 |
| Odaka, N | 1 |
| Kaneko, H | 1 |
| Sunagawa, M | 2 |
| Yin, F | 1 |
| Hu, WH | 1 |
| Qiao, TD | 1 |
| Fan, DM | 3 |
| Shimada, K | 2 |
| Okubo, Y | 1 |
| Tanaka, S | 3 |
| Tanabe, S | 3 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 2 |
| Tanaka, K | 4 |
| Ottey, M | 1 |
| Han, SY | 1 |
| Druck, T | 1 |
| Barnoski, BL | 1 |
| McCorkell, KA | 1 |
| Croce, CM | 1 |
| Raventos-Suarez, C | 1 |
| Fairchild, CR | 1 |
| Wang, Y | 2 |
| Huebner, K | 1 |
| Imaizumi, T | 1 |
| Hirakata, A | 1 |
| Kato, S | 1 |
| Kawano, Y | 1 |
| Mineta, S | 1 |
| Taniai, N | 1 |
| Mamada, Y | 1 |
| Yokomuro, S | 1 |
| Yoshida, H | 2 |
| Akimaru, K | 1 |
| Tajiri, T | 1 |
| Ohgaki, M | 2 |
| Takenaka, A | 1 |
| Shiomi, A | 1 |
| Chou, H | 1 |
| Takashina, K | 1 |
| Kawakami, S | 1 |
| Fujita, Y | 2 |
| Hagiwara, A | 14 |
| Yamagishi, H | 2 |
| Narahara, H | 1 |
| Sugimoto, N | 1 |
| Iishi, H | 1 |
| Tatsuta, M | 2 |
| Zheng, LD | 3 |
| Tong, QS | 3 |
| Qian, W | 1 |
| Kurihara, M | 15 |
| Popiela, T | 3 |
| Kulig, J | 3 |
| Czupryna, A | 1 |
| Szczepanik, AM | 1 |
| Zembala, M | 1 |
| Zeng, FQ | 1 |
| Chen, FM | 1 |
| Dong, JH | 1 |
| Lu, GC | 1 |
| Meng, H | 1 |
| Lu, CD | 1 |
| Dai, DJ | 1 |
| Sun, YL | 1 |
| Tanigawa, N | 1 |
| Kawamura, T | 1 |
| Bandou, E | 1 |
| Takahashi, S | 2 |
| Sawa, T | 12 |
| Matsuki, N | 8 |
| Gnad-Vogt, SU | 1 |
| Willeke, F | 1 |
| Pilz, L | 1 |
| Rudi, J | 1 |
| Werle, S | 1 |
| Bergtholdt, D | 1 |
| Chong, G | 1 |
| Ma, L | 1 |
| Xie, YL | 1 |
| Yu, Y | 1 |
| Zhang, QN | 1 |
| Ji, J | 1 |
| Ji, YB | 1 |
| Yuan, F | 1 |
| Liu, BY | 1 |
| Zhu, ZG | 1 |
| Lin, YZ | 1 |
| Wu, CH | 1 |
| Wu, RL | 1 |
| Tang, HW | 1 |
| Sun, H | 1 |
| Naito, H | 1 |
| Hamada, T | 1 |
| Shinohara, T | 1 |
| Mino, K | 1 |
| Shibazaki, W | 1 |
| Minagawa, N | 1 |
| Orimo, T | 1 |
| Ichimura, W | 1 |
| Giuliani, F | 1 |
| Molica, S | 1 |
| Maiello, E | 1 |
| Battaglia, C | 1 |
| Gebbia, V | 2 |
| Di Bisceglie, M | 1 |
| Vinciarelli, G | 1 |
| Gebbia, N | 1 |
| Colucci, G | 1 |
| Ogata, T | 1 |
| Nishida, J | 2 |
| Seo, K | 1 |
| Hamaya, M | 1 |
| Kouno, T | 1 |
| Sato, S | 4 |
| Yoshida, K | 4 |
| Tsuchida, A | 2 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Kato, R | 1 |
| Fujita, J | 1 |
| Hoshimoto, S | 1 |
| Hejna, M | 1 |
| Wöhrer, S | 1 |
| Schmidinger, M | 1 |
| Raderer, M | 1 |
| Aiko, S | 1 |
| Yoshizumi, Y | 1 |
| Sugiura, Y | 1 |
| Ishizuka, T | 1 |
| Sakano, T | 1 |
| Kumano, I | 1 |
| Maehara, T | 1 |
| Tentes, AA | 1 |
| Markakidis, SK | 1 |
| Karanikiotis, C | 1 |
| Fiska, A | 1 |
| Tentes, IK | 1 |
| Manolopoulos, VG | 1 |
| Dimitriou, T | 1 |
| Yu, W | 4 |
| Sasaki, T | 8 |
| Higuchi, K | 1 |
| Saigenji, K | 1 |
| Qu, QL | 1 |
| Zhang, YG | 1 |
| Yang, LZ | 1 |
| Sun, L | 1 |
| Peng, WZ | 1 |
| Liu, YQ | 1 |
| Fan, YP | 1 |
| Guo, WD | 1 |
| Zhang, Q | 2 |
| Sun, YM | 1 |
| Fu, J | 2 |
| Zhang, W | 2 |
| Zheng, ZX | 1 |
| Huang, CZ | 1 |
| Yuan, XH | 1 |
| Shah, R | 1 |
| Beem, E | 1 |
| Sautina, L | 1 |
| Zharikov, SI | 1 |
| Segal, MS | 1 |
| Wang, XG | 1 |
| Zheng, H | 1 |
| Li, GX | 1 |
| Luo, RC | 1 |
| Oba, K | 1 |
| Tsuburaya, A | 1 |
| Kodera, Y | 2 |
| Kobayashi, M | 3 |
| Sakamoto, J | 2 |
| Cho, BC | 1 |
| Jeung, HC | 1 |
| Choi, HJ | 1 |
| Rha, SY | 2 |
| Hyung, WJ | 1 |
| Cheong, JH | 1 |
| Noh, SH | 3 |
| Chung, HC | 3 |
| Koo, DH | 1 |
| Lee, JS | 1 |
| Chen, ZJ | 1 |
| Huang, YP | 1 |
| Han, SL | 1 |
| Liu, NX | 1 |
| Zhu, GB | 1 |
| Yao, JG | 1 |
| Kerber, A | 1 |
| Dechow, C | 1 |
| Reitsamer, E | 1 |
| Schmidt, S | 1 |
| Kolassa, Y | 1 |
| Neumann, A | 1 |
| Weidmann, E | 1 |
| Pintoffl, JP | 1 |
| Quietzsch, D | 2 |
| Meisinger, I | 1 |
| Horger, M | 1 |
| Nehls, O | 1 |
| Bokemeyer, C | 2 |
| Kanz, L | 2 |
| Sasaki, E | 1 |
| Maeda, Y | 2 |
| Sun, T | 1 |
| Zhang, JR | 1 |
| Jia, HS | 1 |
| Zhang, GY | 1 |
| Chen, XC | 1 |
| Pan, K | 1 |
| Xia, LG | 1 |
| Zuo, M | 1 |
| Zheng, T | 1 |
| Di Bartolomeo, M | 1 |
| Buzzoni, R | 1 |
| Mariani, L | 1 |
| Ferrario, E | 1 |
| Katia, D | 1 |
| Gevorgyan, A | 1 |
| Zilembo, N | 1 |
| Bordonaro, R | 1 |
| Bochicchio, AM | 1 |
| Massidda, B | 1 |
| Ardizzoia, A | 1 |
| Ardizzoni, A | 1 |
| Marini, G | 2 |
| Aitini, E | 1 |
| Schieppati, G | 1 |
| Comella, G | 1 |
| Pinotti, G | 1 |
| Palazzo, S | 1 |
| Cicero, G | 1 |
| Bajetta, E | 1 |
| Villa, E | 1 |
| Fagnani, D | 1 |
| Reguzzoni, G | 1 |
| Agostana, B | 1 |
| Oliani, C | 1 |
| Kildani, B | 1 |
| Duro, M | 1 |
| Botta, M | 1 |
| Mozzana, R | 1 |
| Mantovani, G | 1 |
| Scaringi, S | 1 |
| Kianmanesh, R | 1 |
| Sabate, JM | 1 |
| Facchiano, E | 1 |
| Jouet, P | 1 |
| Coffin, B | 1 |
| Parmentier, G | 1 |
| Hay, JM | 1 |
| Flamant, Y | 1 |
| Msika, S | 1 |
| Fu, ZJ | 2 |
| Wang, XY | 1 |
| Tai, YH | 2 |
| Lim, ST | 1 |
| Jeong, HJ | 1 |
| Kim, DW | 1 |
| Yim, CY | 1 |
| Sohn, MH | 1 |
| Xia, L | 1 |
| Zhang, D | 1 |
| Du, R | 1 |
| Pan, Y | 1 |
| Zhao, L | 1 |
| Sun, S | 1 |
| Hong, L | 1 |
| Fan, D | 1 |
| Chouillard, E | 1 |
| Ata, T | 1 |
| De Jonghe, B | 1 |
| Maggiori, L | 1 |
| Helmy, N | 1 |
| Coscas, Y | 1 |
| Outin, H | 1 |
| Kitaoka, H | 4 |
| Hirano, T | 2 |
| Heim, ME | 3 |
| Gisselbrecht, C | 4 |
| Smith, FP | 5 |
| MacDonald, JS | 6 |
| Korsmeyer, SJ | 1 |
| Boiron, M | 4 |
| Woolley, PV | 4 |
| Schein, PS | 7 |
| Nakao, I | 5 |
| Uchino, H | 2 |
| Orita, K | 8 |
| Kaido, I | 1 |
| Kimura, T | 5 |
| Goto, Y | 3 |
| Kondo, T | 23 |
| Takino, T | 2 |
| Taguchi, T | 34 |
| Fujimoto, S | 27 |
| Miyazaki, T | 1 |
| Miyoshi, A | 1 |
| Yachi, A | 1 |
| Ogawa, N | 10 |
| Furue, H | 6 |
| Grieco, A | 1 |
| Lasorella, A | 1 |
| Astone, A | 1 |
| Vagliviello, L | 1 |
| Bartoloni, C | 1 |
| Barone, C | 1 |
| Matsuka, Y | 1 |
| Ejiri, T | 1 |
| Asano, K | 1 |
| Crocker, J | 1 |
| Jones, EL | 1 |
| Jolivet, J | 1 |
| Giroux, L | 1 |
| Laurin, S | 1 |
| Gruber, J | 1 |
| Bettez, P | 1 |
| Band, PR | 1 |
| Eichler, G | 1 |
| Habs, M | 1 |
| Schmähl, D | 1 |
| Milla, A | 1 |
| Curto, J | 2 |
| Pera, C | 3 |
| Perry, DJ | 1 |
| Niimoto, M | 20 |
| Oride, M | 3 |
| Inagaki, J | 1 |
| Horikoshi, N | 2 |
| Ezaki, K | 1 |
| Inoue, K | 12 |
| Ikeda, K | 4 |
| Usui, N | 1 |
| Nakada, H | 1 |
| Yasue, M | 2 |
| Kito, T | 3 |
| Nakazato, H | 10 |
| Yamada, E | 1 |
| Sekine, S | 1 |
| Katsumi, S | 2 |
| Sato, K | 3 |
| Kawaguchi, T | 2 |
| Tanaka, T | 9 |
| Iguchi, K | 1 |
| Hashimoto, I | 3 |
| Kano, T | 4 |
| Notsuka, T | 2 |
| Hiramoto, Y | 1 |
| Abe, Y | 3 |
| Masuda, H | 4 |
| Kumashiro, R | 4 |
| Saji, S | 12 |
| Kajima, T | 1 |
| Takao, H | 8 |
| Ban, K | 2 |
| Ohashi, H | 3 |
| Kunieda, T | 1 |
| Sakata, K | 3 |
| Ogoshi, K | 4 |
| Kondoh, Y | 2 |
| Tajima, T | 3 |
| Mitomi, T | 5 |
| Tamada, R | 9 |
| Yamada, F | 3 |
| Kagami, H | 1 |
| Fukutome, A | 1 |
| Mastumine, T | 1 |
| Miura, T | 1 |
| Takahashi, M | 18 |
| Ikeuchi, H | 1 |
| Kano, K | 1 |
| Machida, T | 1 |
| Takeda, T | 3 |
| Yamada, S | 2 |
| Takahashi, T | 19 |
| Takagi, K | 1 |
| Kuno, K | 1 |
| Kajitani, T | 2 |
| Wakui, A | 10 |
| Nakagami, K | 1 |
| Hirono, M | 2 |
| Shrestha, RD | 16 |
| Miyazaki, M | 6 |
| Ohyama, Y | 1 |
| Endoh, F | 5 |
| Shimura, T | 4 |
| Takahashi, O | 4 |
| Sugasawa, H | 4 |
| Okui, K | 16 |
| Igarashi, K | 4 |
| Maeta, M | 6 |
| Koga, S | 6 |
| Shimizu, N | 5 |
| Osaki, Y | 2 |
| Kanayama, H | 2 |
| Hamazoe, R | 5 |
| Yamane, T | 2 |
| Karino, T | 2 |
| Oda, M | 2 |
| Abe, O | 20 |
| Muto, T | 6 |
| Izumi, T | 5 |
| Sasaki, Y | 10 |
| Maruyama, T | 2 |
| Miyasaka, K | 1 |
| Suga, S | 9 |
| Kimura, K | 5 |
| Yokoyama, Y | 3 |
| Ueda, T | 2 |
| Takeda, M | 2 |
| Lee, R | 2 |
| Mizuguchi, N | 2 |
| Miwa, H | 4 |
| Imaizumi, M | 4 |
| Kamei, H | 4 |
| Ichihashi, H | 6 |
| Sumi, K | 1 |
| Hakuta, Y | 1 |
| Ashizawa, I | 1 |
| Hara, T | 2 |
| Nakazima, K | 1 |
| Toge, T | 12 |
| Nakao, A | 1 |
| Yoshinaka, K | 10 |
| Sato, H | 7 |
| Suwa, T | 2 |
| Ichinoe, A | 1 |
| Itoh, S | 1 |
| Aoyama, K | 1 |
| Kato, M | 8 |
| Handa, Y | 1 |
| Shirakabe, H | 2 |
| Mukai, M | 4 |
| Yamazaki, Y | 5 |
| Amano, H | 1 |
| Hiura, T | 2 |
| Oda, S | 3 |
| Namiki, S | 3 |
| Nakajima, K | 5 |
| Nagao, K | 4 |
| Panettiere, FJ | 1 |
| Haas, C | 1 |
| McDonald, B | 1 |
| Costanzi, JJ | 1 |
| Talley, RW | 1 |
| Athens, J | 1 |
| Oishi, N | 1 |
| Heilbrun, LK | 1 |
| Chen, TT | 1 |
| Okuyama, K | 3 |
| Isono, K | 2 |
| Satoh, H | 3 |
| Onoda, S | 3 |
| Tohnosu, N | 2 |
| Yamamoto, Y | 2 |
| Ryu, M | 1 |
| Koide, Y | 3 |
| Kimura, M | 2 |
| Hanaoka, A | 1 |
| Kojima, K | 2 |
| Inoue, T | 2 |
| Nakamura, K | 5 |
| Moriyama, M | 1 |
| Oka, T | 3 |
| Tsurumi, T | 1 |
| Iijima, T | 1 |
| Gohchi, A | 1 |
| Kawata, S | 4 |
| Ohta, M | 13 |
| Kawaguchi, M | 2 |
| Arinaga, S | 9 |
| Miyazaki, S | 2 |
| Koba, F | 3 |
| Wada, T | 5 |
| Tsuji, H | 6 |
| Smolianskaia, AZ | 1 |
| Spasibina, TV | 1 |
| Sato, M | 3 |
| Ishidoya, T | 1 |
| Joko, Y | 1 |
| Kiyasu, Y | 1 |
| Sakai, K | 1 |
| Kimura, S | 1 |
| Nosoh, Y | 6 |
| Nishimawari, K | 1 |
| Yamaguchi, M | 5 |
| Toda, T | 3 |
| Furusawa, M | 6 |
| Nakada, M | 2 |
| Lavin, PT | 1 |
| Goudsmit, A | 1 |
| Klaassen, DJ | 1 |
| Paul, AR | 1 |
| Niimi, K | 1 |
| Matsuki, K | 1 |
| Tomoda, S | 1 |
| Nakano, A | 2 |
| Meguro, S | 2 |
| Nagata, T | 2 |
| Yokoyama, K | 2 |
| Chinen, T | 2 |
| Yamazaki, H | 2 |
| Kuraishi, Y | 1 |
| Abe, M | 1 |
| Isogai, Y | 2 |
| Nishi, I | 1 |
| Harashima, S | 1 |
| Ohashi, Y | 1 |
| Kanko, T | 1 |
| Saito, T | 4 |
| Ochi, K | 2 |
| Takeshita, K | 2 |
| Habu, H | 1 |
| Hoshi, K | 1 |
| Tanaka, N | 6 |
| Fornasiero, A | 3 |
| Cartei, G | 2 |
| Daniele, O | 1 |
| Fosser, V | 1 |
| Fiorentino, MV | 1 |
| Ridolfi, R | 2 |
| Casadei Giunchi, D | 1 |
| Cortesi, C | 1 |
| Maltoni, M | 1 |
| Ravaioli, A | 2 |
| Amadori, D | 3 |
| Soukop, M | 2 |
| McArdle, CS | 1 |
| Carter, DC | 1 |
| Smyth, JF | 1 |
| Allan, SG | 1 |
| Kaye, SB | 1 |
| Sangster, G | 1 |
| Calman, KC | 1 |
| Hutcheon, AW | 1 |
| Haim, N | 2 |
| Epelbaum, R | 1 |
| Cohen, Y | 2 |
| Robinson, E | 2 |
| Waldhorn, RE | 1 |
| Tsou, E | 1 |
| Kerwin, DM | 1 |
| Gill, PG | 1 |
| Jones, AM | 1 |
| Abbott, R | 1 |
| Fraschini, P | 1 |
| Beretta, G | 2 |
| Arnoldi, E | 1 |
| Tedeschi, L | 1 |
| Luporini, G | 1 |
| Haas, CD | 1 |
| Mansfield, CM | 1 |
| Leichman, LP | 1 |
| Considine, B | 1 |
| Bukowski, RM | 3 |
| Gunderson, LL | 1 |
| Hoskins, RB | 1 |
| Cohen, AC | 1 |
| Kaufman, S | 1 |
| Wood, WC | 1 |
| Carey, RW | 1 |
| Hara, K | 1 |
| Furuta, K | 1 |
| Shinoda, M | 1 |
| Yajima, K | 2 |
| Yasuda, S | 2 |
| Nakazaki, S | 1 |
| Kiyomitsu, Y | 1 |
| Watanabe, K | 2 |
| Tanneberger, S | 1 |
| Hoth, DF | 1 |
| Brunet, R | 1 |
| Lagarde, C | 1 |
| Belpomme, D | 1 |
| Mignot, L | 1 |
| Marty, M | 1 |
| Mathé, G | 1 |
| Reich, SD | 1 |
| Nakatani, K | 4 |
| Miyagi, N | 4 |
| Ezaki, T | 4 |
| Shiratori, T | 3 |
| Konishi, Y | 2 |
| Ito, S | 1 |
| Hirono, S | 1 |
| Gropp, C | 1 |
| Havemann, K | 1 |
| Kurosu, Y | 2 |
| Fukamachi, S | 1 |
| Honda, T | 1 |
| Morita, K | 1 |
| Sakata, Y | 7 |
| Yoshida, Y | 4 |
| Komatsu, Y | 1 |
| Sugawara, K | 1 |
| Nishimura, S | 1 |
| Den, N | 1 |
| Nakano, N | 1 |
| Asakawa, H | 1 |
| Ono, F | 1 |
| Kasai, Y | 2 |
| Sugie, S | 2 |
| Hayasaka, A | 2 |
| Itoh, I | 3 |
| Sugiyama, Y | 9 |
| Ohya, M | 1 |
| Tomita, M | 3 |
| Kosaki, G | 7 |
| Iwanaga, T | 7 |
| Hioki, K | 1 |
| Yura, J | 2 |
| Hirano, M | 1 |
| Miura, K | 3 |
| Takemiya, S | 1 |
| Hanatani, Y | 1 |
| Tsuyuki, K | 1 |
| Asanuma, F | 2 |
| Ishibiki, K | 10 |
| Takahashi, N | 1 |
| Honigman, J | 1 |
| Seeber, S | 1 |
| Cocconi, G | 3 |
| DeLisi, V | 1 |
| Di Blasio, B | 1 |
| Nagaya, S | 1 |
| Wada, H | 1 |
| Oka, K | 1 |
| Tanigawa, M | 1 |
| Tamaki, S | 1 |
| Tsuzi, K | 1 |
| Miyanishi, E | 1 |
| Wakita, Y | 1 |
| Minami, N | 1 |
| Deguchi, K | 1 |
| Konishi, K | 2 |
| Tsugawa, K | 4 |
| Kuroda, Y | 2 |
| Tsuji, M | 2 |
| Demachi, H | 1 |
| Testa, A | 1 |
| Valenza, R | 1 |
| Latteri, M | 1 |
| Bajardi, G | 1 |
| Mastrandrea, G | 1 |
| Cipolla, C | 1 |
| Pischedda, G | 1 |
| Curto, G | 1 |
| Cannata, G | 1 |
| Yoshino, K | 1 |
| Moriyama, A | 1 |
| Murata, I | 1 |
| Kuroda, T | 2 |
| Yoshikawa, I | 1 |
| Tabaru, A | 1 |
| Ogami, Y | 1 |
| Otsuki, M | 1 |
| Nakagawara, H | 1 |
| Itoh, H | 2 |
| Hirono, Y | 1 |
| Kaji, M | 2 |
| Nakai, M | 2 |
| Kasugai, H | 1 |
| Ishiyama, J | 1 |
| Imai, I | 1 |
| Fukuma, E | 1 |
| Miyajima, N | 1 |
| Kano, N | 1 |
| Yamakawa, T | 1 |
| Goto, S | 3 |
| Kera, J | 1 |
| Takeuchi, S | 1 |
| Kondo, M | 1 |
| Itani, K | 1 |
| Yoshikawa, T | 1 |
| Tanaka, Y | 2 |
| Watanabe, N | 1 |
| Hiraoka, M | 1 |
| Noguchi, M | 1 |
| Nakata, E | 1 |
| Okajima, K | 3 |
| Ishida, Y | 1 |
| Munetomo, Y | 1 |
| Gotoh, K | 1 |
| Toyohara, M | 1 |
| Miyazaki, H | 1 |
| Matsunaga, S | 1 |
| Maeura, Y | 1 |
| Suzuki, S | 1 |
| Muto, I | 1 |
| Nishimaki, T | 1 |
| Suzuki, T | 4 |
| Hatakeyama, K | 1 |
| Tanaka, O | 2 |
| Inoue, H | 6 |
| Adachi, M | 5 |
| Asoh, T | 1 |
| Ueo, H | 5 |
| Lise, M | 3 |
| Nitti, D | 3 |
| Marchet, A | 2 |
| Sahmoud, T | 2 |
| Buyse, M | 3 |
| Duez, N | 4 |
| Fiorentino, M | 1 |
| Dos Santos, JG | 2 |
| Rougier, P | 1 |
| Goseki, N | 1 |
| Maruyama, M | 1 |
| Nagai, K | 3 |
| Kando, F | 2 |
| Endo, M | 5 |
| Shimoju, K | 1 |
| Wada, Y | 1 |
| Adachi, W | 2 |
| Koike, S | 4 |
| Rafique, M | 1 |
| Kajikawa, S | 2 |
| Kaneko, G | 2 |
| Iida, F | 2 |
| Ishii, K | 1 |
| Schwartz, GK | 2 |
| Haimovitz-Friedman, A | 1 |
| Dhupar, SK | 1 |
| Ehleiter, D | 1 |
| Maslak, P | 2 |
| Lai, L | 1 |
| Loganzo, F | 1 |
| Kelsen, DP | 3 |
| Fuks, Z | 1 |
| Albino, AP | 1 |
| Okabayashi, K | 1 |
| Hiratsuka, M | 5 |
| Nishiyama, M | 10 |
| Saeki, S | 3 |
| Aogi, K | 2 |
| Hirabayashi, N | 6 |
| Wang, GM | 1 |
| Sun, GZ | 1 |
| Onodera, T | 2 |
| Nakagawara, G | 5 |
| Sano, K | 2 |
| Kaibara, N | 6 |
| Kakegawa, T | 4 |
| Nakano, S | 4 |
| Kitamura, S | 1 |
| Ohtani, T | 1 |
| Akazawa, S | 2 |
| Takahashi, H | 6 |
| Tokunaga, K | 1 |
| Kawasaki, S | 2 |
| Maruyama, S | 2 |
| Yosizane, K | 1 |
| Morokoshi, Y | 2 |
| Kawai, K | 2 |
| Soda, M | 2 |
| Misumi, T | 1 |
| Ikuta, H | 1 |
| Shibagaki, F | 1 |
| Ilson, DH | 1 |
| Cao, WX | 1 |
| Xiao, HB | 1 |
| Yin, HR | 1 |
| Wang, LM | 1 |
| Wan, WH | 1 |
| Lu, LJ | 1 |
| Tomita, K | 2 |
| Inaba, Y | 1 |
| Ohashi, K | 1 |
| Yoshizane, K | 1 |
| Minato, H | 1 |
| Sawai, K | 3 |
| Sakakibara, T | 2 |
| Fujioka, T | 2 |
| Ohara, M | 1 |
| Yada, Y | 1 |
| Imanishi, T | 1 |
| Ohyama, T | 1 |
| Tsujimoto, H | 2 |
| Ozaki, K | 3 |
| Chohei, S | 1 |
| Shimotsuma, M | 5 |
| Nakano, H | 3 |
| Nakamori, S | 2 |
| Ohigashi, H | 3 |
| Kameyama, M | 4 |
| Hirama, K | 1 |
| Mikami, Y | 3 |
| Nishi, T | 1 |
| Suzuki, H | 8 |
| Konn, M | 2 |
| Tajima, H | 1 |
| Horichi, H | 1 |
| Kumaki, T | 1 |
| Shima, K | 1 |
| Gouchi, A | 1 |
| Mannami, T | 1 |
| Konaga, E | 1 |
| Fuchimoto, S | 1 |
| Okamura, S | 1 |
| Sano, T | 2 |
| Katai, H | 1 |
| Maruyama, K | 1 |
| Bella, M | 1 |
| Zironi, S | 1 |
| Algeri, R | 1 |
| Di Costanzo, F | 2 |
| De Lisi, V | 2 |
| Mazzocchi, B | 1 |
| Rodinò, C | 1 |
| Soldani, M | 2 |
| Shchepotin, IB | 1 |
| Buras, RR | 1 |
| Nauta, RJ | 1 |
| Shabahang, M | 1 |
| Evans, SR | 1 |
| Chen, LJ | 6 |
| Zhang, SY | 5 |
| Zhang, JL | 4 |
| Li, S | 6 |
| Chen, M | 1 |
| Zhang, XY | 5 |
| Chen, XT | 5 |
| Yue, XF | 1 |
| Han, JX | 1 |
| Dai, ZQ | 1 |
| Liu, MZ | 1 |
| Yang, WY | 1 |
| Xu, JY | 1 |
| Zhou, JJ | 1 |
| Carrillo Hernández, JF | 1 |
| Ernesto de Obaldía Castillo, G | 1 |
| Ramírez Ortega, C | 1 |
| Frías Mendivil, M | 1 |
| Pardo, M | 1 |
| Maehara, Y | 13 |
| Okuyama, T | 2 |
| Kakeji, Y | 5 |
| Baba, H | 8 |
| Sugimachi, K | 17 |
| Sasagawa, T | 1 |
| Ho, N | 1 |
| Endo, T | 5 |
| Sekine, T | 1 |
| Sugiyama, K | 9 |
| Tomidokoro, T | 1 |
| Hatakeyama, S | 1 |
| Togashi, M | 1 |
| Onuki, K | 1 |
| Katagiri, J | 1 |
| Sakabe, T | 2 |
| Wakabayashi, K | 1 |
| Kochi, M | 1 |
| Mochizuki, F | 2 |
| Kasakura, Y | 1 |
| Yamagata, M | 1 |
| Noro, M | 1 |
| Osawa, T | 1 |
| Iwai, S | 1 |
| Sakai, Y | 2 |
| Kusano, F | 2 |
| Yamamoto, C | 1 |
| Maekawa, N | 2 |
| Sasaki, N | 1 |
| Tajiri, K | 1 |
| Tazawa, J | 2 |
| Arima, S | 3 |
| Ohsato, K | 3 |
| Hisatsugu, T | 5 |
| Endo, K | 2 |
| Adachi, Y | 1 |
| Kuwano, M | 1 |
| Kuo, TH | 4 |
| Kase, S | 3 |
| Tanino, H | 2 |
| Isobe, Y | 1 |
| Arimori, M | 1 |
| Inoue, Y | 2 |
| Nakamura, H | 1 |
| Akashi, H | 1 |
| Mizumoto, S | 1 |
| Yamasaki, K | 1 |
| Motoo, Y | 1 |
| Sawabu, N | 1 |
| Takemori, Y | 1 |
| Ohta, H | 2 |
| Okai, T | 1 |
| Yokoyama, H | 1 |
| Fujisaki, M | 1 |
| Yamada, Y | 5 |
| Ushijima, Y | 1 |
| Suto, A | 2 |
| Ishihara, S | 1 |
| Oyama, S | 1 |
| Nishi, M | 2 |
| Hamashima, N | 1 |
| Suematsu, T | 1 |
| Kawabata, S | 1 |
| Kodama, I | 2 |
| Maruiwa, M | 2 |
| Ohta, J | 2 |
| Kumegawa, H | 2 |
| Qi, XD | 1 |
| Mai, M | 6 |
| Takahashi, Y | 9 |
| Fujimoto, T | 5 |
| Omote, K | 2 |
| Itoh, T | 4 |
| Anzai, K | 1 |
| Ishii, M | 1 |
| Nishida, H | 1 |
| Kawada, T | 1 |
| Akita, Y | 1 |
| Onuki, M | 1 |
| Mitamura, K | 1 |
| Kawamura, M | 1 |
| Fujita, M | 10 |
| Fujita, F | 5 |
| Inaba, H | 3 |
| Yamaguchi, A | 7 |
| Maeda, A | 1 |
| Hachisuka, K | 1 |
| Honda, K | 1 |
| Honda, H | 1 |
| Yoshizaki, S | 1 |
| Tsuruga, N | 1 |
| Shirakawa, K | 1 |
| Tojo, M | 1 |
| Tsuda, M | 1 |
| Uchida, R | 1 |
| Mimoto, H | 1 |
| Hatamori, N | 1 |
| Okabayashi, Y | 1 |
| Oimomi, M | 1 |
| Miyazaki, N | 1 |
| Ohkura, H | 2 |
| Kajimura, N | 1 |
| Okazaki, N | 1 |
| Kurita, A | 2 |
| Takashima, S | 4 |
| Sakakihara, Y | 1 |
| Tsunekawa, K | 1 |
| Matsuzaka, T | 1 |
| Yamazaki, T | 2 |
| Suzuki, K | 4 |
| Koyanagi, Y | 3 |
| Ashizawa, T | 2 |
| Tsurui, S | 1 |
| Shibata, K | 1 |
| Nakamura, Y | 5 |
| Katho, F | 1 |
| Tada, Y | 1 |
| Tabuchi, Y | 1 |
| Saitoh, Y | 2 |
| Matsunaga, H | 2 |
| Katano, M | 3 |
| Saita, T | 1 |
| Mori, M | 3 |
| Sasaki, A | 1 |
| Tomoda, H | 1 |
| Seo, Y | 1 |
| Ohno, S | 5 |
| Matsukuma, A | 1 |
| Morita, M | 1 |
| Hara, S | 2 |
| Kitano, M | 2 |
| Iwazaki, R | 1 |
| Yasutake, K | 7 |
| Fukuyama, Y | 1 |
| Hasegawa, K | 4 |
| Sasai, T | 3 |
| Kubo, Y | 2 |
| Ishikawa, K | 1 |
| Hayakawa, M | 1 |
| Kofuji, K | 1 |
| Kida, H | 2 |
| Kunieda, K | 5 |
| Umemoto, T | 5 |
| Miya, K | 7 |
| Azuma, S | 10 |
| Furuta, T | 10 |
| Hidaka, K | 1 |
| Mashima, H | 1 |
| Kishikawa, T | 1 |
| Murotani, M | 1 |
| Takami, M | 1 |
| Takada, T | 1 |
| Kitada, M | 1 |
| Tsukahara, Y | 1 |
| Okumura, Y | 1 |
| Saito, M | 1 |
| Shibata, T | 1 |
| Watanabe, Y | 1 |
| Kosaka, T | 5 |
| Takano, Y | 4 |
| Nakano, Y | 2 |
| Akiyama, T | 3 |
| Kiriyama, M | 2 |
| Tomita, F | 6 |
| Kita, I | 3 |
| Nakagawa, T | 1 |
| Oyama, T | 1 |
| Sasaki, S | 1 |
| Sakakura, C | 2 |
| Kono, H | 1 |
| Minami, K | 1 |
| Yamamoto, T | 1 |
| Nagata, N | 1 |
| Daniels, M | 2 |
| Terés, J | 1 |
| Tanemura, H | 7 |
| Nishina, T | 1 |
| Kuno, T | 1 |
| Yamauchi, M | 6 |
| Takeuchi, H | 1 |
| Inutsuka, S | 1 |
| Kohnoe, S | 4 |
| Kiyohashi, A | 2 |
| Ohkubo, T | 3 |
| Watanabe, H | 1 |
| Sakakibara, N | 1 |
| Kinoshita, K | 6 |
| Yoshimitsu, S | 2 |
| Miyazaki, I | 10 |
| Matsui, H | 1 |
| Schnall, S | 1 |
| Hoffman, RM | 2 |
| Ikeguchi, M | 2 |
| Kondou, A | 1 |
| Oka, A | 1 |
| Tsujitani, S | 2 |
| Yumoto, Y | 1 |
| Okuda, T | 2 |
| Shimizu, S | 2 |
| Kawase, K | 1 |
| Fleming, TR | 2 |
| Peterson, RF | 1 |
| Berenberg, JL | 1 |
| McClure, S | 1 |
| Chapman, RA | 1 |
| Eyre, HJ | 1 |
| Solanki, D | 1 |
| Cruz, AB | 1 |
| Gagliano, R | 1 |
| Lasser, P | 1 |
| Gignoux, M | 1 |
| Norum, J | 1 |
| Angelsen, V | 1 |
| Ozaki, H | 1 |
| Kosuge, T | 1 |
| Yamamoto, J | 1 |
| Koyama, Y | 2 |
| Mukai, K | 1 |
| Tsuzuki, H | 1 |
| Niki, M | 1 |
| Ueda, H | 2 |
| Mikami, K | 2 |
| Naito, M | 1 |
| Tomida, A | 2 |
| Yamada, M | 1 |
| Sirakusa, T | 1 |
| Tsuruo, T | 3 |
| Miyaji, M | 2 |
| Kajiura, Y | 3 |
| Kondo, Y | 2 |
| Nishisaki, H | 1 |
| Oya, M | 5 |
| Nakashima, T | 1 |
| Horita, K | 1 |
| Yoshida, R | 1 |
| Nakanishi, Y | 3 |
| Abo, K | 1 |
| Tohyama, Y | 1 |
| Shirota, Y | 1 |
| Nihei, Z | 2 |
| Mishima, Y | 1 |
| Kaminishi, M | 2 |
| Nomura, S | 1 |
| Yoshikawa, A | 1 |
| Yamaguchi, H | 2 |
| Shimoyama, S | 2 |
| Hashimoto, M | 2 |
| Aoki, F | 1 |
| Yasuda, H | 1 |
| Sakai, S | 1 |
| Oohara, T | 1 |
| Imaoka, S | 2 |
| Ishikawa, O | 2 |
| Kabuto, T | 3 |
| Osawa, S | 1 |
| Shiroto, H | 2 |
| Fujisawa, J | 1 |
| Miyakawa, K | 1 |
| Oku, T | 1 |
| Nishimura, A | 2 |
| Uchino, J | 1 |
| Yamada, T | 1 |
| Kawamura, E | 2 |
| Ohmori, Y | 1 |
| Tsavaris, NB | 1 |
| Tentas, K | 1 |
| Kosmidis, P | 1 |
| Mylonakis, N | 1 |
| Sakelaropoulos, N | 1 |
| Kosmas, C | 1 |
| Lisaios, B | 1 |
| Soumilas, A | 1 |
| Mandrekois, D | 1 |
| Tsetis, A | 1 |
| Klonaris, C | 1 |
| Katayama, K | 12 |
| Nagano, H | 2 |
| Niimoto, S | 2 |
| Hirose, K | 3 |
| Mutou, T | 2 |
| Kobayashi, K | 20 |
| Toyosawa, T | 3 |
| Kondoh, K | 1 |
| Ohkubo, H | 4 |
| Kasanuki, J | 1 |
| Hayashi, S | 2 |
| Saito, N | 1 |
| Yamana, H | 1 |
| Ono, T | 3 |
| Tou, Y | 1 |
| Fujii, T | 2 |
| Uhi, T | 1 |
| Nonaka, M | 1 |
| Oosawa, J | 1 |
| Kamiyama, J | 1 |
| Idoguchi, K | 1 |
| Tabata, T | 1 |
| Okuno, T | 1 |
| Itoshima, T | 1 |
| Shishido, T | 1 |
| Yasoshima, T | 1 |
| Denno, R | 1 |
| Sato, N | 1 |
| Muro, K | 2 |
| Kaneko, K | 1 |
| Muto, M | 1 |
| Ohkuwa, M | 1 |
| Ishii, H | 1 |
| Tajiri, H | 1 |
| Kusada, O | 1 |
| Ueda, N | 2 |
| Yoshimitsu, Y | 1 |
| Ohta, N | 1 |
| Kadoya, N | 2 |
| Hirosawa, H | 3 |
| Konishi, I | 1 |
| Izumi, R | 2 |
| Hirono, T | 1 |
| Saito, K | 3 |
| Aichi, A | 1 |
| Nagata, H | 1 |
| Funaki, M | 1 |
| Okabayashi, T | 1 |
| Hiden, A | 1 |
| Iwakaki, H | 1 |
| Kamikawa, Y | 1 |
| Isawa, E | 1 |
| Sumida, M | 1 |
| Grau, E | 1 |
| Perella, M | 1 |
| Gómez, A | 1 |
| Pastor, E | 1 |
| Mirabet, MD | 1 |
| García, F | 1 |
| Ibáñez, JL | 1 |
| Aguiló, J | 1 |
| Tomonaga, M | 1 |
| Oka, M | 1 |
| Narasaki, F | 1 |
| Fukuda, M | 1 |
| Nakano, R | 1 |
| Takatani, H | 1 |
| Terashi, K | 1 |
| Matsuo, I | 1 |
| Soda, H | 1 |
| Cowan, KH | 1 |
| Braybrooke, JP | 1 |
| O'Byrne, KJ | 1 |
| Saunders, MP | 1 |
| Propper, DJ | 1 |
| Salisbury, AJ | 1 |
| Boardman, P | 1 |
| Taylor, M | 1 |
| Ganesan, TS | 1 |
| Talbot, DC | 1 |
| Harris, AL | 1 |
| Wu, DC | 1 |
| Liu, JM | 1 |
| Chen, YM | 1 |
| Yang, S | 1 |
| Liu, SM | 1 |
| Chen, LT | 1 |
| Whang-Peng, J | 1 |
| Yoshioka, T | 1 |
| Oikawa, H | 1 |
| Maeda, S | 2 |
| Ido, T | 1 |
| Akaizawa, T | 1 |
| Kanamaru, R | 3 |
| Ando, S | 2 |
| Katanuma, A | 1 |
| Tsuji, K | 1 |
| Maekubo, H | 1 |
| Kogure, A | 1 |
| Ishii, S | 1 |
| Kakefuda, T | 1 |
| Aiura, K | 1 |
| Arisawa, Y | 1 |
| Kitagawa, Y | 2 |
| Nakagawa, M | 1 |
| Shirasugi, N | 1 |
| Noga, K | 1 |
| Tomita, H | 1 |
| Fukunari, H | 1 |
| Iwasaki, A | 1 |
| Sanada, K | 1 |
| Enomoto, M | 1 |
| Ichikawa, W | 1 |
| Kitago, K | 1 |
| Shirakusa, T | 1 |
| Park, JO | 1 |
| Cho, JY | 1 |
| You, NC | 1 |
| Kim, CB | 1 |
| Min, JS | 2 |
| Roh, JK | 2 |
| Kogawa, T | 1 |
| Yoshii, T | 1 |
| Kokawa, A | 1 |
| Yamamura, H | 1 |
| Yamamoto, K | 3 |
| Ikeuchi, T | 1 |
| Masutani, S | 2 |
| Kawasaki, T | 1 |
| Morimoto, O | 1 |
| Shiozaki, K | 1 |
| Baba, S | 1 |
| Miya, A | 1 |
| Ishida, H | 1 |
| Satomi, T | 1 |
| Tomita, I | 1 |
| Kon, H | 1 |
| Sasaki, R | 1 |
| Makuuchi, H | 1 |
| Ubhi, SS | 1 |
| McCulloch, P | 1 |
| Veitch, PS | 1 |
| Miyasaka, Y | 1 |
| Yo, S | 1 |
| Nagayama, K | 1 |
| Fukasaku, T | 1 |
| Sakuma, I | 1 |
| Sazaki, N | 1 |
| Taniguchi, M | 1 |
| Murata, A | 3 |
| Tsushima, K | 2 |
| Kobayashi, I | 1 |
| Yokomori, T | 5 |
| Iesato, H | 4 |
| Ouya, T | 1 |
| Ohwada, S | 2 |
| Morishita, Y | 2 |
| Takayanagi, N | 1 |
| Danjo, Y | 1 |
| Ueshige, N | 1 |
| Sugaya, J | 1 |
| Tsuchiya, Y | 1 |
| Sasaki, J | 3 |
| Sano, M | 1 |
| Tsutsui, M | 1 |
| Makino, H | 1 |
| Imamoto, H | 1 |
| Kan, K | 1 |
| Hirao, T | 1 |
| Fukunaga, M | 2 |
| Tono, T | 1 |
| Ohzato, H | 1 |
| Maruyama, H | 1 |
| Hasegawa, S | 1 |
| Kondou, M | 1 |
| Kim, Y | 1 |
| Takatsuka, Y | 1 |
| Maruo, H | 1 |
| Kirihara, M | 1 |
| Kawai, S | 1 |
| Tominaga, S | 1 |
| Ichikawa, T | 1 |
| Kume, S | 1 |
| Rosen, HR | 1 |
| Jatzko, G | 1 |
| Repse, S | 1 |
| Potrc, S | 1 |
| Neudorfer, H | 1 |
| Sandbichler, P | 1 |
| Zacherl, J | 1 |
| Rabl, H | 1 |
| Holzberger, P | 1 |
| Lisborg, P | 1 |
| Czeijka, M | 1 |
| Hill, ME | 1 |
| Grandclément, E | 1 |
| Sadeghi-Looyeh, B | 1 |
| Bienvenu, J | 1 |
| Peyrat, PP | 1 |
| Garbit, F | 1 |
| Murano, A | 1 |
| Katsumata, K | 1 |
| Kitamura, K | 2 |
| Mori, Y | 1 |
| Misaka, T | 1 |
| Murohashi, T | 1 |
| Yamashita, S | 1 |
| Sumi, T | 1 |
| Hirota, T | 2 |
| Whang, I | 2 |
| Averbach, A | 2 |
| Chang, D | 1 |
| Sugarbaker, PH | 2 |
| Farsi, K | 1 |
| Spriggs, D | 1 |
| Sasano, N | 1 |
| Demura, H | 1 |
| Sasano, H | 1 |
| Kim, SY | 1 |
| Park, HC | 1 |
| Yoon, C | 1 |
| Yoon, HJ | 1 |
| Choi, YM | 1 |
| Cho, KS | 1 |
| Fass, J | 2 |
| Jansen, M | 2 |
| Zengel, K | 1 |
| Reinecke, T | 1 |
| Asshoff, G | 1 |
| Schumpelick, V | 2 |
| Hoshiya, Y | 1 |
| Watahiki, Y | 1 |
| Kosaka, A | 1 |
| Inada, T | 1 |
| Kawakubo, H | 1 |
| Ichikawa, A | 1 |
| Ogata, Y | 1 |
| Matsuzaki, SW | 1 |
| Teramoto, T | 2 |
| Tamaki, K | 2 |
| Tanzawa, K | 1 |
| Naoe, Y | 1 |
| Inami, M | 1 |
| Matsumoto, S | 1 |
| Takagaki, S | 1 |
| Fujiwara, T | 1 |
| Yamazaki, S | 3 |
| Kawamura, I | 1 |
| Nishigaki, F | 1 |
| Tsujimoto, S | 1 |
| Manda, T | 1 |
| Shimomura, K | 1 |
| Shirasu, M | 1 |
| Okamoto, K | 1 |
| Otsuji, E | 1 |
| Oyama, K | 1 |
| Bando, E | 2 |
| Michiwa, Y | 2 |
| Liu, F | 1 |
| Hanaoka, K | 1 |
| Suzuki, M | 3 |
| Tanzawa, F | 1 |
| Shibayama, T | 1 |
| Miura, S | 1 |
| Iwabuchi, H | 1 |
| Nakagawa, A | 1 |
| Mitsuhashi, Y | 1 |
| Hisaoka, M | 1 |
| Kaneko, M | 1 |
| Wataya, Y | 1 |
| Nomura, T | 3 |
| Matsuda, A | 1 |
| Kurakata, S | 1 |
| Nakajima, Y | 1 |
| Iida, A | 1 |
| Umeda, S | 1 |
| Kusaka, Y | 1 |
| Kumada, T | 1 |
| Itoh, K | 1 |
| Takayasu, Y | 1 |
| Tajima, K | 1 |
| Higashi, S | 1 |
| Kato, C | 1 |
| Sakumoto, H | 1 |
| Sumiyoshi, K | 1 |
| Takahahsi, T | 1 |
| Matsumoto, K | 3 |
| Kane, T | 1 |
| Sakoda, M | 1 |
| Hosono, Y | 1 |
| Asano, M | 1 |
| Yamamoto, A | 1 |
| Takagi, Y | 1 |
| Ito, K | 3 |
| Kasuya, K | 1 |
| Ohashi, M | 3 |
| Daikeler, T | 1 |
| Kollmannsberger, C | 1 |
| Mayer, F | 1 |
| Cirera, L | 1 |
| Balil, A | 1 |
| Batiste-Alentorn, E | 1 |
| Tusquets, I | 1 |
| Cardona, T | 1 |
| Arcusa, A | 1 |
| Jolis, L | 1 |
| Saigí, E | 1 |
| Guasch, I | 1 |
| Badia, A | 1 |
| Boleda, M | 1 |
| Kamoshita, N | 2 |
| Nagaoka, H | 2 |
| Okabe, T | 2 |
| Kato, Y | 2 |
| Nishi, H | 1 |
| Nakahara, M | 1 |
| Kido, T | 1 |
| Yamanishi, H | 1 |
| Nakao, K | 1 |
| Tsujimoto, M | 1 |
| Minatoya, T | 1 |
| Hayashi, T | 3 |
| Ajisaka, H | 1 |
| Yokota, T | 2 |
| Itoh, J | 1 |
| Kunori, T | 1 |
| Mochizuki, M | 1 |
| Asano, S | 1 |
| Shinya, F | 1 |
| Singal, A | 1 |
| Becker, H | 1 |
| Ohya, T | 2 |
| Takeyoshi, I | 1 |
| Loggie, BW | 1 |
| Fleming, RA | 1 |
| McQuellon, RP | 1 |
| Russell, GB | 1 |
| Geisinger, KR | 1 |
| Kretzschmar, A | 1 |
| Reichardt, P | 1 |
| Thuss-Patience, PC | 1 |
| Hohenberger, P | 1 |
| Benter, T | 1 |
| Dörken, B | 1 |
| Köhne, CH | 1 |
| Ajani, JA | 1 |
| Yao, JC | 1 |
| Ochiai, T | 3 |
| Matsubara, H | 2 |
| Arima, M | 1 |
| Hori, S | 1 |
| Hayashi, H | 1 |
| Takeda, A | 1 |
| Yanagawa, T | 1 |
| Sen, K | 1 |
| Konno, H | 1 |
| Baba, M | 1 |
| Kanai, T | 2 |
| Kamiya, K | 1 |
| Ohba, K | 1 |
| Nakamura, S | 1 |
| Hori, K | 1 |
| Tanda, S | 1 |
| Ikeda, Y | 1 |
| Toh, Y | 1 |
| Nakashima, H | 1 |
| Yamasaki, Y | 2 |
| Park, IC | 1 |
| Park, MJ | 1 |
| Hwang, CS | 1 |
| Rhee, CH | 1 |
| Whang, DY | 1 |
| Jang, JJ | 1 |
| Choe, TB | 1 |
| Hong, SI | 1 |
| Lee, SH | 1 |
| Langejürgen, E | 1 |
| Forsch, S | 1 |
| Tietze, L | 1 |
| de Bree, E | 1 |
| Witkamp, AJ | 1 |
| Zoetmulder, FA | 1 |
| Hecht, JR | 1 |
| Sagara, N | 1 |
| Katoh, M | 1 |
| Tamamori, Y | 2 |
| Nishino, H | 2 |
| Yamada, N | 3 |
| Tanaka, H | 2 |
| Ohira, M | 1 |
| Hirakawa, K | 3 |
| Washizawa, N | 1 |
| Tokura, N | 1 |
| Kase, H | 1 |
| Hirano, K | 2 |
| Yoo, CH | 1 |
| Shin, DW | 1 |
| Goda, F | 1 |
| Wakabayashi, H | 1 |
| Maeba, T | 1 |
| Mori, S | 3 |
| Okano, K | 1 |
| Usuki, H | 1 |
| Mihara, T | 1 |
| Uchida, Y | 1 |
| Ohkawa, M | 1 |
| Maeta, H | 1 |
| Senda, S | 1 |
| Kołodziejczyk, P | 1 |
| Gerhardt, P | 1 |
| Danno, M | 2 |
| Sakamoto, Y | 3 |
| Tamura, Y | 3 |
| Kunitomo, K | 1 |
| Matsuoka, K | 1 |
| Hisamatsu, T | 1 |
| Aoyagi, S | 1 |
| Motohashi, Y | 1 |
| Ikezawa, T | 1 |
| Tatsuno, S | 1 |
| Mizuno, Y | 1 |
| Teshima, S | 1 |
| Narushima, Y | 1 |
| Iwamoto, K | 1 |
| Kagami, M | 1 |
| Kikuchi, S | 3 |
| Yamauchi, H | 1 |
| Gupta, S | 1 |
| Raina, V | 1 |
| Jain, P | 1 |
| Gujral, S | 1 |
| Kumar, R | 1 |
| Nishio, Y | 1 |
| Kanamaru, T | 1 |
| Ueno, N | 1 |
| Kawaguchi, K | 1 |
| Xin, M | 1 |
| Zhou, C | 2 |
| Earashi, M | 1 |
| Kobayashi, H | 1 |
| Chung, HY | 1 |
| Jia, J | 1 |
| Huang, T | 1 |
| Kim, JY | 1 |
| Bae, HS | 1 |
| Nozu, S | 1 |
| Saitou, AY | 1 |
| Okayasu, K | 1 |
| Majima, T | 1 |
| Yagi, A | 1 |
| Asami, S | 1 |
| Saito, Y | 2 |
| Daikoku, Y | 1 |
| Hasegawa, M | 1 |
| Nishihara, T | 1 |
| Nakazawa, K | 1 |
| Kawasaki, H | 1 |
| Shibata, S | 1 |
| Sasaki, M | 3 |
| Varvarigos, N | 1 |
| Kamaradou, H | 1 |
| Kourti, A | 1 |
| Papavasiliou, ED | 1 |
| Papaioannou, H | 1 |
| Migdalis, IN | 1 |
| Galanis, C | 1 |
| Kolodziejcyk, P | 1 |
| Hua, B | 1 |
| Wang, A | 1 |
| Zhou, K | 1 |
| Liu, B | 1 |
| Seitz, JF | 1 |
| Duffaud, F | 1 |
| Dahan, L | 1 |
| Ries, P | 1 |
| Ville, E | 1 |
| Laugier, R | 1 |
| Dhar, DK | 2 |
| Kubota, H | 1 |
| Yamanoi, A | 2 |
| Yashimura, H | 1 |
| Tachibana, M | 2 |
| Kohno, H | 3 |
| Nagasue, N | 4 |
| Monden, N | 1 |
| Hishikawa, Y | 1 |
| Yoshimura, H | 1 |
| Kinugasa, S | 1 |
| Manziuk, LV | 1 |
| Artamonova, EV | 1 |
| Sholokhov, VN | 1 |
| Strygina, EA | 1 |
| Tao, H | 1 |
| Lin, Y | 1 |
| Yin, H | 1 |
| Yao, M | 1 |
| Yamao, T | 1 |
| Matsumura, Y | 1 |
| Goto, M | 1 |
| Chin, K | 1 |
| Baldelli, AM | 1 |
| Catalano, V | 1 |
| Giordani, P | 1 |
| Gasparini, G | 1 |
| Mari, D | 1 |
| Maisano, R | 1 |
| Salvagni, S | 1 |
| Barni, S | 1 |
| Frontini, L | 1 |
| Curti, C | 1 |
| Catalano, G | 1 |
| Huang, Y | 1 |
| Wang, W | 1 |
| Su, G | 1 |
| Qi, X | 1 |
| Ma, D | 1 |
| Fan, Y | 1 |
| Morikawa, A | 1 |
| Okabe, R | 1 |
| Hayashi, K | 1 |
| Miyazawa, K | 1 |
| Iijima, S | 1 |
| Suzuki, A | 1 |
| Sugiyama, A | 1 |
| Zhang, B | 1 |
| Minami, S | 2 |
| Joo, HJ | 1 |
| Kim, HS | 1 |
| Yi, JW | 1 |
| Kim, HC | 1 |
| Kim, MW | 1 |
| Lee, KB | 1 |
| Zhou, SQ | 1 |
| Wang, NQ | 2 |
| Liu, T | 2 |
| Dong, ZW | 2 |
| Hihara, T | 1 |
| Nishiumi, T | 1 |
| Yoneyama, T | 1 |
| Chang, YC | 1 |
| Ohiwa, K | 2 |
| Matuki, N | 2 |
| Sakuma, H | 6 |
| Tanaka, M | 4 |
| Karimine, N | 4 |
| Korenaga, D | 4 |
| Kim, JP | 3 |
| Kwon, OJ | 1 |
| Yamaue, H | 1 |
| Tanimura, H | 1 |
| Noguchi, K | 1 |
| Hotta, T | 1 |
| Tsunoda, T | 1 |
| Iwahashi, M | 1 |
| Tamai, M | 1 |
| Iwakura, S | 1 |
| Ward, LC | 2 |
| Fielding, JW | 1 |
| Dunn, JA | 1 |
| Kelly, KA | 2 |
| Saini, A | 1 |
| Waxman, J | 1 |
| Zhang, YT | 1 |
| Li, N | 1 |
| Muraoka, K | 1 |
| Segawa, M | 2 |
| Iwase, K | 1 |
| Takenaka, H | 1 |
| Sumimura, J | 1 |
| Ishizaka, T | 1 |
| Takagaki, M | 1 |
| Bessho, T | 1 |
| Ohata, T | 1 |
| Oshima, S | 1 |
| Fukushima, W | 1 |
| Sahara, H | 1 |
| Saitoh, F | 1 |
| Taniya, T | 1 |
| Nagano, K | 1 |
| Kure, M | 1 |
| Mutoh, T | 1 |
| Kimura, H | 4 |
| Takamuku, K | 3 |
| Nanbara, S | 3 |
| Abe, R | 6 |
| Watanabe, D | 3 |
| Matsuoka, H | 3 |
| Oguro, Y | 1 |
| Jin, ML | 2 |
| Yang, BQ | 1 |
| Ren, P | 1 |
| Hosokawa, T | 1 |
| Kikuchi, H | 1 |
| Katou, M | 1 |
| Kanno, A | 3 |
| Kaneda, N | 1 |
| Yamawaki, Y | 1 |
| Horigome, N | 1 |
| Hanasaki, K | 1 |
| Shiohara, E | 1 |
| Haba, Y | 1 |
| Koide, N | 1 |
| Takegawa, S | 5 |
| Kitabayashi, K | 1 |
| Gotoda, H | 1 |
| Makino, Y | 1 |
| Taniura, H | 1 |
| Uchida, M | 1 |
| Takemoto, Y | 1 |
| Kimoto, T | 1 |
| Tsugita, M | 1 |
| Takasaki, K | 1 |
| Yagawa, A | 1 |
| Aruga, A | 1 |
| Shimizu, Y | 1 |
| Kitamura, Y | 1 |
| Kobayashi, S | 1 |
| Ito, A | 2 |
| Kondo, K | 2 |
| Nakahara, H | 1 |
| Nagai, S | 1 |
| Kuzuya, T | 1 |
| Satta, T | 3 |
| Takagi, H | 4 |
| Nabeyama, A | 1 |
| Nakashima, A | 1 |
| Kanzaki, T | 1 |
| Matsuo, S | 1 |
| Endoh, A | 1 |
| Kai, K | 1 |
| Sasahashi, N | 1 |
| Akagi, M | 1 |
| Shimazu, H | 1 |
| Mashiko, H | 1 |
| Satoh, J | 2 |
| Hatayama, H | 1 |
| Kitamura, H | 1 |
| Oogushi, K | 1 |
| Morita, H | 1 |
| Sunaga, T | 1 |
| Kusumoto, H | 2 |
| Takahashi, I | 1 |
| Anai, H | 3 |
| Mura, T | 1 |
| Bandou, H | 1 |
| Wils, J | 3 |
| Klein, HO | 3 |
| Kirita, T | 1 |
| Ohchi, T | 1 |
| Ihara, H | 1 |
| Nishiyama, T | 1 |
| Kon, M | 1 |
| Imai, S | 2 |
| Hamano, K | 1 |
| Stephens, FO | 2 |
| Cunliffe, WJ | 1 |
| Aigner, KR | 1 |
| Benthin, F | 1 |
| Müller, H | 1 |
| Tohma, H | 1 |
| Shikama, T | 1 |
| Bellmunt, J | 1 |
| Gallego, OS | 1 |
| Vicente, P | 1 |
| Chiba, Y | 1 |
| Fukushi, G | 1 |
| Matsukawa, M | 1 |
| Wada, K | 1 |
| Aoyama, H | 1 |
| Sawada, Y | 1 |
| Fukushi, M | 1 |
| Ishizuka, K | 3 |
| Hoshi, M | 4 |
| Urushiyama, M | 3 |
| Nishibori, H | 1 |
| Kodaira, S | 2 |
| Louvet, C | 1 |
| de Gramont, A | 1 |
| Demuynck, B | 1 |
| Varette, C | 1 |
| Lagadec, B | 1 |
| Cady, J | 1 |
| Krulik, M | 1 |
| Endo, Y | 2 |
| Cirillo, F | 1 |
| Mortini, B | 1 |
| Troiano, L | 1 |
| Agarossi, M | 1 |
| Riboldi, O | 1 |
| Takekawa, S | 2 |
| Ohoyama, S | 1 |
| Kamata, T | 6 |
| Lcobendas, F | 1 |
| Viñolas, N | 1 |
| Ohkuma, R | 2 |
| Fukuyama, N | 2 |
| Yamanouchi, A | 2 |
| Taira, A | 1 |
| Yokoyama, M | 3 |
| Shimizu, H | 1 |
| Hada, R | 2 |
| Miyagishima, K | 2 |
| Daidouji, K | 1 |
| Ozawa, M | 1 |
| Urade, M | 5 |
| Matumoto, H | 1 |
| Kido, Y | 1 |
| Nishijima, J | 1 |
| Matsuura, N | 1 |
| Taniguchi, T | 2 |
| Isobe, K | 1 |
| Nakashima, I | 2 |
| Akiyama, S | 3 |
| Itou, K | 1 |
| Watanabe, T | 5 |
| Yaosaka, T | 1 |
| Inaba, M | 2 |
| Tugawa, K | 1 |
| Kawata, R | 3 |
| Gasa, F | 1 |
| Hakamada, K | 1 |
| Seino, K | 1 |
| Ono, K | 1 |
| Konno, C | 7 |
| Kokubun, M | 12 |
| Kiuchi, S | 9 |
| Suga, T | 3 |
| Fujioka, N | 1 |
| Gotoh, M | 1 |
| Sakon, M | 1 |
| Umeshita, K | 1 |
| Ukei, T | 1 |
| Shimano, T | 1 |
| Monden, T | 1 |
| Morimoto, H | 2 |
| Ishikawa, H | 1 |
| Nakagoe, T | 1 |
| Kusano, H | 1 |
| Kajiwara, K | 1 |
| Ifuku, M | 1 |
| Kawaguchi, A | 1 |
| Shiraishi, E | 1 |
| Kawai, M | 1 |
| Terashima, M | 3 |
| Takagane, A | 2 |
| Yokkaichi, H | 1 |
| Niitsu, Y | 1 |
| Hasegawa, Y | 2 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Nakashima, Y | 1 |
| Feliu, J | 1 |
| Girón, CG | 1 |
| González-Baron, M | 1 |
| Berrocal, A | 1 |
| Barón-Saura, JM | 1 |
| Zhan, SY | 1 |
| Shu, YH | 3 |
| Figoli, F | 1 |
| Galligioni, E | 1 |
| Crivellari, D | 1 |
| Frustaci, S | 1 |
| Talamini, R | 1 |
| Sorio, R | 1 |
| Saracchini, S | 1 |
| Tumolo, S | 1 |
| Lo Re, G | 1 |
| Monfardini, S | 1 |
| Sugimoto, T | 2 |
| Okuyama, Y | 2 |
| Adenis, A | 1 |
| Bonneterre, J | 1 |
| Watanabe, A | 6 |
| Sawada, H | 2 |
| Yano, T | 1 |
| Shino, Y | 1 |
| Zaniboni, A | 1 |
| Simoncini, E | 1 |
| Marpicati, P | 1 |
| Meriggi, F | 1 |
| Arcangeli, G | 1 |
| Garattini, P | 1 |
| Raffaglio, E | 1 |
| Ferragni, A | 1 |
| Maekawa, S | 1 |
| Saku, M | 3 |
| Kinugasa, T | 1 |
| Ikejiri, K | 1 |
| Yakabe, S | 1 |
| Nomura, K | 1 |
| Kobori, O | 1 |
| Kawami, H | 1 |
| Kohdono, S | 1 |
| Oka, N | 2 |
| Kusuyama, T | 4 |
| Nio, Y | 1 |
| Shiraishi, T | 1 |
| Tsubono, M | 1 |
| Tseng, CC | 1 |
| Tobe, T | 1 |
| Hong, WS | 1 |
| Kim, CM | 1 |
| Lee, JO | 1 |
| Kang, TW | 1 |
| Yun, TK | 1 |
| Kim, CY | 1 |
| Roth, A | 1 |
| Zupanc, D | 1 |
| Luetić, J | 1 |
| Kolarić, K | 1 |
| Matsumoto, M | 1 |
| Goshima, H | 1 |
| Kokehara, N | 1 |
| Oota, M | 1 |
| Ishida, N | 1 |
| Itou, F | 1 |
| Tanabe, T | 5 |
| Komi, N | 2 |
| Saeki, T | 4 |
| Toi, M | 1 |
| Hirai, T | 1 |
| Yanagawa, E | 2 |
| Nagamatsu, M | 1 |
| Oohigashi, H | 1 |
| Yoshida, A | 1 |
| Doihara, H | 1 |
| Yokoyama, N | 1 |
| Tanada, M | 1 |
| Soga, H | 1 |
| Takiyama, W | 1 |
| Saeki, H | 1 |
| Moriwaki, S | 1 |
| Deguchi, Y | 1 |
| Minamoto, T | 1 |
| Asai, T | 1 |
| Sawaguchi, K | 2 |
| Ota, J | 1 |
| Ogino, T | 3 |
| Nakagawa, K | 1 |
| Kitani, E | 1 |
| Takashima, Y | 1 |
| Tsuda, S | 1 |
| Fukunaga, J | 1 |
| Kitahama, H | 1 |
| Okuyama, A | 1 |
| Seki, T | 1 |
| Tsurui, K | 1 |
| Saka, M | 1 |
| Sasagawa, M | 1 |
| Hishinuma, S | 1 |
| Kotake, K | 1 |
| Tan, LS | 1 |
| Pan, HZ | 1 |
| Huang, LQ | 1 |
| Katayanagi, N | 1 |
| Okubo, K | 1 |
| Ohi, Y | 1 |
| Bouillet, T | 1 |
| Lepage, E | 1 |
| Kudou, J | 1 |
| Ishibashi, O | 1 |
| Niho, Y | 1 |
| Moriguchi, S | 1 |
| Emi, Y | 1 |
| Jinushi, K | 3 |
| Kirihara, Y | 3 |
| Takagami, S | 4 |
| Ryuji, K | 1 |
| Yorishima, T | 1 |
| Noso, Y | 2 |
| Sugihara, K | 1 |
| Auther, C | 1 |
| Nishihira, T | 1 |
| Matsumoto, T | 1 |
| Kawachi, S | 1 |
| Ishikawa, M | 1 |
| Haraguchi, M | 1 |
| Orita, H | 1 |
| Poch, E | 1 |
| González-Clemente, JM | 1 |
| Torras, A | 1 |
| Darnell, A | 1 |
| Botey, A | 1 |
| Revert, L | 1 |
| Imamura, Y | 4 |
| Yoshimura, Y | 4 |
| Matsushita, K | 3 |
| Tokisue, M | 4 |
| Masuda, T | 6 |
| Watanabe, S | 1 |
| Mayama, M | 1 |
| Oguro, M | 1 |
| Wakatsuki, S | 1 |
| Majima, H | 1 |
| Ono, S | 2 |
| Shimizu, K | 1 |
| Matsui, O | 1 |
| Teranaka, M | 1 |
| Kuwahara, A | 1 |
| Hirao, E | 1 |
| Shimoda, K | 1 |
| Yoshida, T | 1 |
| Miyahara, M | 1 |
| Coombes, RC | 1 |
| Chilvers, CE | 1 |
| Bliss, JM | 1 |
| Rutten, A | 1 |
| Cortes-Funes, H | 1 |
| Villar-Grimalt, A | 1 |
| Miyata, T | 2 |
| Chen, JZ | 1 |
| Kozaczka, A | 1 |
| Machalski, M | 1 |
| Arbuck, SG | 2 |
| Silk, Y | 1 |
| Nava, H | 1 |
| Rustum, YM | 2 |
| Milliron, S | 1 |
| Adams, BG | 1 |
| Crea, P | 1 |
| Sugisaki, T | 2 |
| Sakamoto, K | 3 |
| Fujimoto, K | 1 |
| Morimoto, M | 2 |
| Satoh, M | 1 |
| Ishida, K | 1 |
| Inada, K | 1 |
| Koyama, H | 1 |
| Akita, N | 1 |
| Wada, A | 1 |
| Yasutomi, M | 2 |
| Nishiwada, T | 1 |
| Okumura, T | 1 |
| Yamashita, T | 1 |
| Iwamoto, A | 2 |
| Yoneyama, C | 2 |
| Saito, A | 2 |
| Kondou, T | 1 |
| Iitsuka, Y | 1 |
| Kim, R | 2 |
| Saeki, K | 2 |
| Toyota, T | 1 |
| Asaki, S | 1 |
| Kikuchi, T | 2 |
| Koizumi, M | 1 |
| Nomura, N | 1 |
| Taima, T | 1 |
| Takano, N | 1 |
| Ueno, K | 2 |
| Uogishi, M | 2 |
| Koike, A | 3 |
| Sasabe, T | 1 |
| Itoh, M | 1 |
| Kondoh, S | 1 |
| Seiki, K | 1 |
| Awano, T | 1 |
| Ozaki, M | 1 |
| Gunji, Y | 1 |
| Kinoshita, H | 1 |
| Kawaura, Y | 1 |
| Munemoto, Y | 1 |
| Omura, K | 1 |
| Ishiguro, E | 1 |
| Sekido, N | 1 |
| Iwa, T | 1 |
| Watarai, N | 1 |
| Kataoka, M | 1 |
| Kasugai, T | 1 |
| Taniwaki, S | 1 |
| Kureyama, Y | 1 |
| Mitsui, T | 1 |
| Masaoka, A | 1 |
| Kamejima, N | 1 |
| Mori, N | 1 |
| Tanaka, A | 1 |
| Nakajima, I | 1 |
| Allum, WH | 2 |
| Hallissey, MT | 2 |
| Hockey, MS | 1 |
| Kusumoto, T | 1 |
| Hashimoto, T | 3 |
| Miyata, R | 4 |
| Matsuda, Y | 2 |
| Furukohori, N | 2 |
| Saitoh, S | 2 |
| Munakata, A | 2 |
| Takagi, S | 1 |
| Nasu, H | 1 |
| Nakamura, J | 1 |
| Arakawa, H | 1 |
| Masamune, O | 1 |
| Furuya, M | 1 |
| Ookubo, M | 1 |
| Mukojima, T | 2 |
| Koizumi, R | 1 |
| Flechtner, H | 2 |
| Kabelitz, K | 1 |
| Massner, B | 1 |
| Edler, L | 1 |
| Sakuramoto, K | 1 |
| Iga, C | 1 |
| Nishimura, J | 1 |
| Toyoda, M | 1 |
| Kawashima, Y | 1 |
| Vallejos, C | 1 |
| Payet, C | 1 |
| Nuñez, J | 1 |
| Montalbetti, J | 1 |
| Solidoro, A | 1 |
| Salazar, F | 1 |
| Sánchez, J | 1 |
| Celis, J | 1 |
| Casanova, L | 1 |
| Otero, J | 1 |
| Treat, J | 1 |
| Falchuk, SC | 1 |
| Ahlgren, JD | 2 |
| Neefe, JR | 1 |
| Matsusita, K | 1 |
| Okutani, T | 1 |
| Otsuka, S | 1 |
| Tsubuku, Y | 1 |
| Kenmizaki, H | 1 |
| Tatekawa, I | 1 |
| Li, XT | 1 |
| Cullinan, SA | 2 |
| Moertel, CG | 3 |
| Rubin, JR | 1 |
| Krook, JE | 1 |
| Everson, LK | 1 |
| Windschitl, HE | 1 |
| Twito, DI | 1 |
| Marschke, RF | 1 |
| Foley, JF | 1 |
| Bleiberg, H | 1 |
| Biran, H | 1 |
| Sulkes, A | 1 |
| Biran, S | 1 |
| Miyake, Y | 2 |
| Kido, C | 5 |
| Odaka, Y | 1 |
| Oikawa, K | 1 |
| Guhji, M | 1 |
| Ooi, T | 1 |
| Nyumura, T | 1 |
| Nabeya, K | 1 |
| Hamakubo, S | 1 |
| Higashino, K | 1 |
| Horiuchi, Y | 2 |
| Ohkita, T | 3 |
| Shimaji, T | 1 |
| Nagayo, T | 1 |
| Horiguchi, M | 1 |
| Sonoda, H | 1 |
| Tsukiyama, I | 2 |
| Akine, Y | 2 |
| Yamashita, K | 1 |
| Egawa, S | 2 |
| Hijikata, J | 1 |
| Kitagawa, T | 1 |
| Pan, XY | 2 |
| Li, FQ | 1 |
| Yu, RJ | 1 |
| Xie, GF | 1 |
| Wang, H | 1 |
| Zhao, LY | 1 |
| Shimozuma, K | 4 |
| Kawabe, K | 1 |
| Noto, H | 1 |
| Yagi, M | 2 |
| Ogino, S | 1 |
| Miyazaka, I | 1 |
| Kasuga, Y | 1 |
| Senga, O | 1 |
| Hanamura, N | 1 |
| Oota, H | 1 |
| Katsuyama, T | 1 |
| Tsuchiya, S | 1 |
| Ina, K | 4 |
| Yagita, A | 1 |
| Orima, I | 1 |
| Ootsuka, S | 1 |
| Oda, T | 1 |
| Takeuchi, N | 1 |
| Hosaka, N | 1 |
| Ono, M | 1 |
| Guimaraes dos Santos, J | 1 |
| Nava, HR | 1 |
| Silk, YN | 1 |
| Baroni, M | 1 |
| Nakaya, K | 1 |
| Kimoto, Y | 1 |
| Nomoto, K | 2 |
| Tsuru, S | 1 |
| Awane, Y | 2 |
| Ishibiki, H | 1 |
| Sekiguchi, M | 1 |
| Kasai, M | 1 |
| Konno, K | 1 |
| Nakai, Y | 1 |
| Koie, H | 1 |
| Takami, H | 1 |
| Sadahiro, S | 1 |
| Okuda, K | 1 |
| Yamataka, K | 1 |
| Ishimura, Y | 1 |
| Yasui, K | 1 |
| Morimoto, T | 1 |
| Miyaishi, S | 1 |
| Watai, K | 2 |
| Yanagawa, S | 1 |
| Ono, R | 1 |
| Ushio, K | 1 |
| Sheldon, R | 1 |
| Slaughter, D | 1 |
| Kanou, T | 1 |
| Nosou, Y | 1 |
| Kuramoto, J | 1 |
| Sekino, H | 1 |
| Hisazumi, H | 2 |
| O'Connell, MJ | 1 |
| Schutt, AJ | 1 |
| Hahn, RG | 1 |
| Jakesz, R | 1 |
| Dittrich, C | 1 |
| Funovics, J | 1 |
| Hofbauer, F | 1 |
| Rainer, H | 1 |
| Reiner, G | 1 |
| Schemper, M | 1 |
| Schiessel, R | 1 |
| Starlinger, M | 1 |
| Shimokawa, K | 3 |
| Tsuya, H | 1 |
| Villar, A | 1 |
| Asensio, F | 1 |
| Candel, M | 1 |
| Delgado, F | 1 |
| Garcia, J | 1 |
| Lledó, S | 1 |
| Redón, J | 1 |
| Roig, JV | 1 |
| Sanchez, A | 1 |
| Sanchis, C | 1 |
| Orikasa, H | 1 |
| Usugane, M | 2 |
| Henss, H | 1 |
| Arnold, H | 1 |
| Fritze, D | 1 |
| Herrmann, R | 1 |
| Fritsch, H | 1 |
| Fritz, M | 1 |
| Trux, FA | 1 |
| Yashige, H | 1 |
| Inazawa, J | 1 |
| Yokota, S | 1 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Abe, T | 1 |
| Sadamoto, Y | 1 |
| Haruma, K | 1 |
| Tokumo, K | 1 |
| Teshima, H | 1 |
| Murakami, S | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Yamashita, Y | 1 |
| Morise, K | 2 |
| Simura, H | 1 |
| Origasa, H | 1 |
| Yamada, H | 1 |
| Nakajima, H | 1 |
| Ioka, J | 1 |
| Shirono, K | 1 |
| Ochiai, K | 1 |
| Murakami, A | 1 |
| Wakatsuki, T | 1 |
| Kamano, T | 1 |
| Fukuyama, E | 1 |
| Miyoshi, K | 1 |
| Oda, K | 1 |
| Sakata, A | 1 |
| Ozeki, H | 1 |
| Mukaiyama, T | 1 |
| Nagamine, D | 1 |
| Ito, Y | 2 |
| Imajo, K | 1 |
| Shinagawa, K | 1 |
| Miyoshi, T | 3 |
| Arimizu, N | 2 |
| Hagino, S | 1 |
| Sawazaki, K | 1 |
| Shresta, RD | 1 |
| Arimatsu, N | 1 |
| Tonouchi, H | 1 |
| Takeuchi, K | 1 |
| Iriyama, K | 1 |
| Tashiro, T | 1 |
| Sakurai, Y | 1 |
| Maruo, K | 1 |
| Ohnishi, Y | 1 |
| Ueyama, Y | 1 |
| Baba, T | 1 |
| Kawata, K | 1 |
| Keymling, M | 1 |
| Lübke, HJ | 1 |
| Wörner, W | 1 |
| Blijham, GH | 1 |
| Tonato, M | 1 |
| Leonardi, F | 1 |
| Shioda, Y | 1 |
| Koizumi, S | 1 |
| Furuya, S | 1 |
| Tokunaga, A | 1 |
| Onda, M | 1 |
| Nehashi, Y | 1 |
| Noda, S | 1 |
| Matsusaka, T | 1 |
| Teraoka, H | 1 |
| Ogawa, A | 1 |
| Fukuda, I | 1 |
| de Insausti, CL | 1 |
| Gutiérrez, LE | 1 |
| Kakehi, M | 1 |
| Takeda, N | 1 |
| Matsuura, T | 2 |
| Matsuoka, S | 2 |
| Kim, RH | 1 |
| Lee, YW | 1 |
| Lee, DC | 1 |
| Kim, NH | 1 |
| Choi, JS | 1 |
| Joo, SK | 1 |
| Kim, CS | 1 |
| Gohmann, JJ | 1 |
| Oshita, H | 1 |
| Fukata, D | 1 |
| Sakai, N | 1 |
| Kashizuka, T | 1 |
| Hatoh, T | 1 |
| Torisu, M | 1 |
| Ozawa, H | 1 |
| Cazap, E | 1 |
| Estevez, RA | 1 |
| Marantz, A | 1 |
| Wilcosky, T | 1 |
| Stein, J | 1 |
| Starzyńska, T | 1 |
| Kenis, Y | 1 |
| Athlin, L | 1 |
| Domellöf, L | 1 |
| Swaroop, VS | 1 |
| Kelsen, D | 1 |
| Theodors, A | 1 |
| Purvis, JD | 1 |
| Budd, GT | 1 |
| Weick, JK | 1 |
| Gahbauer, R | 1 |
| Henderson, A | 1 |
| Faedi, M | 1 |
| Amadori, M | 1 |
| Gentilini, P | 1 |
| Biserni, R | 1 |
| Bonaguri, C | 1 |
| Zehner, J | 1 |
| Weber, L | 1 |
| Fischer, M | 1 |
| Gfirtner, H | 1 |
| Breit, A | 1 |
| Hagin, GD | 1 |
| Jain, A | 1 |
| Wadler, S | 1 |
| Green, M | 1 |
| Muggia, F | 1 |
| Suyama, K | 1 |
| Ryu, S | 1 |
| Ariga, T | 1 |
| Nagashima, T | 1 |
| Koh, Z | 1 |
| Odaka, M | 1 |
| Udagawa, I | 1 |
| Hirabayshi, N | 1 |
| Petras, RE | 1 |
| Hart, WR | 1 |
| Sako, T | 1 |
| Nakata, K | 1 |
| Shigemitsu, M | 1 |
| Joya, K | 1 |
| Hanawa, S | 1 |
| Takada, N | 1 |
| Yamada, K | 1 |
| Hashizume, H | 1 |
| Tomirotti, M | 1 |
| Lombardi, F | 1 |
| Biasioli, R | 1 |
| Riundi, R | 1 |
| Scanni, A | 1 |
| Konishi, T | 1 |
| Murai, T | 1 |
| Ishiwata, J | 1 |
| Iwamoto, S | 1 |
| Koike, M | 1 |
| Takeshita, Y | 1 |
| Higashino, Y | 1 |
| Asano, E | 1 |
| Akimoto, R | 1 |
| Uchida, H | 1 |
| Mukawa, A | 1 |
| Nagakawa, T | 1 |
| Kojima, T | 1 |
| Kato, N | 1 |
| Kanabe, S | 1 |
| Tamakuma, S | 1 |
| Mimura, K | 1 |
| Hiraide, H | 1 |
| Mochizuki, H | 1 |
| Kurokawa, T | 1 |
| Kadota, T | 1 |
| Hatsuse, K | 1 |
| Kawano, M | 1 |
| Bai, XW | 1 |
| Di Lauro, L | 1 |
| Balice, A | 1 |
| Carpano, S | 1 |
| Papaldo, P | 1 |
| Lopez, M | 1 |
| Eckhardt, S | 1 |
| Juan, IK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Gastric Carcinomatosis or Positive Cytology[NCT02092298] | Phase 2 | 21 participants (Actual) | Interventional | 2014-05-08 | Completed | ||
| Phase I Study of Daily RAD001 Administered Orally in Combination With Mitomycin C, Administered Every Three Weeks to Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction[NCT01042782] | Phase 1 | 16 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Phase II Trial of Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology[NCT03092518] | Phase 2 | 27 participants (Actual) | Interventional | 2017-06-05 | Active, not recruiting | ||
| Cytoreductive Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy for the Treatment of Peritoneal Carcinomatosis From Gastrointestinal Cancer: an Open Label, Randomized, Prospective, Phase 2 Clinical Trial[NCT00454519] | Phase 2 | 60 participants (Anticipated) | Interventional | 2007-03-31 | Recruiting | ||
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.[NCT02736552] | Phase 3 | 0 participants (Actual) | Interventional | 2016-03-31 | Withdrawn | ||
| A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487] | Phase 2 | 46 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707] | Phase 2 | 55 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus[NCT01334684] | 100 participants (Anticipated) | Interventional | 2011-05-31 | Not yet recruiting | |||
| D2 Radical Resection After Neoadjuvant Chemotherapy Combined With HIPEC for Advanced Gastric Cancer: a Prospective Randomized Controlled Trial[NCT02960061] | Phase 3 | 640 participants (Anticipated) | Interventional | 2016-11-30 | Not yet recruiting | ||
| A Prospective, Multicentral, Open-label, Randomized, Controlled Clinical Trial to Investigation the Value of Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer[NCT02745509] | 508 participants (Actual) | Interventional | 2016-03-31 | Completed | |||
| Comparative Study on the Efficacy of Lobaplatin and Paclitaxel in the Treatment of Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy[NCT04808466] | Phase 2 | 231 participants (Anticipated) | Interventional | 2021-09-18 | Recruiting | ||
| Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding[NCT00539877] | Phase 1 | 17 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| Efficacy of Reza Band for the Treatment of Laryngopharyngeal Reflux[NCT03463395] | 0 participants (Actual) | Interventional | 2020-07-31 | Withdrawn (stopped due to Funding for this study has ended and we were unable to enroll any subjects) | |||
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis[NCT00001569] | Phase 1 | 74 participants | Interventional | 1997-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Primary objective of study is to assess overall survival (OS) in subjects with stage IV gastric cancer representing positive cytology or imaging occult carcinomatosis after laparoscopic hyperthermic intraperitoneal chemotherapy administration. Overall survival measured from time of laparoscopic HIPEC. Patterns of tumor recurrence and survival assessed by reviewing routine surveillance CT scans. Overall survival time estimated using the Kaplan-Meier method. (NCT02092298)
Timeframe: Between the second and sixth week after treatment, up to 5 years
| Intervention | Months (Median) |
|---|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 30.2 |
Primary objective of study is to assess overall survival (OS) in subjects with stage IV gastric cancer representing positive cytology or imaging occult carcinomatosis after the first laparoscopic HIPEC. Patterns of tumor recurrence and survival assessed by reviewing routine surveillance CT scans. Overall survival time estimated using the Kaplan-Meier method. (NCT02092298)
Timeframe: From the day of surgery, until the last day of follow up, until death, up to 5 years
| Intervention | Months (Median) |
|---|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 20.3 |
50 reviews available for mitomycin and Cancer of Stomach
| Article | Year |
|---|---|
Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; | 2002 |
[Chemotherapy of gastric cancer--a review of clinical trials in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Clinical Trials | 2002 |
[Progress in postoperative adjuvant chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Drug Administrat | 2002 |
[CPT-11 combined chemotherapy for metastatic gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cis | 2004 |
Postoperative chemotherapy for gastric cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2006 |
A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clini | 2006 |
Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Humans; Japan; Mitomycin; Pyrimidines; Randomiz | 2006 |
Chemotherapy in alimentary tract malignomas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Cytarabine; Doxor | 1981 |
[Mechanism of neoplasm metastasis and treatment strategy].
Topics: Humans; Immunotoxins; Mitomycin; Neoplasm Invasiveness; Neoplasm Metastasis; Peritoneal Neoplasms; S | 1995 |
[Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Doxorubicin; Fl | 1995 |
Adjuvant postoperative therapy of gastrointestinal malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined | 1994 |
[An extended operation for scirrhous gastric cancer--its significance and procedure].
Topics: Adenocarcinoma, Scirrhous; Cholecystectomy; Colectomy; Gastrectomy; Humans; Infusions, Parenteral; L | 1994 |
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; E | 1994 |
[Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cl | 1994 |
[Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Fl | 1994 |
[Targeting therapy of gastric and colorectal cancer].
Topics: Colorectal Neoplasms; Drug Delivery Systems; Fat Emulsions, Intravenous; Fluorouracil; Humans; Infus | 1994 |
[Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Topics: Adult; Aged; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Prognosis; Sto | 1993 |
Mitomycin therapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1993 |
[Prophylaxis and treatment of peritoneal metastasis from gastric cancer].
Topics: Gastrectomy; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Mitomycin; Peritoneal Neopl | 1996 |
[Adjuvant chemotherapy for advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Doxorubicin; Dru | 1996 |
Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration Schedule; F | 1997 |
[Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials a | 1997 |
[DT-diaphorase].
Topics: Antibiotics, Antineoplastic; Aziridines; Colonic Neoplasms; Cytochrome Reductases; Cytochrome-B(5) R | 1997 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cis | 1998 |
Medical management of advanced gastric cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 1998 |
[A case report of gastric carcinoma with complete remission of paraaortic lymph node metastasis by 5'-DFUR and MMC administration after resection of primary tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Combined Modality Therapy; Floxuridine; Gastr | 1999 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Et | 2000 |
[Tumor microcirculation and selective enhancement of drug delivery--clinical applications based on pathophysiological experiments].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Drug Administr | 2000 |
[State of the treatment for gastrointestinal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II a | 2000 |
Adjuvant therapy for gastric cancer: a reality at last.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Humans; Mitomycin; Neoplasm Staging; Radiothera | 2000 |
[Recent advance in gastric cancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Screening Assays, Antitum | 2000 |
[Irinotecan (CPT-11) therapy for advanced gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Che | 2001 |
[Chemosensitivity test for advanced and recurrent gastric cancer].
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Fluorouracil; Human | 2001 |
[Chemo-hyperthermic peritoneal perfusion for therapy of advanced gastric cancer with peritoneal dissemination].
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Humans; Hyperthermia, In | 2001 |
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirub | 2001 |
Induction chemotherapy using intraarterial infusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Evaluation; Humans; In | 1991 |
The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer.
Topics: Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Evaluation; Fluorouracil; Humans; Infusions, Pa | 1991 |
Rationale for the intraperitoneal approach to surgical adjuvant chemotherapy of gastric cancer.
Topics: Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Fluorouracil; Humans; Infusions, Parent | 1991 |
[Dose intensity in cancer chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Fluo | 1990 |
[Present status of surgical adjuvant chemotherapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Humans; Mit | 1989 |
[Combined chemotherapy with the FEM protocol in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; | 1989 |
[A current overview of chemotherapy in advanced gastric cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Fluor | 1989 |
[Recent development and trends in adjuvant chemotherapy in the surgical field].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrectomy; Humans; Mito | 1986 |
[Recent advanced studies on mitomycins, antitumor activity and mode of action].
Topics: Animals; Cell Line; Colonic Neoplasms; Humans; Leukemia P388; Mitomycin; Mitomycins; Neoplasms; Panc | 1987 |
Chemotherapy of advanced gastric cancer: present status, future prospects.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Fluorouracil; Humans; Mitomy | 1988 |
[A case of an exogastric developing-type carcinoma of the stomach and a review of thirty nine cases reported in Japan].
Topics: Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy P | 1988 |
[Treatment of advanced stomach cancer].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Doxorubicin; Fl | 1986 |
The role of anthracyclines in the treatment of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Drug Administ | 1985 |
The role of chemotherapy in the management of gastric and pancreatic carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
Potentiation of antimetabolite action by alkylating agents.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brea | 1985 |
228 trials available for mitomycin and Cancer of Stomach
| Article | Year |
|---|---|
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Cisplatin; Combined M | 2020 |
Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Gastrectomy; Humans; Hyperthermia, Induced; Laparo | 2018 |
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Floxurid | 2013 |
Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Chemoembolization, Therapeutic; Colorect | 2013 |
5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Su | 2013 |
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose | 2013 |
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Fema | 2014 |
Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study.
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; | 2008 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2009 |
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colorectal | 1972 |
[Combination of irinotecan and Mitomycin C as second-line chemotherapy for patients with unresectable advanced or recurrent gastric cancer in clinical practice].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 2009 |
A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2009 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2010 |
Effect of preoperative intraperitoneal injection of Sapylin in advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Anastomotic Leak; Antibiotics, Antineoplastic; Antineoplastic Agents; Biologic | 2010 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2011 |
No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2011 |
Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Ne | 2011 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2011 |
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Resistanc | 2011 |
B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Chemotherapy, Cancer, Regional Perfus | 2012 |
High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Do | 2002 |
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2002 |
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle | 2002 |
Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 2002 |
[Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisp | 2002 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
[Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters].
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols | 2001 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophos | 2002 |
[Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astragalus propinquus; CD4-CD8 Ratio; Cisplatin; Cyc | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Fema | 2003 |
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2003 |
Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chi-Squar | 2003 |
[Prospective randomized trial of prophylaxis of postoperative peritoneal carcinomatosis of advanced gastric cancer: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Charcoal; Chemotherapy, Cancer, Regional Perfusi | 2003 |
[Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drugs, Chinese Herbal; Female; F | 2003 |
Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Combined Modality | 2004 |
Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Dox | 2004 |
Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antimetabolites, A | 2004 |
Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2004 |
Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Combined Mo | 2004 |
Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Huma | 2005 |
Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorour | 2005 |
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-F | 2005 |
Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Female; F | 2006 |
[Effect of adjuvant chemotherapy of ginsenoside Rg3 combined with mitomycin C and tegafur in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Female; Ginsenoside | 2007 |
Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose- | 2007 |
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Do | 2007 |
[Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 2007 |
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2006 |
Staged laparoscopic adjuvant intraperitoneal chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a preliminary experience.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Cohort Studies; Colorectal Neoplasms; Combined Modali | 2009 |
[Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method].
Topics: Adjuvants, Immunologic; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gl | 1983 |
Mitomycin C as an adjuvant in resected gastric cancer.
Topics: Actuarial Analysis; Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Gastrectomy; H | 1983 |
[Cancer chemotherapy in the field of surgery--with special reference to stomach cancer].
Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Human | 1983 |
[Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; M | 1983 |
[Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report].
Topics: Drug Therapy, Combination; Fluorouracil; Humans; Mitomycin; Mitomycins; Postoperative Period; Random | 1983 |
[Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Mice; | 1983 |
Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubici | 1984 |
[Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Fluorouraci | 1984 |
[Immunological approach and surgical treatment of cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy | 1983 |
Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study.
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Double-B | 1983 |
[Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels].
Topics: Angiotensin II; Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin | 1984 |
Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Moda | 1984 |
Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Sch | 1984 |
A trial of adjuvant combination chemoimmunotherapy for stage III carcinoma of stomach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cholera Vaccines; Clinical | 1984 |
[A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)].
Topics: Clinical Trials as Topic; Drug Administration Schedule; Fluorouracil; Humans; Mitomycin; Mitomycins; | 1984 |
Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical T | 1984 |
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1984 |
[Antineoplastic chemotherapy in advanced gastric cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dox | 1982 |
Pharmaceutics: mitomycin C: a brief review.
Topics: Adenocarcinoma; Clinical Trials as Topic; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Stoma | 1982 |
[Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].
Topics: Drug Therapy, Combination; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Mitomycin; Mitom | 1982 |
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Tr | 1982 |
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Drug Adm | 1982 |
[Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
Topics: Aged; Antibiotics, Antineoplastic; Blood Cell Count; Body Weight; Clinical Trials as Topic; Drug The | 1982 |
[Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Clinical Trials a | 1982 |
Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Therapy, Com | 1982 |
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epir | 1994 |
[Evaluation of intraoperative peritoneal cytology and intraperitoneal chemotherapy using CDDP combined with MMC for gastric carcinomatous peritonitis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Female; Human | 1995 |
[A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Th | 1995 |
[Combination therapy of high dose 5'-DFUR+MMC for advanced or recurrent gastric cancer. 5'-DFUR Joint Research Group in the Osaka District for Gastric Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; | 1995 |
Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 1995 |
[Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
Topics: Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Adminis | 1995 |
Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1995 |
[Clinical and experimental study in treating gastric cancer with replenishing qi and invigorating spleen oral liquid combined with chemotherapy].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Therapy, Combi | 1994 |
[A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)].
Topics: Adolescent; Adult; Aged; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1995 |
[A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
Topics: Adolescent; Adult; Aged; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1995 |
[Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C].
Topics: Adolescent; Adult; Aged; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1995 |
[Effect of intraperitoneal chemotherapy with implantable reservoir against unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etopo | 1995 |
[Effects of preoperative parenteral nutritional support with chemotherapy on tumor cell kinetics in gastric cancer patients].
Topics: Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Chemotherapy, A | 1994 |
[Effects and problems of intraarterial noradrenaline-induced hypertensive chemotherapy for liver metastasis of gastric cancer].
Topics: Aged; Blood Pressure; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusion Pumps, | 1994 |
[The value of hepatic arterial infusion chemotherapy for liver metastases--discussion from viewpoints of prevention of hepatic death and QOL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Fl | 1994 |
[The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Doxorubicin; Drug Administra | 1994 |
[Survival of patients with gastric cancer treated with intra-lymph nodal injection of activated carbon particles absorbed mitomycin C].
Topics: Absorption; Carbon; Gastrectomy; Humans; Injections, Intralymphatic; Lymph Node Excision; Lymphatic | 1994 |
[The prevention of peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles absorbing mitomycin C].
Topics: Absorption; Carbon; Female; Humans; Infusions, Parenteral; Lymphatic Metastasis; Male; Middle Aged; | 1994 |
[Evaluation of intraperitoneal chemotherapy using CDDP combined with MMC in gastric carcinomatous peritonitis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Fe | 1994 |
Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; | 1994 |
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Epir | 1994 |
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modali | 1994 |
[Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Mitomycin; Quality of Life; St | 1994 |
[The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
Topics: Administration, Oral; Adult; Aged; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Flu | 1994 |
Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modali | 1994 |
Dose intensity of mitomycin C in adjuvant cancer chemotherapy for patients with gastric cancer.
Topics: Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Male; Mitomycin; Neoplasm Stag | 1994 |
[Evaluation of combination chemotherapy for advanced gastric carcinoma as a neoadjuvant chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 1994 |
[Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)].
Topics: Administration, Oral; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Diarrhea; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1994 |
Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles for patients with advanced gastric cancer.
Topics: Carbon; Delayed-Action Preparations; Drug Carriers; Humans; Infusions, Parenteral; Mitomycin; Prospe | 1994 |
[Efficacy of FEM (5-fluorouracil, epirubicin, mitomycin C) therapy for resected advanced gastric cancer. Ehime Gastric Cancer Study Meeting].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Sc | 1993 |
[UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Femal | 1993 |
Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Leukopenia; Liver Ne | 1993 |
[Multi-institutional feasibility study of SDI test for its application to the adjuvant chemotherapy of gastric cancer].
Topics: Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Feasibility Studie | 1993 |
Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Mitomycin; Stomach Neoplasms | 1993 |
Mitomycin therapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1993 |
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherap | 1995 |
Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; | 1995 |
Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysi | 1995 |
[Treatment of advanced gastric carcinoma based on histologic type].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Gastrectomy; H | 1996 |
[Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Com | 1996 |
[Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorou | 1996 |
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Epirubicin; Female; Fluorour | 1996 |
Intraperitoneal 5-fluorouracil and mitomycin C as adjuvants to resectable gastric cancer: a status report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Injection | 1996 |
[Preoperative intra tumor biological response modifier injection therapy for patients with stomach neoplasms].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hu | 1995 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 1997 |
Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Diseas | 1997 |
Scientific basis for the combination of tegafur with uracil.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; G | 1997 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fema | 1997 |
[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubic | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fluorouracil; Humans; Infusi | 1998 |
Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug | 1995 |
OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-F | 1998 |
[Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Cancer, Regional P | 1998 |
Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1999 |
[Influence of preoperative on gastric cancer tissues and cells].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1997 |
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined | 1999 |
Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neopla | 1999 |
[Repeated intraperitoneal chemotherapy for peritoneal dissemination from gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Humans; Infusio | 1999 |
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Infusion Pumps | 1999 |
Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Male; M | 1999 |
[Effect of combination chemotherapy with multiple drugs (FLMP therapy) based on the circadian rhythms of the human body in advanced recurrent gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Cisplatin; Drug Administrati | 1999 |
[The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Administ | 2000 |
Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Human | 2000 |
The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcino | 2000 |
[Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2001 |
[Clinical study on Shenqi Fuzheng injection combined with chemotherapy in treating malignant tumor of digestive tract].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Colo | 1998 |
Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Male; | 2001 |
[Repeated intraperitoneal chemotherapy for peritoneal dissemination from gastric carcinoma].
Topics: Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; | 2001 |
A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2001 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastases and lymph node metastases from gastric cancer--comparative analysis for intra-arterial group and non-intra-arterial group].
Topics: Angiotensin II; Antibiotics, Antineoplastic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lym | 2001 |
[Twenty-year experience with multimodal treatment of gastric cancer patients in Poland].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2001 |
[Clinical study on treatment of mid-late stage gastric carcinoma by composite xiansu capsule combined with chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Caps | 1999 |
[Clinical study on effect of shenqi fuzheng injection combined with chemotherapy in treating gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drugs, Chinese Herbal | 1999 |
Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Diarrhea; Dose-Response R | 2001 |
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cost-Benefit Anal | 2002 |
Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer.
Topics: Adenocarcinoma; Charcoal; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Injectio | 2002 |
Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.
Topics: Anastomosis, Surgical; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Pr | 1992 |
The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Coh | 1992 |
Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis.
Topics: Adult; Aged; Ascitic Fluid; Combined Modality Therapy; Female; Histocytochemistry; Humans; Hyperther | 1992 |
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 1992 |
A trial of adjuvant chemoimmunotherapy with mitomycin C and OK-432 for stage III gastric carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitomycin; Picibanil; Stoma | 1992 |
[Chemotherapy for advanced and recurrent cancer patients--the effect of combination chemotherapy using cisplatin, peplomycin, mitomycin C, adriamycin, and 5-fluorouracil].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Colorectal Neopla | 1990 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Proto | 1992 |
Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ma | 1991 |
[Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi | 1991 |
[Randomized controlled trial of induced hypertension chemotherapy (IHC) using angiotensin II human (TY-10721) in advanced gastric carcinoma (TY-10721 IHC Study Group Report)].
Topics: Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Combine | 1991 |
A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administrati | 1991 |
Evaluation of two consecutive regimens in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation | 1991 |
Mitomycin-C, adriamycin, 5-fluorouracil and leucovorin (L-FAM2) in the treatment of advanced gastric cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Female; F | 1991 |
Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemothera | 1990 |
Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.
Topics: Adjuvants, Immunologic; Aminopeptidases; Antibiotics, Antineoplastic; Antineoplastic Combined Chemot | 1990 |
[Intraperitoneal administration of recombinant interferon-beta for prevention in peritoneal metastasis of gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Gastrectomy; Huma | 1990 |
Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Ma | 1990 |
[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supp
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; F | 1990 |
[Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group].
Topics: Adult; Aged; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1990 |
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Combined Mo | 1990 |
[Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1990 |
Chemotherapy of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1988 |
[Adjuvant chemotherapy for gastric cancer--the third study. First report: central randomization by telephone method and analysis of patients' background factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administ | 1989 |
[Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1989 |
Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
Topics: Adult; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Combined Modality Therapy | 1989 |
[Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; | 1989 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug A | 1989 |
[An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1989 |
A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 1989 |
[Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administ | 1989 |
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Evaluat | 1989 |
[Combined UFTM for 140 patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Ch | 1989 |
Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy | 1989 |
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Costs and | 1985 |
An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Europe; F | 1989 |
[Chemoendocrine therapy of gastric "scirrhous" carcinoma].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cli | 1988 |
Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi | 1988 |
Immunochemosurgery as a new approach to reasonable treatment of advanced cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Clinical Trials | 1988 |
Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Dr | 1988 |
[Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy].
Topics: Female; Humans; Lymphatic Metastasis; Lymphocyte Activation; Male; Middle Aged; Mitomycin; Mitomycin | 1986 |
[A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dru | 1986 |
[Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration | 1986 |
[A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy | 1986 |
[A randomized controlled trial of immunochemotherapy using carmofur (HCFU), mitomycin C and immunopotentiators in advanced gastric cancer following noncurative resection and nonresection].
Topics: Adjuvants, Immunologic; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Female; | 1986 |
[Surgery and adjuvant therapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Lymph Node Excisio | 1986 |
Postoperative adjuvant chemotherapy for gastric cancer, the second report. Analysis of data on 2873 patients followed for five years.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Moda | 1986 |
[Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Fluorou | 1986 |
[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
Topics: Biological Products; Drug Therapy, Combination; Humans; Mitomycin; Mitomycins; Picibanil; Postoperat | 1987 |
Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; D | 1987 |
[Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedu | 1987 |
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.
Topics: Adult; Chemotherapy, Cancer, Regional Perfusion; Drug Evaluation; Female; Humans; Hyperthermia, Indu | 1988 |
[UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 1988 |
[Prospective randomized controlled study of bestatin in gastric cancer surgery].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucin | 1988 |
Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Mice; Mice, Inbred BALB C; Mice, N | 1988 |
[Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Top | 1988 |
5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; D | 1988 |
[Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrectomy; H | 1988 |
[A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials as | 1988 |
Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 1988 |
Advanced gastric carcinoma chemotherapy with cisplatin, mitomycin C, BCNU, and 5-fluorouracil in combination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Female; Fluorour | 1987 |
[Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer (the second report)--a randomized controlled study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedu | 1985 |
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi | 1987 |
FAM therapy for advanced gastric cancer: an ideal standard?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Fluorouracil; | 1985 |
The role of anthracyclines in the treatment of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Drug Administ | 1985 |
[Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical T | 1985 |
[Results of phase III study of lentinan].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neopl | 1985 |
[Postoperative adjuvant immunochemotherapy with bestatin for stomach cancer. Randomized controlled trial: first report].
Topics: Adult; Aged; Alanine Transaminase; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy | 1985 |
[Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Mitomy | 1985 |
[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Humans; Mitomycin; Mitomycins; | 1985 |
Gastric cancer: overview of current therapies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
[Intra-arterial infusion therapy with angiotensin II in gastric carcinoma].
Topics: Aged; Angiotensin II; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as To | 1985 |
The role of chemotherapy in the management of gastric and pancreatic carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
[Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality | 1985 |
602 other studies available for mitomycin and Cancer of Stomach
| Article | Year |
|---|---|
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |
Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neop | 2020 |
shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorou | 2020 |
Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
Topics: Adult; Aged; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Fluorouracil; Gastre | 2017 |
Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Carcinoma; Case-Control Studies; Cell | 2017 |
Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
Topics: Antineoplastic Agents; Carcinoma; Cardiac Output; Cisplatin; Colorectal Neoplasms; Cytoreduction Sur | 2018 |
5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Cisplatin; | 2018 |
Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low‑dose chemotherapeutic agents on gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; | 2018 |
Gastrointestinal Elimination of a Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Humans; Live | 2018 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke | 2013 |
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2013 |
The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cells, | 2013 |
Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Cisplatin; Cohort Stu | 2014 |
[A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy | 2014 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Transfusio | 2014 |
O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 2015 |
Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line.
Topics: Animals; Carcinoma, Signet Ring Cell; Cell Line, Tumor; Cell Proliferation; China; Drug Resistance, | 2015 |
Metabolic alteration--Overcoming therapy resistance in gastric cancer via PGK-1 inhibition in a combined therapy with standard chemotherapeutics.
Topics: Adenocarcinoma; Adenoviridae; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug | 2015 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwellin | 2016 |
Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell.
Topics: Active Transport, Cell Nucleus; Basic Helix-Loop-Helix Transcription Factors; Cell Line; Cell Nucleu | 2016 |
Mitomycin C-treated human-induced pluripotent stem cells as a safe delivery system of gold nanorods for targeted photothermal therapy of gastric cancer.
Topics: Animals; Drug Delivery Systems; Female; Gold; Hot Temperature; Humans; Induced Pluripotent Stem Cell | 2017 |
[Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Diffusion Magnetic Resona | 2009 |
Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspases; Cell Line, T | 2010 |
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplast | 2009 |
Using activated carbon nanoparticles to decrease the genotoxicity and teratogenicity of anticancer therapeutic agents.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; Cell Line; Cell Line, Tumor | 2010 |
Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette T | 2012 |
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Cholesterol; Colonic Neoplasms; Drug Carriers; Drug Stability; | 2012 |
Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2012 |
[Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Line, Tumo | 2012 |
Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer.
Topics: Antibiotics, Antineoplastic; Ascites; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Hype | 2013 |
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Cell Survival; Coloring Ag | 2002 |
Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxo | 2002 |
A patient with advanced gastric cancer, underwent curative gastrectomy and partial resection of metachronous hepatic metastases, is surviving for 13 years to date.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Disease-Free Survival; Gastrectomy; Humans; | 2002 |
[Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2002 |
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2002 |
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2002 |
Gastrostomy-site tumor recurrence is not always fatal.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Carcinoma, Squamous Cell; Flu | 2003 |
[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2002 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Hepatectomy; Humans; Infus | 2002 |
[Effect of hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin | 2002 |
[Efficacy of intraperitoneal chemotherapy for advanced Borrmann type IV gastric carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Infus | 2002 |
[Clinical comparison between intraoperative local arterial infusion chemotherapy and systemic venous chemotherapy of gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxo | 2001 |
The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs.
Topics: Antibiotics, Antineoplastic; Cell Cycle; Colonic Neoplasms; Humans; Luminescent Measurements; Mitomy | 2003 |
[Effect of shenqi fuzheng injection on immune function in gastric carcinoma patients in post-operational and chemotherapeutic period].
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Dr | 2001 |
Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2003 |
Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antine | 2003 |
[A case of gastric cancer with liver metastasis in which obstruction of the bile duct and choledocholithiasis was caused by intra-hepatic arterial infusion chemotherapy].
Topics: Angiotensin II; Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Gallstones; Ga | 2003 |
[Study on the chemosensitivity test of human gastric cancer using the MTT assay].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Screening Assays, Antitumor; Fem | 2001 |
Treatment of interstitial peumopathy by fei tong oral liquid in the malignant tumor patients after radio- and/or chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drugs, Chinese | 2003 |
Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.
Topics: Antineoplastic Agents; Cell Division; Cisplatin; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neopla | 2003 |
Mitomycin C-induced renal insufficiency: a case report.
Topics: Anemia, Hemolytic; Antibiotics, Antineoplastic; Humans; Hypertension; Kidney Diseases; Male; Middle | 2003 |
Mitomycin C (MMC) with weekly 24-hour infusions of high-dose 5-fluorouracil and leucovorin in patients with advanced gastric cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C | 2003 |
EARLY RESULTS OF COMBINED RADIATION AND CHEMOTHERAPY IN TREATMENT OF MALIGNANT TUMORS.
Topics: Antineoplastic Agents; Colonic Neoplasms; Dactinomycin; Fluorouracil; Humans; Lung Neoplasms; Mitomy | 1963 |
PRESENT-DAY MANAGEMENT OF GASTRIC CANCER.
Topics: Fluorouracil; Gastrectomy; Humans; Mitomycin; Mitomycins; Mortality; Neoplasms; Stomach Neoplasms | 1964 |
STUDIES ON REGIONAL PERFUSION AND INTRA-ARTERIAL INFUSION FOR CANCER CHEMOTHERAPY.
Topics: Antineoplastic Agents; Breast Neoplasms; Celiac Artery; Chemotherapy, Cancer, Regional Perfusion; Co | 1964 |
[MASSIVE DOSES OF MITOMYCIN DURING SURGERY--THEORY AND RESULTS DURING PALLIATIVE EXCISION IN STOMACH CANCER].
Topics: Antineoplastic Agents; Biometry; Blood; Bone Marrow Transplantation; Gastrectomy; Geriatrics; Humans | 1964 |
CHEMOTHERAPY OF GASTRIC CANCER.
Topics: Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Thiotepa | 1964 |
PAPER ELECTROPHORETIC STUDIES ON SERUM PROTEINS IN THE DISEASES OF THE DIGESTIVE SYSTEM, WITH PARTICULAR REFERENCE TO THE CHANGES IN SERUM PROTEINS IN THE PATIENTS WITH CANCER.
Topics: Antineoplastic Agents; Blood Protein Electrophoresis; Blood Proteins; Carcinoma, Hepatocellular; Dig | 1963 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
LARGE-DOSE ADMINISTRATION OF MITOMYCIN-C DURING GASTRECTOMY FOLLOWED BY HOMOLOGOUS BONE MARROW TRANSPLANTATION.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Drug Therapy; Gastrectomy; Humans; Leukocyte Cou | 1964 |
[EVALUATION OF ADJUVANT POSTOPERATIVE CHEMOTHERAPY AND RADIATION THERAPY IN GASTRIC CANCER].
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Therapy; Humans; Mitomycin; Mitomycins; Neoplasm | 1964 |
EFFECT OF MITOMYCIN C UPON STOMACH CANCER (FROM FOLLOW-UP STUDY OF GASTRECTOMY).
Topics: Drug Therapy; Follow-Up Studies; Gastrectomy; Humans; Mitomycin; Mitomycins; Stomach Neoplasms | 1964 |
[INTRAOPERATIVE USE OF MITOMYCIN C WITH SPLEEN AND BONE MARROW SHIELDING TECHNIQUE IN GASTRIC CANCER SURGERY].
Topics: Bone Marrow; Drug Therapy; Humans; Mitomycin; Mitomycins; Neoplasms; Spleen; Stomach Neoplasms; Surg | 1965 |
[Two advanced gastric cancer patients who showed malignant ileus soon after administration of combination therapy of preoperative intra-peritoneal chemotherapy and gastrectomy].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modal | 2003 |
[Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fl | 2003 |
[Evaluation of arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administrat | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasm | 2003 |
Detection and treatment of the micrometastases of gastric cancer.
Topics: Carcinoembryonic Antigen; Humans; Mitomycin; Peritoneal Neoplasms; Stomach Neoplasms | 2004 |
Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; C | 2004 |
Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter.
Topics: alpha-Fetoproteins; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neop | 2004 |
Unresectable alpha fetoprotein-producing gastric cancer successfully treated with irinotecan and mitomycin C after S-1 failure.
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Ph | 2004 |
Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).
Topics: Animals; Antigens, Differentiation; Antineoplastic Agents; Cell Cycle Proteins; Cell Death; Cell Lin | 2004 |
[A case of effective treatment of oral TS-1 and intravenous MMC administration for multiple metastases of gastric cancer].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Che | 2004 |
[Multidrug resistant effect of alternative splicing form of MAD2 gene-MAD2beta on human gastric cancer cell].
Topics: Adenocarcinoma; Alternative Splicing; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Topics: Acid Anhydride Hydrolases; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; C | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2004 |
[Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients].
Topics: Adsorption; Aged; Antibiotics, Antineoplastic; Ascites; Biomarkers, Tumor; Charcoal; Dosage Forms; F | 2004 |
Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Carrier Proteins; Caspase 3; | 2005 |
Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cisplatin; Combin | 2005 |
[Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2004 |
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2005 |
What is the role of mitomycin C in advanced gastric cancer?
Topics: Humans; Mitomycin; Randomized Controlled Trials as Topic; Severity of Illness Index; Stomach Neoplas | 2005 |
Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cycl | 2005 |
[Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothe | 2005 |
[Regulatory effects on apoptotic activities of gastric cancer cell line by over-expression of Smac gene].
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Humans; Intracellular Signali | 2005 |
[Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
Topics: Animals; Antibiotics, Antineoplastic; Charcoal; Female; Humans; Injections, Intraperitoneal; Male; M | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combi | 2005 |
[Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer].
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Humans; Infusions, Parenteral; Mitomyci | 2005 |
[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2005 |
Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineo | 2006 |
[A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; | 2006 |
TS-1 as first-line therapy for gastric linitis plastica: historical control study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2006 |
[Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Animals; Antibiotics, Antineoplastic; Charcoal; Drug Carriers; Drug Delive | 2006 |
[Effect of combination of glutamine and mitomycin C on human gastric carcinoma cell strain MGC-803].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Dru | 2006 |
[Effects of hyperthermic chemotherapy on gastrointestinal cancer cells in vitro].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Cispl | 2006 |
Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antigens, CD34; Biomarkers; Burkitt Lymphoma; Ca | 2007 |
[Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Survival; Cisplatin; Dox | 2006 |
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro | 2007 |
Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2007 |
[Comparison the standard therapies of gastric cancer in Japan with those in the West].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 2007 |
[Drug sensitivity test and drug-resistance gene assessment for chemotherapy planning for tumors derived from high-passage mouse gastric cancer cells: therapeutic effect observation in mice].
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin | 2007 |
Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
Topics: Antineoplastic Agents; Carcinoma; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; F | 2008 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim | 2007 |
F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis.
Topics: Adult; Carbon; Diagnosis, Differential; Extravasation of Diagnostic and Therapeutic Materials; False | 2008 |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cisplatin; Down-Regulation; D | 2008 |
[Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression].
Topics: Adult; Aged; Antineoplastic Agents; Cell Survival; Cisplatin; Doxorubicin; Drug Screening Assays, An | 2008 |
[Sex hormone dependency in diffuse carcinoma of the stomach and results of chemo-endocrine therapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Animals; Female; Gonadal Steroid Hormones; Humans; Male; Mice; Mice | 1984 |
Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Chemotaxis, Leukoc | 1984 |
The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Combination; | 1983 |
[Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Ev | 1984 |
[Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Colonic Neoplasms; Drug Synergism; Dru | 1983 |
Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Therapy, Combination; Female; Fluorouracil; Hemolytic | 1983 |
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Topics: Adenocarcinoma; Adult; Anemia, Hemolytic; Drug Therapy, Combination; Female; Fluorouracil; Humans; K | 1983 |
Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combina
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Disease Models, Animal; Dox | 1983 |
Reversible microangiopathic hemolytic anemia after mitomycin C.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antibiotics, Antineoplastic; Humans; Male; Mitomycin; Mitom | 1983 |
[Single chemotherapy with 5-fluorouracil or ftorafur and combination chemotherapy with mitomycin C and 5-fluorouracil for inoperable elderly gastric cancers].
Topics: Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Mitomycin; Mitomycins; Stomach | 1983 |
[Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
Topics: Adenocarcinoma; Adult; Aged; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; M | 1983 |
[Intra-arterial chemotherapy combined with noradrenaline--histopathological effect in stomach cancer].
Topics: Adult; Aged; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Mid | 1983 |
[Chemotherapy of gastric cancer patients with hepatic metastases].
Topics: Administration, Oral; Antibiotics, Antineoplastic; Fluorouracil; Humans; Liver Neoplasms; Mitomycin; | 1983 |
[Adjuvant chemotherapy for aged patients with gastric carcinoma].
Topics: Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Mitomyci | 1983 |
[A study on postoperative long-term continuous immuno-chemotherapy with PSK and 5-FUDS for advanced gastric and colo-rectal cancers].
Topics: Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Human | 1983 |
[Effect of PSK on cell-mediated immune status in the patients of stomach cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Therapy, Combination; Female; Humans; Immunity, Cellu | 1983 |
Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection.
Topics: Antibiotics, Antineoplastic; Carcinoma; Dose-Response Relationship, Drug; Drug Administration Schedu | 1983 |
[Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
Topics: Aged; Drug Therapy, Combination; Fluorouracil; Humans; Kidney Diseases; Male; Mitomycin; Mitomycins; | 1983 |
[Effect of intracavitary administration of an anticancer agent with glucocorticoid on cancer patients complicated with malignant effusion].
Topics: Antineoplastic Agents; Breast Neoplasms; Dexamethasone; Female; Humans; Male; Mitomycin; Mitomycins; | 1983 |
[Treatment of recurrent gastrointestinal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Humans; Infusions, I | 1983 |
[Conditions suitable for chemotherapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; Humans; Mitomycin; Mitomyc | 1983 |
[Conditions suitable for the adjuvant chemotherapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; Humans; Mitomycin; Mitomyc | 1983 |
[Analysis of factors affecting clinical cancer chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Fluorouraci | 1983 |
[Evaluation of chemotherapy for resected stomach cancer: second-look operation].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Male; Midd | 1983 |
[Combined antitumor therapy with polyamine biosynthesis inhibitors and mitomycin C].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Eflornithine; Humans; Mice; Mice, Nude; Mit | 1983 |
[Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Male; Midd | 1983 |
[Chemotherapy of unresectable Borrmann's type IV stomach cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Mitomycin; Mitomy | 1983 |
[Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema | 1983 |
[Pre-operative endoscopic infusions of an adsorbent containing mitomycin C (MMC-CH44) in stomach cancer].
Topics: Adsorption; Aged; Antibiotics, Antineoplastic; Charcoal; Gastroscopy; Humans; Lymphatic Metastasis; | 1983 |
Immunochemotherapy with levamisole for stage III gastric cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1983 |
[Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion].
Topics: Female; Hot Temperature; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Ovarian Neoplasms; Perfusion | 1984 |
[A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxo | 1984 |
[UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; | 1984 |
[Clinical studies on preoperative abdominal arterial infusion of anticancer agents].
Topics: Abdomen; Alanine Transaminase; Aspartate Aminotransferases; Doxorubicin; Humans; Infusions, Intra-Ar | 1984 |
[Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorourac | 1984 |
[Basic and clinical studies on metastatic cancer--with special reference of multidisciplinary treatment of gastric and colorectal cancer patients with hepatic metastasis].
Topics: Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Ar | 1983 |
[The tumor--immunological significance of splenectomy for cancer therapy].
Topics: Animals; Combined Modality Therapy; Humans; Immunity, Cellular; Immunotherapy; Mice; Mitomycin; Mito | 1983 |
[Combined therapy with polyamine biosynthesis inhibitors and mitomycin C].
Topics: Animals; DNA Replication; DNA, Neoplasm; Drug Therapy, Combination; Eflornithine; Guanidines; Humans | 1984 |
Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; H | 1984 |
[Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation].
Topics: Breast Neoplasms; Female; Humans; Infusions, Parenteral; Kinetics; Mitomycin; Mitomycins; Neoplasms; | 1984 |
[Chemotherapy of unresectable Borrmann type 4 gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Fluorouracil; Humans | 1984 |
[Constant intra-aortic infusion chemotherapy for advanced abdominal cancer--a technic and the effect in patients with peritoneal metastases].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Coloni | 1984 |
Combination chemoimmunotherapy for advanced gastric carcinoma.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Ca | 1984 |
[Sensitivity test of anticancer agents using human tumor xenografts in nude mice with special reference on correlation between clinical effects and chemotherapy].
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclophosphamide; Drug Resistance; Fluorouracil; Gast | 1984 |
[Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].
Topics: Abdomen; Carbon; Colonic Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Middle Aged; Mitomyc | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Syner | 1984 |
[Chemosensitivity to mitomycin C and cell kinetics of human tumor xenografts serially transplanted into nude mice].
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Survival; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitom | 1984 |
[Experimental hyperthermo-chemotherapy for human gastric carcinoma transplanted in the nude mice].
Topics: Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; DNA Replication; Hot Temperature; H | 1984 |
[2 cases of solitary metastasis to the large intestine from gastric carcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; | 1984 |
Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; D | 1984 |
[Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
Topics: Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Hum | 1984 |
[Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anorexia; Antibiotics, Antineoplastic; Aspartate Amin | 1984 |
Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Humans; L | 1984 |
Sequential changes in nuclear DNA content by chemotherapy observed in experimental canine gastric cancer.
Topics: Adenocarcinoma; Animals; Carcinogens; Cell Nucleus; DNA, Neoplasm; Dogs; Flow Cytometry; Methylnitro | 1984 |
FAM2 regimen in disseminated gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; | 1984 |
A retrospective study of FAM regimen in 38 patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Midd | 1984 |
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Doxorubicin; D | 1984 |
Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1984 |
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin | 1984 |
Chemotherapy of advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Drug Therapy, Combinat | 1983 |
Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1983 |
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1983 |
Combined modality treatment of gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Therap | 1983 |
[A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyt | 1984 |
The FAM regimen for gastric cancer: a progress report.
Topics: Adult; Aged; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Hu | 1981 |
Chemotherapy of carcinomas of the digestive tract.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Esop | 1982 |
[Heterotransplantation of human stomach carcinomas into nude nice. 3. Effects of MMC and 5FU on 7 strains of transplantable human gastric cancer in nude mice].
Topics: Animals; Fluorouracil; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantati | 1982 |
[Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Agents; Aspirin; Chromomycin A3; Dipyridamole; Female | 1982 |
[Antitumor treatment for synchronous hepatic metastasis from stomach cancer].
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver N | 1982 |
[Chemotherapy of stomach cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cisplatin; Doxorubicin; Drug Administration Sched | 1982 |
Effect of spleen-derived cells on autochthonous peripheral blood lymphocyte responses to mitogens in gastric cancer patients.
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; Cells, Cultured; Concanavalin A; Humans; Immune | 1982 |
[MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytara | 1982 |
[Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Topics: Aged; Animals; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Ehrlich Tumor; Drug Ther | 1982 |
[Cytological studies of esophageal carcinoma and gastric carcinoma receiving radiation and chemotherapy].
Topics: Antineoplastic Agents; Cytodiagnosis; Esophageal Neoplasms; Humans; Mitomycin; Mitomycins; Radiother | 1982 |
[Effect of immunochemotherapy on the cases of advanced gastric cancer stage III].
Topics: Drug Therapy, Combination; Fluorouracil; Gastrectomy; Humans; Levamisole; Lymphatic Metastasis; Mito | 1982 |
[Preoperative OMF therapy for gastric cancer--examination of macroscopical effect in comparison with histological effect].
Topics: Adult; Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Mid | 1982 |
[Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].
Topics: Animals; Cell Division; Colonic Neoplasms; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm | 1982 |
[Clinical studies of cancer chemotherapy combined with angiotensin-II (ANG-II)].
Topics: Adult; Aged; Angiotensin II; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Pressure; Bre | 1982 |
Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Dru | 1982 |
[Chemotherapy of gastric carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Cytokines; Disseminated Intravascular | 1995 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1995 |
Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1994 |
Pericardiac metastasis from advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorouracil; Heart Neoplasms; Human | 1995 |
[Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined | 1995 |
[A case of intrahepatic infusion chemotherapy with angiotensin II human for liver metastasis from early gastric cancer].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure | 1995 |
[A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Enterobacteriaceae; Epirubicin; Fluorouracil; | 1995 |
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating | 1995 |
Immunohistochemical features of HLA-DR antigen expression and lymphoid infiltrates in gastric carcinoma after low-dose interleukin-2 and mitomycin C.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Femal | 1995 |
Mitomycin C directly augments the expression of HLA-DR antigen in a gastric carcinoma cell line.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Dose-Response Relationship, Drug; HLA-DR Antigens; Human | 1994 |
Preoperative intraperitoneal chemotherapy for gastric cancer, with special reference to delayed peritoneal complications.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1995 |
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Topics: Apoptosis; Drug Resistance; Drug Synergism; Humans; Mitomycin; Protein Kinase C; Sphingosine; Stereo | 1995 |
[Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
Topics: Carcinoma, Squamous Cell; Cell Division; Dicumarol; DNA Damage; Humans; Leukemia, Myeloid; Mitomycin | 1993 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined | 1995 |
[A bispecific monoclonal antibody with versatile adaptor mediating different cytotoxicities].
Topics: Animals; Antibodies, Monoclonal; Doxorubicin; Haptens; Humans; Hybridomas; Immunotoxins; Mice; Mice, | 1994 |
[A case of gastric cancer with Borrmann type 4 responding to 5-FU-MMC combined chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fluoro | 1994 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 1994 |
Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma.
Topics: Adenocarcinoma; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hyperthermia, | 1994 |
[Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm].
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Humans; Immunotoxins; Interferon Type I; Mice; Mice | 1993 |
[Characterization of a fluorouracil-resistant human gastric carcinoma cell line and its morphological behavior].
Topics: Animals; Cell Division; DNA, Neoplasm; Drug Resistance; Fluorouracil; Humans; Mice; Mice, Nude; Mito | 1993 |
Gastric carcinoma: curative resection and adjuvant chemotherapy.
Topics: Adenocarcinoma; Aged; Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Chemot | 1994 |
[A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administrati | 1994 |
Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.
Topics: Aclarubicin; Animals; Carbazilquinone; Carcinoma; Cell Nucleus; CHO Cells; Cisplatin; Cricetinae; Cy | 1994 |
Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; | 1994 |
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver | 1994 |
Long-term follow-up of mitomycin C nephropathy.
Topics: Hemolytic-Uremic Syndrome; Humans; Hypoaldosteronism; Kidney Diseases; Male; Microscopy, Electron; M | 1994 |
Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Cisplatin; Coloring Agents; Doxorubicin; Drug Screening Assays, | 1994 |
[Complete response in a case of unresectable gastric cancer treated by combined chemoimmunotherapy of MMC, 5-FU and OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; | 1994 |
[Intraoperative lymph nodes dissection guided by preoperative endoscopical injection of mitomycin C absorbed activated carbon (MMC-CH40) at pericancerous gastric mural in patients with gastric cancer].
Topics: Charcoal; Gastroscopy; Humans; Lymph Node Excision; Lymphatic Metastasis; Mitomycin; Particle Size; | 1993 |
[Neoadjuvant chemotherapy for far-advanced gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Dr | 1994 |
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colonic Neoplasms; Deoxycytidine; Drug Admini | 1994 |
Semiautomated 14C-thymidine incorporation assay for in vitro screening of anticancer drug.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Signet Ring Cell; Cell Divis | 1993 |
[A case of advanced gastric cancer responding well by preoperative chemotherapy with CDDP and MMC].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Ga | 1993 |
[Prophylactic effects of mitomycin C (MMC) on the liver recurrence in a rabbit gastric VX2 cancer model with high frequency of the recurrence].
Topics: Animals; Disease Models, Animal; Female; Injections, Intravenous; Liver Neoplasms; Mitomycin; Neopla | 1993 |
Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol.
Topics: Adenocarcinoma; Alkynes; Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Dru | 1994 |
[Effect of adjuvant chemotherapy for patients with early gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 1994 |
[Ultrasonic findings of the cholecyst and biliary tract after gastrectomy].
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Biliary Tract; Cholelithiasis; Femal | 1993 |
A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; Doxoru | 1993 |
[A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 1993 |
[Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytokines; Doxorubicin; Fluorouracil; Humans; Immuno | 1993 |
[Clinical study on the effect of continuous transarterial infusion chemotherapy of CDDP for metastatic liver tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Admi | 1993 |
[Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administratio | 1993 |
[Evaluation of subselective intraarterial infusion chemotherapy in far advanced gastric and colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Inf | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluoroura | 1993 |
[Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles].
Topics: Adenocarcinoma; Adult; Aged; Carbon; Chemotherapy, Adjuvant; Delayed-Action Preparations; Female; Ga | 1993 |
[A case of gastric cancer with multiple liver metastases responding significantly to intra-arterial infusion of epirubicin/mitomycin C-lipiodol suspension].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1993 |
Synergistic antitumor activity of mitomycin C and cisplatin against gastric cancer cells in vitro.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Humans; M | 1993 |
[A case of secondary leukemia induced by chemotherapy with a CDDP-based regimen for gastric cancer 5 years following radical resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans | 1993 |
[Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test].
Topics: Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neopla | 1993 |
[Evaluation of long-term administration of oral anti-cancer agent].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Coloni | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 1993 |
Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Combined Modali | 1993 |
Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Lymphat | 1995 |
[FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intrava | 1996 |
An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Combined Modality Therapy; Duod | 1996 |
[Successful combination chemotherapy for a post-operative gastric cancer patient with multiple liver metastases and elevated CEA].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Combined Modality Th | 1996 |
DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; Base Sequence; Colonic Neoplasms; Cytochrome P-450 Enzyme System; Cytoc | 1996 |
[A case of advanced gastric cancer with liver metastasis with no recurrence and long survival].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1996 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridi | 1996 |
[A case of nonresectable advanced gastric cancer responding to combined chemotherapy with 5'-DFUR, CDDP, and MMC].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Flox | 1996 |
[Evaluation of drug sensitivities to gastric cancers by SDI test--study of quality control of SDI test by simulation test].
Topics: Animals; Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Mi | 1995 |
[Studies on the in vivo and in vitro chemosensitivity tests using human tumor xenografts].
Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, An | 1995 |
[Liver resection in a case of multiple liver metastases of gastric cancer following hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1996 |
Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Combined Modalit | 1996 |
Mechanism and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to carbon particles.
Topics: Antibiotics, Antineoplastic; Carbon; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; | 1996 |
Heated intraperitoneal mitomycin C infusion treatment for patients with gastric cancer and peritoneal metastasis.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Humans; Hyperthermia, Induced | 1996 |
Monocyte function associated with intermittent lentinan therapy after resection of gastric cancer.
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; A | 1996 |
[An experimental study on antitumor effect of MMC-fibrin glue mixture].
Topics: Animals; Esophageal Neoplasms; Fibrin Tissue Adhesive; Mice; Mice, Nude; Mitomycin; Stomach Neoplasm | 1996 |
[Induced hypertensive chemotherapy with angiotensin-II for liver metastases from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Female; Fluoro | 1996 |
[A case of gastric cancer with peritoneal dissemination and malignant biliary stenosis treated by loco-regional cancer therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Cisplatin; Combined Modality Ther | 1996 |
Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cyclohexanes; Female; Humans; Liver Neoplasms; | 1996 |
[Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Embolization, Therapeutic; Gastr | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseas | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 1996 |
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.
Topics: Carcinoma; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mito | 1997 |
[Diagnosis and therapeutic management of gastric lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1996 |
The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers.
Topics: Antineoplastic Agents; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Etoposide; Genes, MD | 1996 |
Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Deoxyglucose; Doxorubicin; Fluorine Radio | 1997 |
[Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Sc | 1997 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug C | 1997 |
[Combination therapy with 5'-DFUR, MMC and CDDP in patient with far advanced gastric cancer: report of a case].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; F | 1997 |
Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplasti | 1997 |
[Percutaneous transcatheter thermotherapy (PTCT): use of hotwire for local tumor control].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1997 |
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; | 1997 |
[Evaluation of intraperitoneal chemotherapy using CDDP/MMC or CDDP for gastric carcinomatous peritonitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Inf | 1997 |
[Extra-arterial dislocation of indwelling catheter in hepatic arterial infusion chemotherapy--special reference to tissue destruction by 5-fluorouracil].
Topics: Aged; Aneurysm, False; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protoco | 1997 |
[Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Female; Humans; Immunity | 1997 |
Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy.
Topics: Adenocarcinoma; Adsorption; Aged; Antibiotics, Antineoplastic; Carbon; Female; Humans; Male; Middle | 1997 |
[New combination therapy with FTM [5-FU, pirarubicin (THP) and MMC] for treatment of inoperable advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1997 |
[Therapeutic effect of matrix metalloproteinase inhibitor (R-94138) for peritoneal metastasis of stomach neoplasm models].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, Animal; Injectio | 1997 |
[Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxo | 1998 |
[A case of multiple liver metastasis of gastric cancer responding to hepatic arterial infusion chronotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Cisplatin; Drug Ad | 1998 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |
[Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; Infusion Pumps, Imp | 1998 |
[Intrahepatic arterial infusion chemotherapy with angiotensin II for liver metastasis from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administr | 1998 |
[Long-term survival in a case of multiple liver metastasis from postoperative gastric cancer effectively treated by hepatic intraarterial infusion chemotherapy using MMC and pirarubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Gastrectomy; Hepatic Artery; Humans; In | 1998 |
[Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluo | 1998 |
[Clinical result of intraperitoneal hyperthermic chemoperfusion for gastric cancer with serosal invasion to prevent peritoneal recurrence].
Topics: Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Hyperthermia, | 1998 |
[Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Ascites; Carcinoma; Cause of Death; Chemotherapy, Cancer, | 1997 |
[Preoperative intra-arterial and venous neoadjuvant chemotherapy for advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Female; Fl | 1998 |
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; DNA Fra | 1997 |
Clinical applications of the histoculture drug response assay.
Topics: Antineoplastic Agents; Cell Culture Techniques; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorecta | 1995 |
[Effect of combination chemotherapy with mitomycin C and cisplatin on advanced gastric carcinoma].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1999 |
[Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 1999 |
Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice.
Topics: Acetamides; Animals; Antineoplastic Agents; Cisplatin; Gelatinases; Humans; Male; Matrix Metalloprot | 1999 |
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biotransformation; Body Weight; Carcinoma, Large Cel | 1998 |
[Preoperative chemotherapy targeting lymphatic apparatus in the peritoneal cavity of gastric cancer patients with serosal invasion using mitomycin C bound to activated carbon particles].
Topics: Adult; Aged; Carbon; Female; Humans; Infusions, Parenteral; Lymphatic System; Male; Middle Aged; Mit | 1999 |
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1999 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformatio | 1999 |
[A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II].
Topics: Aged; Angiotensin II; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic C | 1999 |
[Percutaneous ethanol injection therapy with hepatic arterial infusion chemotherapy for liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Ethanol; Fluorouracil; Hepatic Art | 1999 |
[Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administr | 1999 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorour | 2000 |
Epithelioid leiomyosarcoma of the stomach: report of a case.
Topics: Abdominal Pain; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Biopsy; Combined Moda | 2000 |
Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Can | 2000 |
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Chem | 2000 |
A feasibility study of chemosensitivity assay by adhesive tumor cell culture system using biopsy specimens for gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Cisplatin; Doxorubicin; Drug S | 2000 |
Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Cell Divi | 2000 |
Unresectable advanced gastric cancer effectively treated by combined chemo-immunotherapy: a report of two cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouraci | 2000 |
Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; | 2000 |
Effects of intraperitoneal mitomycin C adsorbed on activated carbon on adhesion formation and mesothelial cells in vitro.
Topics: Animals; Charcoal; Disease Models, Animal; Epithelial Cells; Fibrinolysis; Humans; In Vitro Techniqu | 2000 |
Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Hypert | 2000 |
Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.
Topics: Amino Acid Sequence; Antibiotics, Antineoplastic; Cloning, Molecular; DNA, Complementary; DNA, Neopl | 2000 |
[Hepatic arterial infusion chemotherapy for unresectable liver metastasis of gastrointestinal cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Fluorouracil; Hepati | 2000 |
[A case of stage IV gastric cancer responding to combined chemotherapy by intravenous, intraarterial and intraperitoneal injection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Fluorouraci | 2000 |
Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemoth | 2001 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; He | 2000 |
Advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-FU, MMC and peroral administration of 5-FU: a case report.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; | 2000 |
Options for investigative postsurgical therapy for gastric cancer, and case report of using the option for combined immunotherapy and chemotherapy.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Combin | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineopla | 2001 |
Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prognosis; Stomach | 2000 |
Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; | 2000 |
[A case of multiple liver metastasis of gastric cancer which was effectively treated by arterial infusion chemotherapy with hyperthermia and 10 years survival].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Embolization, Therapeutic; | 2001 |
[Fundamental study on the sensitivity test inhibiting fibroblast proliferation].
Topics: Agar; Animals; Antineoplastic Agents; Cell Division; Cisplatin; Culture Media; Doxorubicin; Drug Scr | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri | 2001 |
Endoscopic Nd:YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cardia; Combined Modality Th | 2001 |
[Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colorectal Neoplasms | 2001 |
[Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2001 |
[Hepatic resection for synchronous liver metastases of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatectomy; Hepatic Art | 2001 |
Cardiac tamponade as the first manifestation of gastric cancer and remission after chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Cisplatin; | 2001 |
[Basic study on the sensitivity test for inhibiting fibroblast proliferation (II)].
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; | 2001 |
[Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease?].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Combined Modality | 2001 |
Selective approaches to gastric cancer patients with liver metastases: role of liver-directed chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Doxorubicin; Fluorouracil; Humans; Infusi | 2001 |
The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfa | 1999 |
[Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2001 |
[Effect of anti-vascular endothelial growth factor antibody on the progression of human gastric cancer orthotopic xenotransplanted into nude mice].
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Combined Modality Therapy; Drug Synerg | 1999 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Car | 2002 |
Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transport | 2002 |
[Experimental study of tumor directed therapy with gastric cancer monoclonal antibody-mitomycin conjugate combined with propranolol or angiotensin II].
Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Drug Combinations; Humans; Immunotoxins; Male; Mice | 1992 |
[A case of metastatic urinary bladder tumor from gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; | 1992 |
Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Cisplatin; Doxorubicin; Epirubicin; Flow Cytomet | 1992 |
Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1992 |
Immunohistochemical analysis of lymphocyte subsets infiltrating gastric carcinoma after mitomycin C administration.
Topics: Aged; Carcinoma; CD4 Antigens; CD8 Antigens; Female; Humans; Immunohistochemistry; Lymphocyte Subset | 1992 |
Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
Topics: Adult; Aged; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; | 1992 |
Chemotherapy for gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Hum | 1992 |
[The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
Topics: Animals; Antibodies, Monoclonal; Doxorubicin; Immunotoxins; Male; Mice; Mice, Inbred BALB C; Mice, N | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; | 1992 |
[A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluoro | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1992 |
The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.
Topics: Aged; Biopsy; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Mitomycin; Sto | 1992 |
A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine diet.
Topics: Adenosylmethionine Decarboxylase; Animals; Body Weight; Cell Division; Combined Modality Therapy; Di | 1992 |
Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C.
Topics: Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eosinophilia; | 1992 |
[Trend and problems of chemotherapy of stomach neoplasms with metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; Mitomycin; Neoplasm | 1992 |
High dose mitomycin C for treatment of advanced gastric cancer.
Topics: Adult; Aged; Anorexia; Cardia; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; | 1992 |
Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 1992 |
[Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration | 1992 |
[Treatment of liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 1992 |
[Complications related to catheter indwelling in intra-arterial infusion chemotherapy from the standpoint of the route of cannulation].
Topics: Antineoplastic Agents; Aorta; Catheters, Indwelling; Doxorubicin; Femoral Artery; Fluorouracil; Gast | 1992 |
[Experimental study of the treatment of carcinomatous peritonitis in gastric cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Infusions, Parente | 1992 |
[Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Topics: Cisplatin; Humans; Immunotherapy; Infusions, Parenteral; Mitomycin; Pancreatic Neoplasms; Peritoniti | 1992 |
[Evaluation of intraoperative intraperitoneal administration on anti-cancer drug for gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Gastrectomy; Huma | 1992 |
[Effective treatment of liver metastasis and peritoneal dissemination of gastric cancer using intra-arterial therapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Fluoro | 1992 |
[Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver].
Topics: Catheterization; Catheters, Indwelling; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; | 1992 |
[An evaluation of perioperative and continuous infusion of tegafur as surgical adjuvant chemotherapy of resected gastric cancer].
Topics: Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Mid | 1992 |
[Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Screening Assays, Antitumor; Female; | 1992 |
[A case of recurrent liver tumor from gastric cancer responding remarkably to hepatic arterial infusion of large doses of mitomycin C and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastrectomy; Hepatic Artery; Hum | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neopla | 1992 |
[Strategy for therapy of malignant ascites using MTT assay].
Topics: Antineoplastic Agents; Ascitic Fluid; Breast Neoplasms; Cisplatin; Clinical Protocols; Doxorubicin; | 1992 |
Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Topics: Aclarubicin; Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Sc | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 1992 |
MMAF for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Methotrexate; Mit | 1992 |
[Clinical evaluation of intra-arterial infusion of hyperthermo-chemotherapy in gastric cancer].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1991 |
Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Celiac Artery; Doxorubicin; Evaluation Studies as To | 1991 |
[Antineoplastic chemotherapy in digestive tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Fluorouracil; Hum | 1991 |
[Preoperative role of angiotensin II induced hypertension chemotherapy (IHC) in advanced gastric carcinoma].
Topics: Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Combine | 1992 |
Increased drug resistance of cultured human cancer cell lines in three-dimensional cellular growth assay using collagen gel matrix.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Collagen; Colonic Neoplasms; Culture Media; Doxoru | 1992 |
[Evaluation of induced hypertension chemotherapy (IHC) in ambulatory cancer patients].
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Breast | 1991 |
[Nutritional support for cancer bearing patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Home Nursing; Humans | 1991 |
[Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer].
Topics: Adult; Aged; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; M | 1991 |
[In vitro chemosensitivity test using collagen gel matrix for human gastric carcinomas].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Agents; Cisplatin; Collagen; Doxorubicin; Drug Screening A | 1991 |
[The surgical treatment of gastric cancer. A review of the results and a comparison with Japanese experience].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1991 |
[A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrectomy; Humans; Lymphatic | 1991 |
[Treatment of gastric cancer patients with peritoneal metastasis by continuous hyperthermic peritoneal infusion with mitomycin C and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Hyperthermia, Induced; Infusions, | 1991 |
[Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorub | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Moda | 1991 |
[A pilot study of the combination of 5-FU and epirubicin for gastric cancer as an adjuvant chemotherapy].
Topics: Administration, Oral; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Flu | 1991 |
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Com | 1991 |
Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.
Topics: Animals; Blotting, Northern; Cell Line; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Resistance; | 1991 |
Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Fluorouracil; Huma | 1991 |
[Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Doxorubicin; Drug Screening Assays, | 1991 |
The influence of stromal cells on the MTT assay (I)--In vitro chemosensitivity of the tumor and stromal cells to mitomycin C.
Topics: Drug Screening Assays, Antitumor; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tetrazolium Salt | 1991 |
[Chemosensitivity test for gastric cancer by in vitro MTT assay].
Topics: Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Et | 1991 |
[A long-term survival case of advanced gastric cancer undergoing radical gastrectomy by second-look operation after successful chemotherapy (CDDP, MMC, 5-FU)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1991 |
[Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; | 1991 |
[Clinical evaluation of intra-peritoneal hyperthermic perfusion under hypothermic general anesthesia for advanced gastric cancer].
Topics: Anesthesia, General; Combined Modality Therapy; Female; Gastrectomy; Humans; Hyperthermia, Induced; | 1991 |
[Effect of intraarterial noradrenaline-induced hypertensive chemotherapy of hepatic metastasis in gastric cancer].
Topics: Aged; Blood Pressure; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver | 1991 |
[Experimental study on local attachment of Beriplast P membrane including MMC].
Topics: Animals; Antineoplastic Agents; Fibrin Tissue Adhesive; Humans; Membranes; Mice; Mice, Inbred BALB C | 1991 |
[The efficacy of intra-arterial infusion chemotherapy in patients with metastatic liver tumors].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Catheters, Indwelling; Colonic Neoplasms; Combi | 1991 |
[A study on hepatic arterial infusion for metastatic liver tumor].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; | 1991 |
[Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration | 1991 |
[Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration S | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
Alternating chemotherapy in advanced gastric cancer. A phase II study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Doxoru | 1991 |
Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Humans; Immunotoxins; | 1991 |
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Div | 1991 |
Chemotherapy in advanced gastric carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Methotrexate; Mit | 1991 |
[Enhancement of the carcinomatous peritonitis of human gastric cancer by pretreatment of mitomycin C in nude mice: preliminary report].
Topics: Animals; Cell Division; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplan | 1991 |
[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines].
Topics: Alkaloids; Antineoplastic Agents; Benzylisoquinolines; Cell Division; Doxorubicin; Drug Synergism; F | 1991 |
[Therapeutic effects of 9 antitumor drugs on stomach adenocarcinoma (MKN-28) in nude mice].
Topics: Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Cyclophosphamide | 1990 |
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation.
Topics: Adult; Cisplatin; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Kidney; Laparoto | 1990 |
[A case report of advanced gastric cancer remarkably responding to mitomycin C, aclacinomycin A, SF-SP and lentinan combination therapy].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Immunotherapy; Lentinan | 1990 |
[An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrecto | 1990 |
[Intraoperative intraperitoneal administration of CDDP against gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Ascitic Fluid; Cisplatin; Female; Gastrectomy; Humans; Intraoperative Care; Male; Middl | 1990 |
[Experimental studies on subrenal capsule assay using cyclosporin A treated mice--the optimal treatment schedules of CsA and anticancer agents (mitomycin C and 5-fluorouracil)].
Topics: Animals; Body Weight; Breast Neoplasms; Colonic Neoplasms; Cyclosporins; Female; Fluorouracil; Human | 1990 |
Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay.
Topics: Breast Neoplasms; Carbazilquinone; Cisplatin; Colorectal Neoplasms; DNA, Neoplasm; Doxorubicin; Drug | 1990 |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1990 |
[Subrenal capsule assay in normal mice immunosuppressed by cyclosporin A].
Topics: Animals; Cisplatin; Cyclophosphamide; Cyclosporins; Immune Tolerance; Male; Mice; Mitomycin; Mitomyc | 1990 |
Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cytotoxicity, Immunologic | 1990 |
Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1990 |
[Clinical results of intraperitoneal hyperthermic perfusion combined with surgery in patients with peritoneal recurrence from gastric cancer].
Topics: Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middl | 1990 |
[A case of unresectable liver metastasis from leiomyosarcoma of the stomach successfully treated by intra hepato-arterial chemotherapy with Infuse-A-Port].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hepatic Artery; Humans; I | 1990 |
The effect of recombinant interleukin 2 in combination with mitomycin C on advanced cancer.
Topics: Aged; Breast Neoplasms; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Immunization, | 1990 |
[Pharmacokinetics and prophylactic effect of intraperitoneal administration of mitomycin C resulting in IC50 of gastric cancer].
Topics: Cell Division; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Infusions, Parenteral; Ly | 1990 |
[Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
Topics: Adult; Aged; Biological Products; Female; Gastrectomy; Humans; Infusions, Parenteral; Intraoperative | 1990 |
[Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Colorectal Ne | 1990 |
[Clinical evaluation of recurrent patterns of gastric cancer after intraperitoneal hyperthermic perfusion].
Topics: Aged; Ascitic Fluid; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Pa | 1990 |
[Clinical effect of intraperitoneal hyperthermochemotherapy on the survival rate for advanced gastric cancer patients].
Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; | 1990 |
[Long-term arterial infusion chemotherapy to the cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubic | 1990 |
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1990 |
[Evaluation of the liver and peritoneal metastasis in the treatment of gastric carcinoma with intra-arterial injection in terms of survival period].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Int | 1990 |
[Study of intraarteric infusion chemotherapy with drug delivery system].
Topics: Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Cisplatin; Doxorubicin; Drug Administra | 1990 |
[A case of Borrmann type 4 gastric carcinoma which disappeared by intraaortic infusion chemotherapy with ADM and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Combined Modality Therapy; Doxorubicin; Femal | 1990 |
[Clinical evaluation and problem of intra-arterial infusion chemotherapy of liver metastasis from digestive organ cancer].
Topics: Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantabl | 1990 |
Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cytotoxicity Tests, Immunologic; Daunorubici | 1990 |
Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Female; Gastrectomy; | 1990 |
[An experimental study of anticancer agent sensitivity test in human gastric cancer cell lines by flow cytometry].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA, Neopla | 1990 |
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mit | 1990 |
Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherap | 1990 |
[Multivariate analysis of gastric cancer patients with liver metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1990 |
[Successful treatment of advanced gastric cancer with multiple liver metastasis by combination chemotherapy using mitomycin C, 5-fluorouracil, and high-dose leucovorin: a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; | 1990 |
[Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Scree | 1990 |
Adjuvant mitomycin-C prolongs survival time of patients undergoing extensive en bloc resection of carcinoma of the stomach invading the adjacent organs.
Topics: Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Humans; Mitomycin; Mitomycins; Neoplasm | 1990 |
Silent renal microangiography after mitomycin C therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Human | 1990 |
Selective cytotoxicity against human tumor cells by an anti-gastric cancer monoclonal antibody-mitomycin C conjugate.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cytotoxicity, Immunologic; Humans; Imm | 1990 |
[Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Daunorubicin; Immunoto | 1990 |
[A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxoru | 1990 |
[The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
Topics: Adolescent; Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemother | 1990 |
[A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Humans; M | 1990 |
[Study on endoscopic features in responders to systemic chemotherapy in advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fema | 1990 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1990 |
[A case of recurrent liver tumor from gastric cancer responding remarkably to intra-hepato-arterial infusion of CDDP, MMC and Lipiodol].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Hepatic Art | 1990 |
[Specific targeting of mitomycin C to tumors with the use of anti-gastric cancer monoclonal antibody].
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Humans; Immunotoxins; Mice; Mice, Nude; Mitom | 1990 |
[A case of nonresectable gastric cancer completely responding to combined chemotherapy according to the mode of progression].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 1990 |
[Clinical effect of chemotherapy combined with Chinese herbs and western drugs on leukocytes of gastric cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drugs, Chinese Herbal; Fema | 1990 |
A new chemotherapeutic regimen in the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1990 |
[Dose intensity and clinical response in patients with advanced gastric carcinoma treated by induced hypertension chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Fluorou | 1990 |
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Female; F | 1990 |
Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Combined Modality Therapy; Doxorubicin; Female; Foll | 1986 |
[A study of the antineoplastic activity of K18].
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Drug Combinations; Drug Synergism; Fluorourac | 1986 |
Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line; Cisplatin; DNA; Dose-Response Rel | 1987 |
[Analysis of the chemosensitivity test by subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colonic Neoplasms; Colony-Forming Units Assay; | 1987 |
[A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Live | 1988 |
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice].
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomy | 1988 |
[The drug sensitivity of human gastric cancer implanted into the subcutis and stomach wall of nude mice].
Topics: Adenocarcinoma; Animals; Bleomycin; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbr | 1989 |
[Intraoperative chemotherapy against peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles adsorbing mitomycin C].
Topics: Adsorption; Carbon; Gastrectomy; Humans; Intraoperative Care; Mitomycin; Mitomycins; Neoplasm Seedin | 1989 |
Postoperative adjuvant chemotherapy inhibits early recurrence of early gastric carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Drug Evaluation; Gastrectomy; Humans; Lymphatic Metastasis; Mi | 1989 |
[Chemotherapeutic effect on metastatic tumors].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Fluorou | 1989 |
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay].
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Humans; Mice; Mice, Inbred Strains; Mitomyc | 1989 |
[Pharmacokinetic analysis in intraperitoneal hyperthermic perfusion using mitomycin C in far-advanced gastric cancer].
Topics: Adult; Ascitic Fluid; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Mitomycin; | 1989 |
Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.
Topics: Adult; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Humans; Hyperthe | 1989 |
[Clinical evaluation of intraperitoneal hyperthermic perfusion in far-advanced gastric cancer].
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Evaluation Studies | 1989 |
[Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
Topics: Absorption; Aged; Carbon; Combined Modality Therapy; Gastrectomy; Humans; Intraoperative Care; Mitom | 1989 |
[Preventive hepatic arterial infusion in high risk cases of liver metastasis from gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Evaluation; Fluorour | 1989 |
[Over two years survival of intra-arterial infusion chemotherapy in gastric cancer with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fluoro | 1989 |
[Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Aorta; Doxorubicin; Fluorouracil; He | 1989 |
[Comparative study of tegafur (p.o.) and mitomycin C (MMC) plus tegafur in cases of unresectable gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Humans | 1989 |
[An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubic | 1989 |
[Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; Humans; | 1989 |
Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro.
Topics: Azirines; Carbazilquinone; Carcinoma; Cells, Cultured; Colorectal Neoplasms; HeLa Cells; Humans; Hyp | 1989 |
[Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 1989 |
Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Human | 1989 |
[A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modali | 1989 |
Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Fluo | 1989 |
[A study of combined chemotherapy with MMC, ADM, CDDP, VP-16 and 5'DFUR (MAC-VD) in advanced cancers of digestive organs].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Coloni | 1989 |
[Metastatic liver cancer from the stomach successfully treated by combined immunochemotherapy and transarterial embolization].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabin | 1989 |
[Chemosensitivity of MGc 80-3 human gastric adenocarcinoma cells and its clinical significance].
Topics: Adenocarcinoma, Mucinous; Amdinocillin; Antineoplastic Agents; Drug Screening Assays, Antitumor; Flu | 1989 |
[Characterization of human AFP producing stomach cancer xenotransplanted in nude mice and effect of a conjugate of MMC and antibody to human AFP on this tumor].
Topics: Aged; alpha-Fetoproteins; Animals; Antibiotics, Antineoplastic; Antibodies, Neoplasm; Female; Humans | 1985 |
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Doxorubicin; Female; Fluor | 1989 |
[A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Flu | 1989 |
[Clinical effectiveness of arterial infusion chemotherapy in advanced and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; | 1989 |
[Combination intra-arterial chemotherapy with degradable starch microspheres and mitomycin C against inoperable hepatic metastases].
Topics: Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microsp | 1988 |
[Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; | 1988 |
[Cancer chemotherapy of scirrhous type gastric cancer and evaluation of chemotherapeutic efficacy].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyt | 1988 |
[Therapeutic treatment of Borrmann type 4 (scirrhous) gastric cancer-chemotherapy and histopathological studies].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 1988 |
[A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastroscopy; | 1988 |
Radiation therapy for advanced gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; | 1988 |
[Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Allyl Compounds; Animals; Antibiotics, Antineoplastic; Cel | 1988 |
[Combination chemotherapy of human gastrointestinal and breast cancer xenografts in nude mice with 5'-deoxy-5-fluorouridine and mitomycin C].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Female | 1986 |
[Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colonic Neopla | 1987 |
[Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Admin | 1987 |
[Low-dose intermittent intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dox | 1985 |
[Chemo-endocrine therapy of diffuse carcinoma of the stomach and its clinical evaluation].
Topics: Adenocarcinoma, Scirrhous; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy | 1985 |
[PMU therapy of recurrent gastric cancer. A case report].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; | 1986 |
[A case of bilateral metastatic breast carcinoma from gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1986 |
[Chemotherapy of Borrmann type 4 gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Drug Adm | 1986 |
[A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Product | 1987 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Age | 1987 |
[Antineoplastic agent sensitivity of primary and metastatic foci of nude mouse-transplantable human gastric cancer].
Topics: Animals; Colony-Forming Units Assay; Fluorouracil; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; | 1986 |
[Treatment of gastric cancer based on the pathological and biophysiological aspects of cancer].
Topics: Combined Modality Therapy; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Mitomycin | 1986 |
[Antitumor effect of interferons with chemotherapeutic agents].
Topics: Antineoplastic Agents; Cell Line; Cells, Cultured; Cisplatin; Drug Therapy, Combination; Fluorouraci | 1986 |
[Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; DNA, Neo | 1986 |
[Changes in cancer associated cellular proteins after administration of antitumor agent using 2-dimensional PAGE--index of efficacy of antitumor agents].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Electrophoresis, Polyacrylamide Gel; Female; Humans; | 1986 |
[Adjuvant therapy of gastric cancer in the literature from 1980-1984].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Administration Schedule; Fluorouracil; Humans; Mitomyc | 1986 |
A case of advanced gastric cancer with long-term survival as the results of combined radiation therapy and chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gastroscopy | 1986 |
[Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined M | 1986 |
A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Hypoxia; | 1986 |
[Microangiopathic hemolytic anemia associated with gastric cancer].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Benzodiazep | 1986 |
[A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mitomycin; Mit | 1986 |
Prediction of individual tumor chemosensitivity in subrenal capsule assay.
Topics: Animals; Antineoplastic Agents; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin | 1986 |
[Huge Virchow's metastasis in gastric cancer made resectable by hyperthermochemoradiotherapy].
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hypertherm | 1986 |
Enhanced chemosensitivity of cells from malignant effusions under condition of exposure to high temperature.
Topics: Ascitic Fluid; Breast Neoplasms; Cells, Cultured; Colonic Neoplasms; Colony-Forming Units Assay; Dox | 1986 |
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Human | 1987 |
[A model for the sensitivity determination of anticancer agents against human cancer using nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Cisplatin; Colonic Neoplas | 1987 |
[Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gas | 1987 |
[The problems of postoperative adjuvant chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Lymphatic Metastasis; Mitomycin | 1987 |
[Subrenal capsule assay for chemosensitivity testing].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; Dox | 1987 |
[Comparative study with reduction rate of tumor and decrease rate of tumor markers as an effect of MMC on human cancer producing CEA and CA19-9 xenotransplanted in nude mice].
Topics: Animals; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Carcinoembryonic Antigen; Dru | 1987 |
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug E | 1987 |
[Prospectives on cancer treatment in the future--from its clinical aspects].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrectomy; Humans; Lymp | 1987 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methot | 1987 |
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 1987 |
[Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Mitomycin; Mitom | 1987 |
[Subrenal capsule assay as a chemosensitivity test (III)--Comparison of host reaction, experimental chemotherapy and use of nude mice].
Topics: Animals; Breast Neoplasms; Cell Line; Drug Evaluation, Preclinical; Fluorouracil; Humans; Mice; Mice | 1987 |
[A case of gastric cancer with marked response to intra-arterial infusion of cisplatinum, mitomycin C and 5-fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Infusions, | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1987 |
[Multimodal therapy using hyperthermia for gastric cancer--with special reference to histological studies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Hypert | 1987 |
[Antitumor efficacy of polyamine antimetabolites and mitomycin C under polyamine-free diet].
Topics: Animals; Diet; DNA Replication; Drug Administration Schedule; Eflornithine; Humans; Mice; Mice, Inbr | 1987 |
[Experience with CDDP therapy in advanced and recurrent gastric cancer cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Doxorubic | 1987 |
[Subrenal capsule assay as a chemosensitivity test (V)--Experimental chemotherapy of cyclosporin A-treated mice and nude mice].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cy | 1988 |
[Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Fluorou | 1988 |
[Chemosensitization with nitroimidazole to human gastric cancer transplanted into nude mice].
Topics: Animals; Cell Division; DNA Replication; Drug Synergism; Humans; Metronidazole; Mice; Mice, Nude; Mi | 1988 |
[Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric carcinoma. Hokuriku Cisplatin Round-table Conference].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule | 1988 |
[Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers].
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Humans; Hyperthermia, Induced; Metronidaz | 1988 |
[Flow cytometry DNA analysis of a gastric cancer before and after intra-arterial anticancer chemotherapy--report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Doxorubicin; Fe | 1988 |
Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorourac | 1988 |
Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Humans; Hy | 1988 |
[Chemotherapy and enteral nutrition in stomach cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 1988 |
[Changes in two-dimensional gel electrophoretic patterns of cellular protein spots in tumors after administration of mitomycin C].
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Electrophoresis, Polyacrylamide Gel; Female; Mice; Mice, | 1988 |
Background for and progress of an ongoing EORTC phase-II study in metastatic gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Fluorouracil; Humans; | 1988 |
[Two cases of obstructive jaundice due to advanced gastric cancer with marked response to the intravenous administration of cisplatinum].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Cisplatin; Female | 1988 |
[A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
Topics: Ascitic Fluid; Cisplatin; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; | 1988 |
[Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1988 |
[Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].
Topics: Combined Modality Therapy; Humans; Injections, Intraperitoneal; Mitomycin; Mitomycins; Stomach Neopl | 1988 |
[Hemolytic-uremic syndrome caused by mitomycin C].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hemolytic-Uremic Syndr | 1988 |
Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits.
Topics: Adsorption; Adult; Aged; Animals; Antineoplastic Agents; Carbon; Female; Humans; Intraoperative Peri | 1988 |
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Infusions, Parenteral; Lethal Dos | 1988 |
[Thermochemotherapy of cancer of the stomach].
Topics: Antineoplastic Agents; Humans; Hyperthermia, Induced; Mitomycin; Mitomycins; Stomach Neoplasms; Tega | 1988 |
[Extended treatment for gastric cancer patients with peritoneal seeding].
Topics: Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middl | 1988 |
[Morphologic evaluation of systemic chemotherapy for gastric cancer--using new criteria of the Research Society for Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Mitomycin; | 1988 |
[Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colonic Neoplasms; Cytarabine; Fe | 1988 |
[5-FU/ADR/MMC combined hepatic infusion in liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Doxorubicin; Drug Evaluation; Fem | 1988 |
[Preliminary results of a phase II study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Dr | 1987 |
[Medical decision in clinical oncology: the example of drug therapy of gastric cancer in the advanced stage during the last decade].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Fluorouracil; | 1987 |
Response of human monocyte phagocytosis to FAM (fluorouracil, adriamycin, mitomycin).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Humans; Mal | 1987 |
Chemotherapy of gastric cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Do | 1986 |
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carm | 1987 |
Chemotherapy for advanced gastric carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Mitomycin; Mitomy | 1986 |
Chemotherapy improves pulmonary function in a patient with gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hum | 1986 |
Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Huma | 1986 |
[Adjuvant chemotherapy in advanced stomach cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1986 |
Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fema | 1985 |
Preoperative chemotherapy in patients with gastric cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Doxoru | 1985 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabi | 1985 |
[Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorourac | 1985 |
[Preoperative cancer chemotherapy for gastric cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorou | 1985 |
[Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique].
Topics: Animals; Cell Line; Colonic Neoplasms; Colony-Forming Units Assay; Drug Synergism; Humans; Interfero | 1985 |
[Comparison of the cytotoxic effect of fresh garlic, diallyl trisulfide, 5-fluorouracil (5-FU), mitomycin C (MMC) and Cis-DDP on two lines of gastric cancer cells].
Topics: Allyl Compounds; Antibiotics, Antineoplastic; Cell Line; Cisplatin; Disulfides; Dose-Response Relati | 1985 |
Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice.
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromatography, | 1985 |
[A case of gastric cancer successfully treated with hyperthermo-chemo-radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; H | 1985 |
Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Diagnosis, Differential; Endoscopy; Epithelium; Female; Gastrec | 1985 |
[Colony assay for clinical application].
Topics: Adult; Agar; Aged; Antineoplastic Agents; Cell Count; Cell Division; Cells, Cultured; Colonic Neopla | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1985 |
[UFT, UFTM, and UFTM-Dpc treatment of gastric cancer].
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia L1210; Male; Mice; M | 1985 |
[Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].
Topics: Animals; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Drug Evaluatio | 1985 |
Combination of mitomycin C + etoposide in advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle | 1985 |
[Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma 256, Walker; Doxorubicin; Humans; | 1985 |
[Administration of mitomycin-C with an inactivator].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Drug Therapy, Combination; Humans; Lactates; L | 1985 |
[Combined therapy of gastric cancer].
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Emulsions; Gastrectomy; Humans; Hyperthermia | 1985 |
[Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer].
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Humans; Hyperthermia, Induced; Mitomycin; Mi | 1985 |
In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Colony-Forming Units Assay; | 1985 |
[Clinical application of local hyperthermia combined with antineoplastic agents].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents; Body Temperature; Cis | 1985 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |
Mononuclear phagocyte colony formation of human spleen cells in liquid culture.
Topics: Cell Adhesion; Cell Communication; Cell Count; Clone Cells; Colony-Stimulating Factors; Granulocytes | 1985 |
[Hypertensive chemotherapy of advanced gastric cancer].
Topics: Adult; Aged; Angiotensin II; Antibiotics, Antineoplastic; Blood Pressure; Combined Modality Therapy; | 1985 |
[Mitomycin C and cisplatin as single agents in the second-line treatment of advanced gastric cancer].
Topics: Adult; Aged; Cisplatin; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; S | 1985 |
[Effect of immunochemotherapy with levamisole on gastric cancer patients--three-year survival rates].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gast | 1985 |
Evaluation of treatment for gastric cancer with liver metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Evaluation Studies as Topic; Female; Fl | 1985 |
[A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
Topics: Adult; Aged; Animals; Antibiotics, Antineoplastic; Biliary Tract Neoplasms; Colonic Neoplasms; Colon | 1985 |
Immunochemosurgery for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modali | 1985 |
Sequential changes of nuclear DNA content caused by chemotherapy in experimental canine gastric cancer.
Topics: Animals; Cell Cycle; DNA, Neoplasm; Dogs; Endoscopy; Female; Male; Methylnitronitrosoguanidine; Mito | 1985 |